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The integral membrane protein sodium potassium adenosine triphosphate (Na-K-ATPase), has 
been extensively studied in various animal cell models. Na-K-ATPase is a multifunctional 
enzyme which plays a significant role in cellular physiology by regulating electrochemical 
potential, cell volume, pH, cytosolic calcium, and many nutrient and electrolyte transport 
processes. As such, it has been implicated in the pathogenesis of inflammatory bowel diseases 
(IBD) and has been shown to play a vital role in the malabsorption of nutrients and electrolytes. 
In this context, a significant amount of research has been done over the last two decades to 
understand the mechanisms of alteration of various nutrient absorptive processes in IBD. Though 
it has been well acknowledged that Na-K-ATPase plays an essential role in the alteration of 
nutrient absorptive mechanisms during inflammation of the intestine, the molecular mechanisms 
responsible for the modulation of Na-K-ATPase in IBD was not known. 
To study the regulation of Na-K-ATPase, we used an in vitro model (rat intestinal epithelial cell 
line, IEC-18 cells) of intestinal epithelial cells that matured from the crypt to villus cells, very 
similar to that seen in the mammalian system. During the maturation process, these cells show an 
increase in Na-K-ATPase activity to support the absorptive capacity of the villus cells. The 
increased activity of Na-K-ATPase was found to be likely due to phosphorylation of the α1 
subunit of Na-K-ATPase rather than altered transcription or trafficking of the enzyme.  
Numerous inflammatory mediators are produced during IBD; therefore, it is beneficial to 
uncover the role of individual inflammatory mediators in regulating transport processes regulated 
by Na-K-ATPase. We found that the inflammatory mediator leukotriene D4 (LTD4) stimulates 
the activity of Na-K-ATPase through a Ca-activated PKC pathway in crypt-like cells, while 
xviii 
prostaglandin E2 (PGE2) reduces the activity of Na-K-ATPase through cAMP-activated PKA 




CHAPTER 1: Na-K-ATPase 
1.1 GENERAL INTRODUCTION 
Over the last 60 years, since the discovery of Na-K-ATPase by Dr. Skou in 1957, the 
significance of Na-K-ATPase has increased tremendously (Skou, 1957). The goal of this 
introductory section is to provide some basic information on Na-K-ATPase before delving into 
its complexity. This membrane-bound protein, which belongs to the large family of P-type-
ATPases, transports three sodium ions (Na+) out and two potassium ions (K+) into all animal 
cells. Since transportation of these ions is against their gradients, the required energy is generated 
by catalyzing ATP. Conventionally, Na-K-ATPase is considered as a pumping protein that 
primarily maintains electrochemical potential, cell volume, cytosolic pH, and cytosolic Ca2+ 
level (Jorgensen, Hakansson, & Karlish, 2003; Skou, 1990; Skou & Esmann, 1992). 
Additionally, the pumping function also provides the essential gradient to drive secondary 
transport processes for transportation of other ions, nutrients, and neurotransmitters across the 
plasma membrane (Jorgensen et al., 2003; Skou, 1990; Skou & Esmann, 1992). However, within 
the last two decades, it has been demonstrated that in addition to the pumping function, Na-K-
ATPase also has a signaling role regulating various signaling pathways involved in cell 
proliferation, cell cycle, fibrosis, and cell adhesion (Contreras, Shoshani, Flores-Maldonado, 
Lazaro, & Cereijido, 1999; Nguyen, Wallace, & Blanco, 2007; Shapiro & Tian, 2011). Since Na-
K-ATPase has been demonstrated as an essential protein involved in cellular physiology, the 
abnormal function of Na-K-ATPase results in the pathological states or diseases such as 
hyperkalemia, cataracts (Babula, Masarik, Adam, Provaznik, & Kizek, 2013; Delamere & 
Tamiya, 2009; Suhail, 2010), hypertension (Lingrel, 2010; Matchkov & Krivoi, 2016; Therien & 
Blostein, 2000), and diabetes (Suhail, 2010).  
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1.2 STRUCTURE 
Na-K-ATPase is a multimeric protein consisting of three different subunits a, b, and g 
(Figure 1). There are tissue-specific isoforms of these subunits, and the combination of these 
isoforms yields the functional Na-K-ATPase (Jewell, Shamraj, & Lingrel, 1992). Each subunit 
has distinct mRNA and is synthesized independently (Geering, 1988).  
 
Figure 1: Schematic representation of Na-K-ATPase subunits in plasma membrane. (Figure 
adapted after the permission from Blanco et al. (Blanco & Mercer, 1998b)). 
1.2.1. The Alpha (a) Subunit 
The mass of the a subunit is ~112 kDa, having binding sites for ions, ATP, and cardiac 
glycosides. The a subunit, also known as the catalytic subunit of Na-K-ATPase, cleaves ATP to 
generate the energy required for the pumping of ions. This subunit consists of ten transmembrane 
a-helical segments and several cytoplasmic loops, in which both the N- and C-termini of the 
3 
chains reside inside the cytosol (Fambrough et al., 1994). The transmembrane domain is 
primarily the site of cation binding, specifically by transmembrane helices M4, M5, M6, and M8. 
However, helices M7, M9, and M10 anchor the a subunit to the membrane (Shinoda, Ogawa, 
Cornelius, & Toyoshima, 2009). Cytoplasmic regions are primarily known for ATP binding and 
are divided into three different domains: the A-actuator domain acts as a piston during the 
pumping activity of the Na-K-ATPase while passing through E1 and E2 stages, the P-
phosphorylation domain phosphorylates the enzyme, and the N-nucleotide binding domain binds 
the nucleotide as well as proteins including Src.   
1.2.2. The Beta (b) Subunit 
The b subunit by itself does not  play a role in pumping of ions but helps newly 
synthesized a subunit to fold correctly and integrate into the plasma membrane (Gatto, McLoud, 
& Kaplan, 2001; Geering, 2001). Additionally, the b subunit modulates the function of Na-K-
ATPase by changing the cation binding affinity (Laughery, Todd, & Kaplan, 2003). It has also 
been reported that this ~55 kDa subunit plays the role in forming cell-cell junctions (Geering, 
2008).  
Unlike a subunit, this subunit is a highly glycosylated protein, having two to four 
glycosylation sites. The number of glycosylation sites is specific to its isoform (Toyoshima, 
Kanai, & Cornelius, 2011). It has also been reported that these glycosylation sites regulate a-b 
dimer formation. The b subunit consists of three domains: the N-terminal cytoplasmic domain, 
one helical transmembrane domain, and the extracellular domain that interacts with the a-subunit 
(Toyoshima et al., 2011). Since the b subunit plays a role in stabilization of the a subunit and 
cation binding of the holoenzyme, abnormalities (mutation or deletion) of the b subunit have 
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created deleterious effects like hearing or sight loss in Drosophila, motor disabilities in mice, and 
polycystic kidney disease in humans (Wilson et al., 2000).  
1.2.3. FXYD (g) subunit 
The FXYD protein family is not required for the Na-K-ATPase function, but there are 
numerous pieces of evidence that this subunit plays an active role in the regulation of Na-K-
ATPase (Beguin et al., 1997; Jones, Davies, & Kidder, 1997). This protein subunit is found to 
explicitly modulate the kinetics of Na-K-ATPase by regulating the affinity of ions and ATP for 
the enzyme (Csupor, Csorba, & Hohmann, 2016; Klodos & Ottolenghi, 1975). The FXYD 
subunit also consists of three domains: the cytoplasmic domain that is primarily a 
phosphorylation site for different kinases (PKA and PKC), the helical transmembrane domain, 
and the N-terminal extracellular domain (Dey, Rahaman, Chakraborti, & Chakraborti, 2013). It 
has already been established that the extracellular domain interacts with Na-K-ATPase, thereby 
regulating its function. However, it is still unclear how the FXYD proteins change the binding 
capacities of Na+ and K+ and affect their kinetic properties. 
 
1.3. ISOFORMS OF Na-K-ATPase SUBUNITS 
There are several isoforms of each subunit. To date, there exist four isoforms of the a 
subunit, three isoforms of the b subunit, and seven isoforms of FXYD subunit, expressed 
differentially in mammals in a tissue-specific manner, as summarized in Table 1.  
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Table 1: Tissue distribution of Na-K-ATPase subunit isoforms.
Subunit 
Isoform 
Tissue  References 
a1 Kidney, Lung, Liver, 
Heart, Skeletal muscle, 
Thymus, Brain, Intestine, 
and Pineal gland 
(Fowles, Green, & Ouyang, 2004; He et al., 2001; Hundal, Marette, Ramlal, Liu, & Klip, 1993; 
Saha et al., 2015; Shyjan, Cena, Klein, & Levenson, 1990; Shyjan & Levenson, 1989; Sun & 
Ball, 1992; Sweadner, McGrail, & Khaw, 1992; Thompson & McDonough, 1996; Urayama, 
Shutt, & Sweadner, 1989) 
a2 Skeletal muscle, Cardio 
myocytes and Brain 
(Fowles et al., 2004; He et al., 2001) 
a3 Brain and pineal gland (Shyjan et al., 1990; Shyjan & Levenson, 1989; Urayama et al., 1989) 
a4 Testis / reproductive cells (Blanco, Sanchez, Melton, Tourtellotte, & Mercer, 2000; Shamraj & Lingrel, 1994; Woo, James, 
& Lingrel, 2000) 
b1 Kidney, Lung, Liver, 
Heart, Skeletal muscle, 
Intestine and Brain 
(He et al., 2001; Hundal et al., 1993; Saha et al., 2015; Shyjan et al., 1990; Shyjan & Levenson, 
1989; Sun & Ball, 1992; Sweadner et al., 1992; Thompson & McDonough, 1996; Urayama et al., 
1989; Woo et al., 2000) 
b2 Skeletal muscle, Thymus, 
Pineal gland and Brain 
(Blanco et al., 2000; Fowles et al., 2004; He et al., 2001; Hundal et al., 1993; Shamraj & Lingrel, 
1994; Shyjan et al., 1990; Sun & Ball, 1992; Thompson & McDonough, 1996; Woo et al., 2000) 
b3 Lung, Liver, Skeletal 
muscle and Testis 
(Blanco et al., 2000; Fowles et al., 2004; He et al., 2001; Hundal et al., 1993; Shamraj & Lingrel, 
1994; Shyjan et al., 1990; Sun & Ball, 1992; Thompson & McDonough, 1996; Woo et al., 2000) 
FXYD1 Heart and Skeletal muscle (Bell et al., 2008; Geering, 2006; Lubarski, Pihakaski-Maunsbach, Karlish, Maunsbach, & Garty, 
2005; Sweadner & Rael, 2000) 
FXYD2 Kidney (Geering, 2006; Jones et al., 2005; Lubarski et al., 2005; Sweadner & Rael, 2000) 
FXYD3 Intestine, Stomach (Geering, 2006; Lubarski et al., 2005; Sweadner & Rael, 2000) 
FXYD4 Kidney (Geering, 2006; Goldschmidt et al., 2004; Lubarski et al., 2005; Sweadner & Rael, 2000) 
FXYD5 Testis, Intestine (Geering, 2006; Lubarski et al., 2005; Sweadner & Rael, 2000) 
FXYD6 Brain (Geering, 2006; Lubarski et al., 2005; Sweadner & Rael, 2000) 
FXYD7 Brain (Geering, 2006; Lubarski et al., 2005; Sweadner & Rael, 2000) 
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1.4. PUMPING MECHANISM OF Na-K-ATPase 
The current understanding of how the pumping mechanism of Na-K-ATPase works is 
mostly based on the earlier studies. In the 1960s, Post and Albers postulated the principle 
mechanism for the pumping activity of Na-K-ATPase, which has been the framework for 
numerous investigations until now (Albers, 1967; Post, Sen, & Rosenthal, 1965). According to 
Post and Albers, Na-K-ATPase exists in two conformation states, E1 and E2. These states are 
influenced by interaction with Na+, K+, ATP, and other cardiac glycosides, such as Ouabain, and 
they lead to the formation of different intermediates, as shown in Figure 2.  
 
Figure 2: Post-Albers’ model for the Na-K-ATPase pump cycle. Figure reproduced from 
(Kaplan, 2002). 
The pumping mechanism of Na-K-ATPase can be explained in various steps. First, when 
the enzyme is in E1 conformation, it binds to 3Na+ and ATP with high affinity in the cytoplasmic 
domain of the enzyme, forming E1ATP3Na. Binding of 3Na+ to this orientation leads to the 
phosphorylation of the enzyme, which in turn forms E1P-ADP3Na. The occluded ADP is 
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detached from the E1 state, and now the binding site of Na reorients itself to the extracellular 
side, forming the E2 state (E2P(3Na)). Three Na+ are released extracellularly, leaving the E2 state 
with a phosphate (E2P). In the E2P conformation, Na-K-ATPase binds two K+ with high affinity, 
forming E2P2K. The K+ binding induces the dephosphorylation of the enzyme by releasing Pi 
intracellularly, forming the better binding of two K+. At this state, (E2(2K)) attaches ATP with 
low affinity intracellularly and reorients the K+ binding site to the cytoplasmic domain forming 
E1ATP2K. The binding of ATP induces E1 conformation and triggers the release of K+ into the 
cells. Thus, releasing two K+ into the cells, Na-K-ATPase returns to the same conformation 
E1ATP, which is reactivated to pursue the next cycle. Inhibitory molecules such as cardiotonic 
steroids (Ouabain) can bind to Na-K-ATPase on its extracellular site (E2P conformation) 
irreversibly.  
Despite the robust evidence that most of the steps in Post and Albers scheme are crucial 
to the Na-K-ATPase pumping activity, there are controversies regarding the sub-steps of the 
reaction cycle (Kaplan, 2002) and whether the functional unit of the enzyme is an ab-protomer 
or an oligomer (Dey et al., 2010; Repke & Schon, 1973; Vilsen, Andersen, Petersen, & 









1.5. Na-K-ATPase AS A SIGNALING MOLECULE 
Any modulation in the Na-K-ATPase activity by extrinsic or intrinsic factors alters the 
physiological state of cells. Hence, the inhibition of the Na-K-ATPase activity leads to changes 
in intracellular ion homeostasis primarily by increasing intracellular sodium [Na+]i. This buildup 
of  [Na+]i leads to changes in intracellular pH via Na+/H+ exchanger, and intracellular calcium 
[Ca2+]i via Na+/Ca2+ exchanger (Blaustein, 1993). Such alterations in ions’ dynamics in cells 
affect the cellular physiology inducing various signaling processes. 
 
Figure 3: Schematic representation of Na-K-ATPase-mediated signaling through protein 
interaction. EGFR- Epidermal growth factor receptor, PLC- Phospholipase C; PKC- Protein 
kinase. (Figure reproduced from (Cui & Xie, 2017)).  
Low doses of ouabain lead to the activation of classical signaling pathways such as ERK 
(Extracellular signal-regulated kinases) and Src pathways. It has been reported that Na-K-
ATPase has been linked with Src protein, forming the Na-K-ATPase-Src complex (Abram & 
Courtneidge, 2000; Brown & Cooper, 1996). Src, a non-receptor tyrosine kinase, phosphorylates 
various tyrosine-mediated downstream signaling pathways. One of the classical pathways 
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activated by Src tyrosine kinase is the phosphorylation of epidermal growth factor receptors, 
which in turn activates downstream signals such as the activation of the Ras/Raf/MEK/ERK 
pathway, and the production of reactive oxygen species (ROS) (Boscher & Nabi, 2012; Wu et 
al., 2013; Yuan et al., 2005). These pathways indeed affect the proliferation, differentiation, 
migration, and metabolism of cells resulting in various pathophysiological alterations.  
Moreover, Na-K-ATPase has also been associated with various other proteins like PI3K 
(Phosphoinositide 3-kinase), PLC (Phospholipase C), IP3R (Inositol triphosphate receptor), and 
caveolin-1. Interaction of such proteins with Na-K-ATPase creates a series of signal transduction 
pathways, which are collectively named as ‘signalosome’ in caveolae (Blanco, Sanchez, & 















1.6. REGULATION OF Na-K-ATPase  
Na-K-ATPase, a regulatable enzyme, is considered to be regulated both short-term and 
long-term depending upon the stimulus. Short-term regulation typically involves either 
modulation in kinetic properties of the enzyme or alteration in the trafficking of Na-K-ATPase 
from the cytoplasm to the plasma membrane (Therien & Blostein, 2000). The long-term 
regulation of Na-K-ATPase, on the other hand, generally affects the synthesis and degradation of 
Na-K-ATPase (Therien & Blostein, 2000). There is a considerable amount of investigation 
indicating that Na-K-ATPase is regulated by various intrinsic and extrinsic factors. Various 
extrinsic factors like inflammatory mediators, hormones, neurotransmitters, and cardiotonic 
steroids modulate Na-K-ATPase activity. Also, Na-K-ATPase is intrinsically regulated through 
phosphorylation and dephosphorylation reactions by kinases and phosphatases respectively, 
which are in turn stimulated by extrinsic factors and intracellular second messengers (Aperia, 
1995; Bertorello & Katz, 1993). 
The phosphorylation-mediated regulation of Na-K-ATPase is primarily carried out by 
protein kinase C (PKC), protein kinase A (PKA), and protein tyrosine kinases (PTKs). These 
protein kinases directly or indirectly regulate the activity of Na-K-ATPase. The direct regulation 
of Na-K-ATPase activity is through phosphorylation of its subunits (a and g), whereas indirect 
regulation of Na-K-ATPase involves the signaling of various pathways that affect the 
transcription factor associated with regulating gene expression of the Na-K-ATPase.  
1.6.1. PKC-mediated Na-K-ATPase regulation 
There are contradictory reports suggesting that the activation of PKC results in the 
stimulation or inhibition of Na-K-ATPase activity depending upon cell type and experimental 
conditions. One study reported that dopamine reduced Na absorption by inhibiting Na-K-ATPase 
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activity in proximal tubule cells and the reduction in activity was mediated by PKC (Aperia, 
1995; Bertorello & Katz, 1993). According to a different study, the same hormone increased Na-
K-ATPase activity in pulmonary epithelial cells and the stimulation was also through PKC 
(Barnard et al., 1999; Bertorello, Ridge, Chibalin, Katz, & Sznajder, 1999). Additionally, another 
study done by Efendiev et al. suggests that the ultimate activity of Na-K-ATPase is PKC 
isoform-dependent (Efendiev, Bertorello, & Pedemonte, 1999). Therefore, the effect of PKC on 
Na-K-ATPase activity has been suggested to be cell- and tissue-specific.  
Studies performed by Pedemonte et al. and Feraille et al. suggest that stimulation of PKC 
by PMA (phorbol 12-myristate 13-acetate) stimulated the activity of the Na-K-ATPase (Feraille 
et al., 1995; Pedemonte, Pressley, Cinelli, & Lokhandwala, 1997; Pedemonte, Pressley, 
Lokhandwala, & Cinelli, 1997). The increase in the activity of Na-K-ATPase was due to the 
translocation of Na-K-ATPase to the membrane. Another study by Efendiev et al reported that 
mutation in Ser16 (analogous to Ser11-after posttranslational modification) and Ser23 (analogous to 
Ser18-after posttranslational modification) of the a subunit was unable to produce the PMA-
mediated stimulation of Na-K-ATPase, suggesting the N terminus Ser11 and Ser18 are the 
phosphorylation sites for PKC (Efendiev et al., 2000). In contrast, dopamine inhibited the Na-K-
ATPase in renal proximal tubule cells and opossum kidney cells. The reduction of enzyme 
activity was mediated through PKC phosphorylation of the a subunit at Ser18 causing Na-K-
ATPase at the plasma membrane to translocate into the cytoplasmic compartment (Chibalin, 
Katz, Berggren, & Bertorello, 1997; Chibalin et al., 1999; Chibalin, Pedemonte, et al., 1998; 
Chibalin, Zierath, Katz, Berggren, & Bertorello, 1998).  
On the other hand, various transcription factors also regulate the activity of Na-K-
ATPase. These factors are specific to the subunits and isoforms of Na-K-ATPase (Li & 
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Langhans, 2015). One of the studies done by Galuska et al. reported that stimulation of renal 
tubular cells with C-peptide increases the activity of Na-K-ATPase. Increase in enzyme activity 
was due to increased expression of a1 subunit by activation of transcription factor ZEB through 
PKC and MAPK (Microtubule associated protein kinase) pathways (Galuska et al., 2011).  
1.6.2. PKA-mediated Na-K-ATPase regulation 
Similar to PKC-mediated regulation of Na-K-ATPase, there are also conflicting reports 
suggesting that there is inhibition (Bertorello, Aperia, Walaas, Nairn, & Greengard, 1991), 
activation (Cornelius & Logvinenko, 1996), or no effect on Na-K-ATPase activity (Cornelius & 
Logvinenko, 1996; Feschenko & Sweadner, 1994) by PKA. A possible justification to these 
contradictions is phosphorylation of different isoforms of the a subunit by PKA. This 
justification was further corroborated by the study conducted in insect cells (Sf-9), where all 
isoforms of the a subunit are expressed. In this study, an endogenous activation of PKA in SF-9 
cells activates a3b1 isoenzyme but inhibits a1b1 and a2b1 isoenzyme (Blanco, Sanchez, & 
Mercer, 1998). Unlike PKC phosphorylation, PKA targets phosphorylation of the serine residue 
present in the C terminus of a subunit, specifically Ser943 (Beguin et al., 1994; Feschenko & 
Sweadner, 1994; Fisone et al., 1994).  
1.6.3. PKG-mediated Na-K-ATPase regulation 
Similar to the PKA- and PKC-mediated regulation, protein kinase G (PKG) also regulates 
Na-K-ATPase activity in a tissue- and isoform-specific manner. It has been reported that there is 
a cyclic guanosine monophosphate (cGMP)-mediated decrease in Na-K-ATPase in the kidney 
(McKee, Scavone, & Nathanson, 1994; Scavone, Scanlon, McKee, & Nathanson, 1995). The 
reduced enzyme activity is primarily due to decreased expression of the a1 subunit. However, in 
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another study, there is a marked increase of Na-K-ATPase in Purkinje neurons, due to increased 
expression of Na-K-ATPase a3 subunit (Nathanson, Scavone, Scanlon, & McKee, 1995). 
1.6.4. Tyrosine kinase-mediated regulation of Na-K-ATPase 
Besides activation of the tyrosine kinase signaling cascade as discussed above, tyrosine-
protein kinase (Sarcoma (Src)) also phosphorylates the tyrosine residue at Tyr10 (analogous to 
Tyr5-after posttranslational modification) of the a subunit, resulting in an increase in enzyme 
activity (Chibalin et al., 1999). Studies on skeletal muscle stimulation by insulin (Chibalin et al., 
2001), and in kidney proximal tubules where dopamine-like receptor are stimulated (Narkar, 
Hussain, & Lokhandwala, 2002) have shown increased tyrosine phosphorylation resulting in 
increased Na-K-ATPase activity. Other studies have reported that an increased tyrosine 
phosphorylation of Na-K-ATPase α1, by inhibiting protein tyrosine phosphatase (PTP) on 
human and pig renal cells, reduces the activity of Na-K-ATPase (El-Beialy et al., 2010) 
1.6.5. FXYD-mediated regulation of Na-K-ATPase 
FXYD is a signal transmembrane protein composed of an extracellular -N terminus and a 
cytoplasmic-C terminus (Dey et al., 2013). A specific domain at the N-terminus interacts with 
Na-K-ATPase and hence regulates the activity of Na-K-ATPase, whereas the -C terminus 
consists of phosphorylation sites (Dey et al., 2013). To date, there are at least 12 different 
members of FXYD expressed differentially in a cell- and tissue-specific manner. FXYD family 
proteins are expressed in a wide array of tissues including kidney, colon, pancreas, heart, and 
skeletal muscle (J. Y. Cheung et al., 2010). Also, due to the presence of phosphorylation sites in 
the C-terminus, FXYD proteins are subject to phosphorylation by different protein kinases 
(Cornelius & Mahmmoud, 2007; Cortes, Ribeiro, Barrabin, Alves-Ferreira, & Fontes, 2011; 
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Mounsey et al., 2000). Moreover, phosphorylation of FXYDs by kinases modulate the activity of 
Na-K-ATPase.  
1.6.6. Transcriptional regulation of Na-K-ATPase 
The Na-K-ATPase expression is modulated by various factors including hormones, 
growth factors, lipids, transcription factors, and extracellular stimuli. These factors modulate the 
expression by transcriptionally regulating the subunits of Na-K-ATPase. In the current study, the 
focus is on the regulation of a1 and b1 subunit.  
1.6.6.1. Transcriptional regulation of Na-K-ATPase a1 subunit 
ATP1A1 is the gene responsible for transcribing the a1 subunit. It contains a TATA box 
(M. M. Shull, Pugh, & Lingrel, 1990), two mineralocorticoid/glucocorticoid response element 
(MRE/GRE) sites (Kolla, Robertson, & Litwack, 1999), binding sites for AP-1, AP-2, AP-3 (M. 
M. Shull et al., 1990), SP1 and CTF/NF-1 binding site (M. M. Shull et al., 1990). Additionally, 
ATF/CRE binding site is also found in the promoter region of ATP1A1 (Kobayashi & 
Kawakami, 1995). 
Specificity protein (SP) consists of various transcription factors: Sp1, Sp2, Sp3, and Sp4. 
Among these SP transcription factors, Sp1, Sp3, and Sp4 had been shown to increase 
transcription of the a1 subunit (Johar, Priya, & Wong-Riley, 2012; M. M. Shull et al., 1990). 
Another transcription factor is cAMP response element binding protein family (CREB), 
Phosphorylation of CREB by cAMP has been shown to increase transcription of the a1 subunit 
(Dagenais et al., 2001). Similarly, phosphorylation of activating transcription factor 1 (ATF-1) 
also transcriptionally upregulate the a1 subunit (Kobayashi, Shimomura, Hagiwara, & 
Kawakami, 1997). The zinc finger E-Box Binding Homeobox 1 (ZEB1/AREB6) also bind to the 
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promoter region of ATP1A1 and stimulates the transcription of a1 subunit in a tissue-specific 
manner (Watanabe, Kawakami, Hirayama, & Nagano, 1993).  
1.6.6.2. Transcriptional regulation of Na-K-ATPase b1 subunit 
The b1 subunit is encoded by the gene ATP1B1 and has been widely studied among all 
other subunits. The ATP1B1 gene consists various transcription factors binding sites: three 
MRE/GRE half-sites (Derfoul, Robertson, Lingrel, Hall, & Litwack, 1998), four E-boxes 
(Espineda, Chang, Twiss, Rajasekaran, & Rajasekaran, 2004), one NF-1 (Espineda et al., 2004), 
three prostaglandin response elements (PGRE) (Matlhagela, Borsick, Rajkhowa, & Taub, 2005; 
Matlhagela & Taub, 2006b), a hypoxia response element (HRE) (Mony, Lee, Harper, Barwe, & 
Langhans, 2013), Smad binding domain (SBD) (Mony et al., 2013), three thyroid response 
elements (TRE) (Feng, Orlowski, & Lingrel, 1993), three progesterone element (PRE) half sites 
(Cochrane et al., 2012), several Sp1 binding sites (Matlhagela et al., 2005; Matlhagela & Taub, 
2006b), and a Cebpb binding sites (Deng et al., 2013). Moreover, the TATA box of ATP1B1 also 
consist of calcium and serum response elements (Liu & Gick, 1992).  
Similar to the a1 subunit, the b1 subunit is also transcriptionally upregulated by Sp1, 
Sp3, and Sp4 in murine neurons by binding to their promoter regions (Johar et al., 2012). Cebpb 
also increases the b1 subunit in human epithelial cells by binding to the CCAT box (Deng et al., 
2013). Beside transcriptional upregulation of the b1 subunit, it is transcriptionally repressed by 
Snail protein by binding to the E-box on the promoter region (Espineda et al., 2004). Another 
transcription factor that represses the b1 subunit is hypoxic-inducible factor-1(HIF-1), which 
suppress the transcription of the b1 subunit by binding to a HRE (Hypoxia response element) 
(Mony et al., 2013).  
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CHAPTER 2: THE GASTROINTESTINAL TRACT AND ROLE OF EICOSANOIDS  
2.1. THE GASTROINTESTINAL TRACT 
Every day the human gastrointestinal (GI) tract processes 8 to 10 liters of fluid which is 
taken orally or secreted inside the intestine every day. Because of the robust absorption 
mechanism in the GI tract it only eliminates 100 to 200 mL of fluid waste each day (Kiela & 
Ghishan, 2016). Along with fluid secretion and absorption, the GI tract also extracts nutrients, 
vitamins, and minerals that are ingested as food material, and provides a barrier against harmful 
pathogens and toxins (Kiela & Ghishan, 2016). The process of absorption, secretion and defense 
mechanism go hand-in-hand in normal homeostatic conditions. The multiplicity of GI activity is 
only possible due to the unique tissue, cellular, and molecular architecture of the small and large 
intestine (Figure 4), as well as in combination with other regulatory mechanisms. Regulation of 
GI activity includes the complex crosstalk between endocrine and paracrine hormones, 
neurotransmitters, immunomodulators, and luminal factors (Kumral & Zfass, 2018; Track, 
1980).   
2.1.1. Intestinal architecture  
The structure of the small intestine gives an advantage for proper absorption of nutrients, 
electrolytes, and fluids. The cylindrical small intestine consists of special structural features such 
as circular folds (plicae circulares), villus-crypt architecture, and microvilli, which amplify the 
absorption process by increasing the surface area about 600-fold (Hilton, 1902; Walton, 
Mishkind, Riddle, Tabin, & Gumucio, 2018). However, the large intestine, which generally lacks 
these structural features, is only efficient to reabsorb fluid and some fatty acids.      
The small intestine has the ability to multitask, for which it needs a variety of cells, 
including enterocytes (nutrient absorption), goblet cells (mucus secretion), Paneth cells (defensin 
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production against antimicrobial agents) and enteroendocrine cells (Barker & Clevers, 2010). All 
these cell lineages are derived from the stem cells which lie in the pit known as the crypt. Stem 
cells divide into rapidly proliferating transit-amplifying cells, which subsequently arise from the 
crypt and start to differentiate and begin to express differentiation markers for three lineages: 
enterocytes, enteroendocrine and goblet cells (Barker & Clevers, 2010). These cells are fully 
differentiated as they reach the crypt-villus junction. These cells move along the crypt-villus axis 
as they grow and mature and eventually undergo apoptosis and slough off from the tip of the 
villus (Barker, van de Wetering, & Clevers, 2008; van der Flier & Clevers, 2009). The whole 
process from the origin of the cell to its death takes about 3 to 5 days (Tesori, Puglisi, Lattanzi, 
Gasbarrini, & Gasbarrini, 2013).     
 
Figure 4: Schematic diagram of small intestine architect including crypt and villus cells. 
 
Some stem cells differentiate into Paneth cells that migrate to the bottom of the crypts. 
However, the intestinal lining mostly consists of enterocytes that help to absorb nutrients from 
the lumen. These enterocytes, while growing from immature crypt cells to fully mature 
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absorptive villus cells, have various morphological and physiological alterations. Therefore, 
depending on the position of enterocytes along the crypt-villus axis, there is a differential 
expression of transport proteins. Most of the transporters (Na-nutrient, NHE3 (Na-hydrogen 
exchanger) and SLC26A6) are accrued while moving towards the villus, whereas transporters 
like CFTR (Cystic fibrosis transmembrane conductance regulator) exhibit a greater density in the 
base of the crypt. However, some of the transporters are expressed equally throughout the crypt-
villus axis (Field, 2003; S. K. Singh, Binder, Boron, & Geibel, 1995).  
2.1.2. Epithelial cell model  
The monolayer of enterocytes in the small intestine provides a semipermeable barrier and 
separates two distinct compartments, outer mucosal (lumen) and inner serosal (blood-side) 
(Schneeberger, Roth, Nieuwenhuis, & Middendorp, 2018). All enterocytes from the small 
intestine to the colon (colonocytes) share a common topography. Enterocytes are polarized 
epithelial cells with morphologically and molecularly distinct apical (brush border or luminal) 
and basolateral (serosal) membranes (Figure 5). Enterocytes are adhered together from the lateral 
side by junctional proteins (such as tight junctions, 
adheren junctions, and desmosomes proteins) (Anderson 
& Van Itallie, 1995; Giepmans, 2004; Marchiando, 
Graham, & Turner, 2010). Tight junction permeability is 
relatively leaky towards the small intestine, whereas very 
tight towards the colon (Field, 2003). 
 
 
Figure 5: Typical small intestine epithelial cell. 
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Enterocytes acquire distinct polarized characteristics specifically by inserting transporters 
into the brush border or basolateral membrane. Intracellular trafficking processes, cytoskeletal 
and protein-sorting signals interact synergistically to direct de novo proteins to either the brush 
border or basolateral membrane (Apodaca, 2001; Massey-Harroche, 2000). Generally, 
glycosylphosphatidylinositol (GPI) anchors (e.g., alkaline phosphatase) are associated with lipid 
rafts, and the GPI anchor targets newly synthesized proteins to the apical membrane (Alberts, 
Johnson, & Lewis, 2007). Specific membrane-sorting signals (amino acid sequences) in the 
cytoplasmic tail direct proteins to the basolateral membrane. Proteins lacking the membrane 
sorting signal and GPI anchor are arbitrarily inserted into either the brush border or basolateral 
membrane. Finally, the intracellular trafficking regulation ensures delivery of the right protein to 
the right membrane (Schneeberger et al., 2018). All these processes mentioned above are major 
factors that contribute to the development of polarized epithelial cells and thus support nutrient 
and electrolyte transport. There is variation in the intestinal transport system, along the 
cephalocaudal length of intestine and along the crypt-villus axis within the specific segment.  
2.1.3. Na-dependent transporters in the intestine 
Various transporters present in the membrane of the enterocytes facilitate its absorptive 
capacity. These transporters might be present on any side of the enterocytes. Some of them are 
coupled transporters, which transport two substrates at a time; whereas others are not, as they 
transport only a single substrate. Among coupled transporters, we are mostly focused here on 
Na-dependent transporters that are present in the brush border membrane of enterocytes and help 
in the absorption of nutrients and electrolytes. Some of the Na-dependent transporters present in 
the brush border membrane of enterocytes are Na-amino acids [Na-glutamine (B0AT1), Na-
alanine (NAcT)], Na-glucose (SGLT1), and Na-bile acid. All these Na-dependent transporters 
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perform perfectly only when there is an optimum Na+ gradient maintained between the lumen 
and enterocytes. Therefore, Na-K-ATPase, a basolateral membrane protein maintains the Na+ 
gradient that is necessary to drive Na-dependent transporters.  
2.2. EICOSANOID BIOSYNTHESIS  
2.2.1. Arachidonic acid synthesis 
The lipolytic enzyme known as phospholipase A2 (PLA2) catalyzes the hydrolysis of cell 
membrane phospholipids into free fatty acids and a lysophospholipid. PLA2 is a member of a 
superfamily of enzymes consisting of various classifications.  PLA2 has been broadly classified 
 
Figure 6: Major pathways of arachidonic acid metabolism. Figure reproduced from (Harizi, 
Corcuff, & Gualde, 2008). 
into three types: secretory (sPLA2), cytosolic Ca2+-dependent (cPLA2), and cytosolic Ca2+-
independent (iPLA2) (Balsinde, Winstead, & Dennis, 2002). This systematic classification has 
been based on various properties such as their amino acid sequences (Dennis, 1994; Six & 
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Dennis, 2000), and specificity to the substrate and catalytic function (Balsinde et al., 2002). In 
response to various stimuli such as cAMP, intracellular Ca2+ and other responses, PLA2 releases 
20-carbon free fatty acid derivative known as arachidonic acid (AA) from the phospholipid, as 
shown in Figure 6. Different eicosanoids products, including prostaglandins (PGs), leukotrienes 
(LTs) and lipoxins are generated from this free-formed AA (Smith, DeWitt, & Garavito, 2000).  
2.2.2. Arachidonic acid metabolism  
Released arachidonic acids are metabolized into various eicosanoids products primarily 
through three major oxidative pathways: cyclooxygenase, lipoxygenase, and cytochrome P450 
pathways, which are explained below (Figure 6) (Moskowitz, Shapiro, Schook, & Puszkin, 
1983).  
2.2.2.1. Prostaglandin biosynthesis 
Different kinds of PGs are produced by the enzyme cyclooxygenase, thus named the 
cyclooxygenase pathway. Cyclooxygenase exists into two isoforms; cyclooxygenase-1 (COX-1) 
and cyclooxygenase-2 (COX-2) (Mohajer & Ma, 2000). These enzymes catalyze the oxidation of 
AA into PGG2 by inserting two oxygen molecules. The reduction of PGG2 converts it into 
PGH2, which is further converted to other eicosanoids including prostaglandins (PGE2, PGD2, 
PGF2), thromboxanes (TXA2, TXB2) and prostacyclin (PGI2) (DuBois, Eberhart, & Williams, 
1996). COX-1, known as constitutive cyclooxygenase, basically maintains the mucosal integrity 
by performing under the basic homeostatic conditions. However, COX-2 is expressed in 
response to extrinsic or intrinsic stimuli; therefore the enzyme is named as inducible 
cyclooxygenase (DuBois et al., 1996). COX-2 has been observed as a key player to initiate PGs 
involved inflammation, resulting in swelling and pain (Mitchell & Evans, 1998), as well as 
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participating in housekeeping functions (DuBois et al., 1996). These COX enzymes are the target 
of various nonsteroidal inflammatory drugs (NSAIDs) for reducing inflammation.  
2.2.2.2. Lipoxygenase biosynthesis 
Lipoxygenase enzyme catalyzes the conversion of AA to various 
hydroperoxyeicosateraenoic acids (HPETEs) and hydroxy eicosatetraenoic acids (HETEs) by 
inserting one molecule of oxygen into AA (Lewis, Austen, & Soberman, 1990). 5-HETEs are 
converted to LTA4 and subsequently converted to cysteinyl LTs (LTC4, LTD4, LTE4), LTB4, 
and lipoxins (LXA4, LXB4). Similarly, 15-HPETEs are also converted to lipoxins (LXA4, 
LXB4) (Harizi & Gualde, 2005). 
2.2.2.3. Cytochrome P450 pathways 
The cytochrome P450 epoxygenase pathway catalyzes the formation of epoxides and 













2.3. EICOSANOIDS IN CELLULAR SIGNALING  
Eicosanoids produce various physiological alterations by binding to membrane receptors. 
Binding with different receptors can result in various 
changes, including increase or decrease in cytosolic 
secondary messengers (cAMP, Ca2+), stimulation of 
specific protein kinases, and changes in membrane 
potential, subsequently modulating the physiological 
state (Harizi et al., 2008) (Figure 7). Here, we will focus 
on PG and LT signaling because of their importance in 
the small intestine and its pathophysiological state.  
 
Figure 7: Canonical pathway for eicosanoids signaling 
 
2.3.1. Prostaglandin receptor signaling  
PGs are secreted endogenously or during pathophysiological conditions, and mediate 
their action by binding to specific membrane surface G-protein-coupled receptors (GPCRs) 
(Dore, 2011; Liu, Qu, & Yan, 2015). To date, there exist at least nine prostanoid receptors in 
mice and humans, as well as other splice variants (Narumiya & FitzGerald, 2001). Among these 
nine receptors, four of the receptors (EP1, EP2, EP3, and EP4) bind to PGE2, two (DP1 and DP2) 
bind to PGD2, FP specifically binds to PGF2a, and two bind to prostacyclin and thromboxane 
(Hirai et al., 2001; Monneret, Gravel, Diamond, Rokach, & Powell, 2001). These receptors are 
further classified into four different categories based on the specific isoform of G protein 
involved in signaling. The first group, DP1, EP2, and EP4 receptors exert signaling through Gs-
mediated intracellular cAMP. EP2 and EP1 receptors are a second group that signal through Gq-
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mediated intracellular Ca2+. EP3 falls into the third category, which regulates adenyl cyclase 
activity through activation of Gi and Gs proteins. Unlike other receptors, the last group DP2 is a 
member of a chemoattractant receptor family (Harizi et al., 2008; Hirai et al., 2001; Monneret et 
al., 2001). Prostanoid receptors are mostly localized to the plasma membrane; however some are 
found at the nuclear membrane as well (Bhattacharya et al., 1998; Bos, Richel, Ritsema, 
Peppelenbosch, & Versteeg, 2004).  
2.3.2. Leukotriene receptor signaling 
LTs mediate signaling through four different kinds of GPCR. The first, BLT1, known as 
a high-affinity LTB4 receptor, mediates signaling through cGMP via guanylyl cyclase. It also 
mediates signaling through Gq and Gi (Yokomizo, Izumi, Chang, Takuwa, & Shimizu, 1997; 
Yokomizo, Kato, Terawaki, Izumi, & Shimizu, 2000). The second, BLT2, reported as a low-
affinity LTB4 receptor, signals through Gq. The other two subtypes, CysLT1 and CysLT2, are 
cysteinyl-LT receptors that are targeted by LTC4 and LTD4. CysLT1 is activated explicitly by 











2.4. ROLE OF EICOSANOIDS IN THE SMALL INTESTINE 
2.4.1. Eicosanoids in intestinal secretion 
Large volumes of fluid are secreted into the lumen of the small intestine during digestion. 
However, these fluids are reabsorbed back into the body. Fluids are secreted either by an 
increase in luminal osmotic pressure or by PG-induced secretion. The mechanism by which a 
PG-induced intestinal fluid secretion is mediated is through intracellular secondary messengers 
such as cAMP, Ca2+, and acetylcholine. These secondary messengers induce intestinal secretion 
by stimulating chloride and bicarbonate secretion and inhibiting sodium and chloride absorption 
(Diener, Bridges, Knobloch, & Rummel, 1988a, 1988b; Powell, 1986; Racusen & Binder, 1980; 
Rask-Madsen, Bukhave, & Lauritsen, 1988).  
Various in vitro and in vivo studies reported that PG stimulates intestinal secretion 
(Diener et al., 1988a, 1988b; Rask-Madsen et al., 1988). In rats, when PGE2 was administered 
orally, it induced fluid secretion (Ruwart, Klepper, & Rush, 1979). Similarly, when PGE2 and 
PGF2 were administered intravenously, they produced a secretory effect (Milton-Thompson, 
Cummings, Newman, Billings, & Misiewicz, 1975). Like in other studies in which PG perfusion 
was performed in different segments of animals (Canine jejunum, Rat jejunum and Cat ileum), it 
yielded fluid secretion (Gaginella, 1990). The fluid secreted was rich in chloride but low in 
calcium and sodium. In contrast, when PG synthesis was reduced by blocking COX with a 
nonspecific COX inhibitor (indomethacin), it resulted in decreased fluid secretion (Ruwart et al., 
1979). This gives us the premise that reduction of PG endogenously may reduce the fluid 
secretion in the small intestine.  
As shown in Figure 7, secondary messengers when activated induce protein kinases, 
which subsequently induce the phosphorylation of specific substrate proteins present in the 
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cytoplasm or cell membrane. These activated substrate proteins urge apical membrane anionic 
channels to open, resulting in secretion of chloride and bicarbonate anions into the lumen of the 
small intestine (Diener et al., 1988a; Rask-Madsen et al., 1988). Thus, the secretion of chloride 
ions creates an electrochemical gradient between serosal and mucosal layers, where the serosal 
layer lacks anions and the mucosal layer is rich in anions. The electrochemical gradient thus 
produced withdraws positively charged Na+ and water into the lumen through a paracellular 
route, resulting in net fluid secretion in the lumen (Gaginella, 1990; Robert, Nezamis, Lancaster, 
Hanchar, & Klepper, 1976; Turnberg, 1991).  
Additionally, PG-mediated fluid secretion is also regulated through central and peripheral 
nervous systems. PG induces the myenteric ganglia and cholinergic nerve terminal to produce 
acetylcholine, which activates muscarinic receptors on enterocytes to increase the influx of Ca2+ 
into the cytoplasm. Thus, this increased Ca2+ stimulates Cl- secretion in the lumen (Ehrenpreis, 
1981; Keast, 1987).  
2.4.2. Eicosanoids in epithelial barrier   
The monolayer of intestinal epithelial cells forms a cellular barrier that prevents harmful 
pathogens, toxins, and immunogenic substances from reaching the subepithelial tissue. The 
epithelial layer consists of a lipid bilayer at the apical membrane and tight junction (TJ) proteins 
at the lateral surface (Figure 8), which obstruct such harmful molecules from reaching into the 
systemic circulation (Anderson & Van Itallie, 1995; Madara, 1989). Although enterocytes form 
the structural barrier, they also transport all molecules through two major pathways: transcellular 
pathway - transport of molecules through the apical plasma membrane, and paracellular 
pathway- transport of molecules laterally through TJ barrier (Ma, 1997). However, hydrophilic 
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molecules which do not have specific transporter on membrane permeate through TJs rather than 
lipid bilayers.  
 
Figure 8: Pathways for transportation of molecules in small intestinal epithelial cells. 
 
Therefore, the permeability of hydrophilic molecules is solely dependent on the relative 
tightness of the TJ barrier (Ma, 1997; Madara, 1989). Thus, enterocytes in normal conditions 
have a restrictive permeability and are referred to as non-leaky enterocytes, whereas enterocytes 
with an increase in permeability during pathophysiological conditions are known as leaky 
enterocytes.  
Given this background, PGs also play a vital role in growth, maintenance and 
fortification of the intestinal epithelial barrier. In one study, it has been reported that there is an 
increase of PGE2 along with the maturation of the intestinal epithelial barrier (Gerstle, Seaton, 
Kauffman, & Colony, 1994). In the same study, inhibition of PGE2 in mature animals (rats) by a 
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COX-inhibitor (indomethacin) caused an increase in epithelial permeability (Gerstle et al., 1994). 
Similarly, in another in vitro study, intestinal ischemia produced a marked increase in epithelial 
permeability and reduced epithelial resistance in porcine ileum (Blikslager, Roberts, Rhoads, & 
Argenzio, 1997). However, ischemic porcine ileum recovered back to normal after the exposure 
to PGI2 and PGE2 (Blikslager et al., 1997). Moreover, cAMP and Ca2+ ionophores A23187 also 
restored epithelial resistance, thus concluding that PG restoration reverts injured intestinal 
epithelial back to normal. Consistent with the studies referenced above, various NSAIDs 
(indomethacin, aspirin, and ibuprofen) have been shown to increase intestinal permeability and 
hence decrease intestinal epithelial barrier function in humans (Bjarnason, Fehilly, Smethurst, 
Menzies, & Levi, 1991; Bjarnason & Thjodleifsson, 1999).  
2.4.3. Eicosanoids in mucosal protection 
Mucosa provides an additional layer of defense against varying temperature, pH, 
osmolarity, cytotoxic substances and bacterial products dispersed in the lumen (J. L. Wallace, 
2008). Therefore, mucosal integrity and health are essential for protection against invasion of 
noxious agents into the serosal layer. Numerous studies have reported that PG treatment has a 
protective effect on mucosal damage (Robert, 1976, 1981). PGs are involved in mucus synthesis 
and secretion, mucosal bicarbonate secretion, and fluid secretion. All of these processes help in 
developing mucosal health and integrity by diluting noxious substances present in the intestinal 
lumen (Leung, Miller, Reedy, & Guth, 1989; Lugea, Salas, Guarner, Azpiroz, & Malagelada, 
1992).  
 Another important role of gastroduodenal mucosa is to secrete bicarbonate ions (HCO3-) 
into the lumen to neutralize the acidic pH of the lumen from gastric acid which can reduce the 
luminal pH to 1.5-2 (Bukhave, Rask-Madsen, Hogan, Koss, & Isenberg, 1990; Takeuchi, Yagi, 
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Kato, & Ukawa, 1997). HCO3- secretion is regulated by endogenous PGs and the nervous 
system. Moreover, Bukhave et al. have reported that patients with duodenal ulcers have reduced 
HCO3- secretion and reduced endogenous PGs compared to normal patients, indicating that 
endogenous PGs have a role in HCO3- secretion (Bukhave et al., 1990). 
Additionally, endogenous PGs have also been involved in the proliferation of crypt cells. 
In this regard, NSAIDs have shown to reduce villus height, crypt depth, and the number of 
enterocytes (Uribe, Alam, & Midtvedt, 1992).  
2.4.4. Eicosanoids in endothelial barrier   
Endothelial cells are also an important source of eicosanoids. Endothelial cells have all 
major pathways involved in the production of eicosanoids, including PGI2, PGE2, PGF2a, 
thromboxane A2, LTs and hydroxy fatty acids (Schror, 1985). Eicosanoids produced by 
endothelial cells have been shown to regulate vascular tone, cell locomotion, platelet activation 
and cell proliferation (Schror, 1985). One of the deleterious effects of NSAID- or ethanol-
induced GI mucosal injury has been due to damaged vasculature, resulting in increased vascular 
permeability. This increased vascular permeability eventually leads to the formation of 
interstitial edema, compression of blood vessels, thrombosis, ischemia, and stasis of blood 
vessels (Szabo, 1987). In concordance with previous studies, PG treatment to NSAID-induced 
GI injury improved vasculature and mucosal blood flow (L. Y. Cheung, 1980; Guth, 1986; 
Szabo, 1987; Szabo & Goldberg, 1990). Therefore, PGs have been shown to protect GI injury 
from NSAIDs by fortifying the endothelial barrier function. 
2.4.5. Eicosanoids in intestinal muscle motility  
Like other organ systems in which PGs stimulate the contraction of smooth muscles, PGs 
are also involved in contraction of the small intestine, specifically initiation and propagation of 
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migrating motor complex (MMC) in the intestine (Burakoff, Nastos, & Won, 1990; Karim & 
Filshie, 1970). It has been reported that when human duodenum was exposed to PGE2, there was 
a delay in initiation of MMC as well; PGE2 prevented propagation of initiated MMC (Tollstrom, 
Hellstrom, Johansson, & Pernow, 1988). However, PGF2a has been found to induce motility in 
the small intestine (Tollstrom et al., 1988).  
The opposite effect of PGs in small intestinal motility is explained by various muscle 
layers involved in contraction, specifically longitudinal and circular smooth muscle. PGE2 has 
been shown to stimulate contraction of longitudinal smooth muscles, whereas it relaxes the 
circular smooth muscles (Bennett & Fleshler, 1970; Waller, 1973). However, PGF2a has been 
reported to stimulate both longitudinal and circular smooth muscle layers (Bennett & Fleshler, 














2.5. ROLE OF EICOSANOIDS IN INFLAMMATORY BOWEL DISEASE (IBD) 
Besides being involved in maintaining normal homeostatic intestinal physiology, 
eicosanoids also play a crucial role during pathophysiological conditions. During 
pathophysiological conditions, eicosanoids might alter intestinal motility, mucosal growth and 
development, endothelial functions, and transport processes (electrolyte and nutrient) involved in 
intestinal secretion, and absorption. However, in this section we will focus on the enterocyte 
transport process in regard to inflammatory bowel disease (IBD). IBD is known as inflammation 
of the GI tract and includes ulcerative colitis and Crohn’s disease. Ulcerative colitis is primarily 
the inflammation of the colon whereas Crohn’s disease is the inflammation of the small intestine 
and/or colon.  
2.5.1. Role of Prostaglandin  
As mentioned before, due to the diverse role of PGs in the intestine, many elaborative 
studies are devoted to the understanding of the role PGs play in IBD. It has been reported that 
there is increased production of cyclooxygenase products during IBD: about ~ 100% increase of 
PGE2 and thromboxane and ~ 50% increase in prostacyclin (Ligumsky et al., 1981; 
Rachmilewitz, Ligumsky, Haimovitz, & Treves, 1982; Sharon & Stenson, 1984). During 
intestinal pathological conditions like Crohn’s disease or ulcerative colitis, there is excessive 
production of PGs causing diarrhea (Hawkey, Karmeli, & Rachmilewitz, 1983; Hawkey et al., 
1998). The cause of diarrhea may be due to the following two mechanisms: 1) PG-mediated 
secretion of intestinal fluid, and 2) PG-induced stimulation of small intestinal motility. The 
increase in PGs level during Crohn’s ileitis is due to up-regulation of COX-2 but not COX-1 
expression (Hendel & Nielsen, 1997; Singer et al., 1998). Singer et al. has reported that COX-1 
expression is limited to crypt cells of the small intestine during normal and inflamed condition; 
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whereas, COX-2 expression was elevated in Crohn’s ileitis and limited to villus epithelium. 
Furthermore, COX-2 was also seen to be markedly increased in mononuclear cells in Crohn’s 
ileitis. However, the increased level of COX-2 was relatively higher in epithelial cells compared 
to mononuclear cells present in lamina propria (Singer et al., 1998). These findings suggest that 
COX-2 induced PG is involved in the induction of intestinal inflammation. However, in clinical 
studies, inhibiting COX with NSAIDs did not recover the patient from IBD, rather aggravated 
the situation (Bjarnason & Peters, 1989; Kaufmann & Taubin, 1987; Rampton & Sladen, 1981). 
2.5.2. Role of Leukotrienes  
The role of LTs was observed much later than the role of PGs in IBD. Actually, the role 
of LTs in the context of IBD gathered attention after Musch et al. reported that LOX product 
stimulates colonic secretion (Musch, Miller, Field, & Siegel, 1982). Biopsy samples of active 
IBD patients showed a remarkable rise in the lipoxygenase products 5-HETE and LTB4 (Sharon 
& Stenson, 1984), and the mechanism behind the increase of LTB4 was due to reduced activity 
of w-hydroxylase and increased activity of 5-LOX (Ikehata et al., 1995). Peskar et al. also 
reported there was a significant increase in peptide LTs (LTC4, LTD4, LTE4) in IBD patients 
(Peskar, Dreyling, Peskar, May, & Goebell, 1986). The IBD patients treated with NSAIDs 
showed more aggravating conditions compared to non-treated patients (Hudson, Balsitis, Everitt, 
& Hawkey, 1993). The mechanism behind the aggravating situation was due to NSAIDs 
shunting AAs to a remarkable increase in LTB4 production (Hudson et al., 1993).  
In several investigations with animal models of IBD, there has been success in treating IBD with 
inhibitors of LT (J. L. Wallace et al., 2011). However, when IBD patients were treated with the 
selective inhibitor of LTB4 (MK-591), it did not produce a significant improvement in the 
clinical activity of the patients (Roberts et al., 1997). Likewise, when patients were treated with a 
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5-LOX inhibitor (zileuton), the IBD group had the same remission rate compared to the placebo 
group (Hawkey, Dube, Rountree, Linnen, & Lancaster, 1997). All these studies indicate that 
there might be a possibility that LT might play a role in IBD, but the mechanisms need to be 
explored further.  
2.5.3. Role of eicosanoids in Intestinal epithelial transporters  
The small intestine is the major site of nutrient and electrolyte absorption. However, 
ample evidence exists to show that Na-coupled co-transporters including Na-glutamine (System 
B0 amino acid transporter 1 (B0AT1)), Sodium-alanine co-transporter (NAcT), Soidum-Glucose 
transporter 1 (SGLT1) and Na-neutral amino acid co-transporter are reduced in absorptive villus 
cells during in vivo or in vitro IBD-related studies (Table 2). The mechanism of reduced co-
transporter activity is confined to the specific co-transporters, either due to a decrease in protein 
expression or a decrease in affinity (1/Km) (Table 2). Unlike villus cells, the Na-glutamine 
(System N transporter 2 (SN2)) co-transporter in crypt cells is stimulated during IBD, and the 
mechanism is an increase in affinity of the co-transporter rather than the change in expression of 
the protein (Table 2). In all of these studies, at the intact cell level, there is a positive correlation 
between Na-dependent transporter and Na-K-ATPase, indicating that the reduced or increased 
activity of the Na-dependent co-transporter is in part due to the activity of Na-K-ATPase.  
Moreover, there is a differential effect on isoforms of Na/H exchanger during IBD. There 
are mixed reports with increased or decreased activity of NHE1 (performs housekeeping 
function), whereas NHE3 (performs the absorptive function) appeared to have reduced activity 
during IBD (Magalhaes, Cabral, Soares-da-Silva, & Magro, 2016). 
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2.5.3.1 Role of eicosanoids in Na-K-ATPase 
Widespread studies in humans, animals, and cell lines provide robust evidence suggesting 
that there is decreased Na-K-ATPase during IBD or when cells are exposed to IBD-associated 
proinflammatory factors (Table 3 & 4). The mechanism is mostly due to reduced levels of a1 
and b1 isoforms, resulting in a decrease in the number of functional pumps in the membrane. 
However, there are alternative mechanisms responsible for the reduction of Na-K-ATPase 
activity: 1) stimulation of the PKC-STAT1 phosphorylation downstream signaling pathway 
without changing the level of Na-K-ATPase protein, and 2) lack of Na-K-ATPase to properly 
adhere to membranes due to downregulation and depolarization of ankyrin protein (Table 3 & 4).  
35 
 
Table 2: Studies on small intestinal epithelial Na-dependent transporters (Na-bile acid, Na-glucose, Na-glutamine and Na-K-
ATPase) in animal IBD models or animal cells. WB- Western blot, COX- cyclooxygenase, LOX- Lipoxygenase, ATK-Arachidonyl 
Trifluoromethyl Ketone, PRX- piroxicam, Affinity of transporter (1/Km), PGE2- Prostaglandin E2, LTD4- Leukotriene D4, IEC-
Intestinal epithelial cell (Rat ileum). Û-no change, ¯- down regulation in activity and expression, ­ up-regulation in in activity and 
expression. 




Inorganic phosphate (Pi) 
measurement  
WB 
¯ Na-bile acid (ASBT)/  ¯ Na-K-ATPase in IBD  
Whereas, Glucocorticoid (Methylprednisolone) 
treatment reversed the IBD effect. 
 
ASBT - ¯ Vmax / ­ Km 
¯ Protein expression in IBD 
ASBT - ­ Vmax / ¯ Km 
­ Protein expression in treated 
(Coon, Kekuda, Saha, & 
Sundaram, 2010) 
Rabbit treated with cNOS 
inhibitor (L-Name) 
Radioactive uptake, 
Pi measurement  
WB, qRT-PCR 
¯ SGLT-1(Na-glucose)/ ­ Na-K-ATPase / ÛNAcT 
(Na-neutral amino acid) 
 
SGLT1 mechanism- ¯Km 
ÛmRNA expression 
ÛProtein synthesis 





Pi measurement, WB 
¯ B0AT1(Na-glutamine)/ ¯Na-K-ATPase in IBD 
Whereas, Glucocorticoid (Methylprednisolone) 
treatment reversed the IBD effect. 
B0AT1- ¯ Vmax / Û Km 
¯ Protein expression in IBD 
B0AT1- ­Vmax / Û Km 
­ Protein expression in treated 
(Arthur, Saha, Sundaram, 
Kekuda, & Sundaram, 
2012; Saha, Arthur, 
Kekuda, & Sundaram, 
2012) Rabbit IBD 
(Crypt cells) 
Radioactive uptake, 
Pi measurement, WB 
­ SN2 (Na-glutamine)/ ­ Na-K-ATPase in IBD 
Whereas, Glucocorticoid (Methylprednisolone) 
treatment reversed the IBD effect. 
Û Vmax, ¯ Km and ÛProtein 
expression in IBD 
Û Vmax,  ­ Km and ÛProtein 
expression in treated 
Rabbit IBD (Crypt cells) 
Treated with COX and LOX 
inhibitors 
Radioactive uptake, 
Pi measurement, WB 
ATK-PLA2 inhibitor-Reversed IBD effect  
PRX- COX inhibitor-Did not reverse 
MK886- LOX inhibitor-Reversed 
LOX pathway mediated stimulation of SN2 in crypt 
cells during IBD 
¯  SN2 / ¯  Na-K-ATPase in treated 
animal. Because of ÛVmax, ­ Km 
and ÛProtein expression of SN2 
(S. Singh, Arthur, & 
Sundaram, 2018) 
Rabbit IBD (Villus cells) 
Treated with COX and LOX 
inhibitors  
Radioactive uptake, 
Pi measurement, WB 
ATK-PLA2 inhibitor-Reversed IBD effect  
PRX- COX inhibitor- Reversed IBD effect 
MK886- LOX inhibitor- Did not reverse 
COX pathway mediated reduction of B0AT1 in 
crypt cells during IBD 
­ B0AT1, ­Na-K-ATPase activity in 
treated animal. Because of ­ Vmax, Û 
Km and ­ protein expression 
(Arthur, Singh, & 
Sundaram, 2018) 
Rabbit IBD Radioactive uptake, 
Pi measurement, WB 
¯ NAcT (Na-alanine) / ¯Na-K-ATPase in IBD 
Whereas, Glucocorticoid (Methylprednisolone) 
treatment reversed the IBD effect. 
­ NAcT activity in treated animal. 
Because of ¯Km and ÛmRNA level,   
(Sundaram, Wisel, & 
Coon, 2007) 
IEC-18 cells 
Treated with LTD4 (1 uM) 
Radioactive uptake, 
Pi measurement, WB 
¯ NAcT (Na-alanine) / ÛNa-K-ATPase 
 
NAcT- ÛVmax, ­ Km and  
Û protein expression 
(Talukder, Kekuda, Saha, 
& Sundaram, 2008) 
IEC-6 
Treated with PGE2 (1 nM) 
Radioactive uptake, 
Pi measurement, WB 
 ¯SGLT-1 / ÛNa-K-ATPase 
 
SGLT-1- ¯ Vmax and decrease in 
protein synthesis  
(Talukder, Griffin, Jaima, 




Related Methods Major Findings 
(Function) 
Mechanisms References 
Colonic UC biopsies  N/A ¯Na-K-ATPase was lower in UC biopsies 
compared to normal 
N/A (Rachmilewitz, Karmeli, 
& Sharon, 1984) 






­HETEs, LTB4, ROS 
N/A (Allgayer, Kruis, & 
Erdmann, 1988) 
Colonic UC or CD 
biopsies 
Coupled optical assay of 
Na-K-ATPase activity  
¯Na-K-ATPase N/A (Allgayer, Kruis, 
Paumgartner, et al., 1988) 
Rectal UC or CD Pi measurement ¯Na-K-ATPase in patients with UC with severe 
rectal inflammation 
Û Na-K-ATPase in patients with mild UC or no 
rectal inflammation 
 (Ejderhamn, Finkel, & 
Strandvik, 1989) 
Distal colon inflamed 
mucosa of UC or CD 
Isc measurement (activity) 
under mystatin and [Na+] 
variation 
¯Na-K-ATPase ¯ number of pumps (Sandle et al., 1990) 
Sigmoid biopsies of 
UC, CD or normal 
patients 
Coupled optical assay 
(activity) and 3H Ouabain 
binding assay 
Glucocorticoids reduced diarrheal symptoms in 
IBD and shows anti-inflammatory effects 
­ Na-K-ATPase (Scheurlen, Allgayer, 
Hardt, & Kruis, 1998) 
Sigmoid and proximal 
rectal UC biopsies 
WB, IHC, NB ¯ a1 isoform protein level 
Û a1 isoform mRNA level 
  
Mucosa of sigmoid 
and proximal rectal 
biopsies of UC  
WB-WC, IHC, NB ¯ a1 and b1 isoform protein level 
Û a1 and b1 isoform mRNA level 
 (Greig, Boot-Handford, 
Mani, & Sandle, 2004) 
Inflamed ileal and 
sigmoid mucosa of 
UC or CD biopsies  
WB-WC, IHC ¯ a1 isoform protein level  (Sullivan et al., 2009) 
Caco-2 Cell line WB-PM, Pi measurement IFN-g reduces ¯Na-K-ATPase in time and 
concentration dependent manner 
Û Protein level 
PKC-STAT1 phosphorylation 
RAF-1, MEK, ERK2 and p38 
pathways involved 
(Magro, Fraga, Ribeiro, 
& Soares-da-Silva, 2004) 




Caco-2 Cell line WB-PM, Pi measurement Long term treatment of IFN-g ¯Na-K-ATPase, 
Whereas TGF-b Û Na-K-ATPase 
 (Magro, Fraga, Ribeiro, 
& Soares-da-Silva, 2005) 
 
Table 3: Studies on Na-K-ATPase in human IBD or human intestinal epithelial cells/tissues. UC-Ulcerative colitis, CD- Crohn’s 
disease, IBD-inflammatory bowel disease, WB-WC-Western blot in whole cell, WB-PM-Western blot in plasma membrane, IHC-
immunohistochemistry, NB- northern blotting, HETEs- hydroxyeicosatetraenoic acid, LTB4- Leukotriene B4, PGE2 -Prostaglandin 





Related Methods Major Findings 
(Function) 
Mechanisms References 
Ileal enterocytes isolated from 
TNBS treated rats  
N/A ¯Na-K-ATPase compared to 
normal 
¯ a1 and b1 isoform protein 
and 
mRNA levels 
(Wild & Thomson, 1995) 




IFN-g - ¯Na-K-ATPase Due to nitric oxide-dependent 
manner 
(Yoo et al., 2000) 
Isolated Jejunal enterocytes of 
healthy rat  
WB-PM, radiolabeled 
ouabain binding and Pi-
measurement 
IL-1b - ¯Na-K-ATPase ¯ a1 isoform protein level (Kreydiyyeh & Al-Sadi, 2002a) 




IL-1b - ¯Na-K-ATPase ¯ a1 isoform protein level (Kreydiyyeh & Al-Sadi, 2002b) 
Isolated colonic surface and 
crypt cells of healthy rats 
WB-PM, and Pi-
measurement 
TNF-a reduces ¯Na-K-ATPase 
through PGE2 
¯ a1 isoform protein level (Markossian & Kreydiyyeh, 2005) 
Mucosa of colon, jejunum and 




¯Na-K-ATPase on proximal 
colon 
­ Na-K-ATPase on distal colon 
¯ a1 isoform protein level in 
proximal colon 
(Magro, Fraga, & Soares-da-Silva, 
2005) 
Colonic crypts of healthy rats  Isc activity NH2Cl -­ Na-K-ATPase N/A (Schultheiss, Lan Kocks, & Diener, 
2005) 
Colonic mucosa of NHE3-/- mice  RT-qPCR ­ a1 isoform mRNA level   (Laubitz et al., 2008) 
Colonic mucosa of DSS- and 
TNBS-treated rats  
WB-WC, IHC Û a1 isoform protein level in 
colitis model 
 (Sullivan et al., 2009) 
Colon and ileum of DSS-treated 
mice 
WB, RT-qPCR ¯ a1 isoform protein level 
Û a1 isoform mRNA level 
 (Hirota & McKay, 2009) 
Villus cells from rabbit IBD 
model 
WB-PM, WB-WC, IHC, 
RT-qPCR and Pi-
measurement 
Û  a1 and b1 isoform protein 
mRNA level in whole cell, but  
¯  a1 and b1 isoform protein 
mRNA level in plasma membrane 
 
Downregulation and 
depolarization of ankyrin 
protein 
(Saha et al., 2015) 
 
Table 4: Studies on Na-K-ATPase in animal IBD or animal intestinal epithelial cells/tissues. IBD-inflammatory bowel disease, 
WB-WC-Western blot in whole cell, WB-PM-Western blot in plasma membrane, IHC-immunohistochemistry, IFN-g- interferon 
gamma, IL-Interleukin, and Isc- Short-circuit current. Û-no change, ¯- down regulation in activity and expression, ­ up-regulation in 
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The most important function of the mammalian intestinal cells is the absorption of 
nutrients, electrolytes, and water. In the mammalian small intestine, nutrients are primarily 
absorbed via Na-nutrient co-transport processes on the brush border membrane (BBM) of 
primarily absorptive villus cells. The necessary favorable transcellular Na gradient for the proper 
functioning of Na-dependent nutrient co-transporters is provided by Na-K-ATPase on the 
basolateral membrane of enterocytes. In the intestine, as a primarily secretory crypt cell matures 
to a primarily absorptive villus cell, it acquires all the BBM Na-solute co-transport processes that 
are dependent on Na-K-ATPase. Indeed, as cells mature from crypt to villus, Na-K-ATPase 
doubles, to accommodate for the increased BBM Na-dependent nutrient absorption. However, 
the mechanism of increase of Na-K-ATPase during growth and maturation of intestinal cells 
from the crypt to villus is not known. Therefore, this study aimed to determine the mechanisms 
involved in the functional transition of Na-K-ATPase during the maturation of crypt to villus 
cells. Rat intestinal epithelial cell (IEC-18 cell line) is an excellent model of in vitro crypt (0 day) 
to villus (4 days) maturation. Na-K-ATPase activity, as measured by inorganic phosphate release 
and 86Rb+ uptake, gradually increased as the cells matured in vitro from day 0 through day 4 of 
post-confluence. mRNA abundance and Western blot studies showed no change in the levels of 
Na-K-ATPase subunits α1 and β1 from 0 to 4 days post-confluence. However, Na-K-ATPase α1 
phosphorylation levels on serine and tyrosine, but not threonine, residues gradually increased as 
cells matured in vitro from day 0 to 4. These data indicate that as enterocytes mature from crypt-
like to villus-like in culture, the functional activity of Na-K-ATPase increases secondary to 
altered affinity to accommodate the functional preference of the intestinal cell type without 
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changing its membrane expression levels. This altered affinity is likely due to phosphorylation of 
























An essential function of the mammalian small intestine is nutrient absorption (Gerbe, 
Legraverend, & Jay, 2012). While the intestinal epithelium is composed of multiple specialized 
cells types including goblet cells, enteroendocrine cells, Paneth cells, and enterocytes (de Santa 
Barbara, van den Brink, & Roberts, 2003), only enterocytes are responsible for nutrient 
absorption from the intestinal lumen. The enterocytes are comprised of undifferentiated crypt 
cells, which proliferate and differentiate to mature villus cells (Babyastsky & Podolsky, 1999). 
Nutrient, electrolyte and fluid absorption primarily occur by the villus cells while the crypt cells 
are thought to be primarily secretory. 
During the differentiation process, enterocytes acquire more transporters on both sides 
and are physiologically able to absorb more nutrients compared to undifferentiated crypt cells.  
Among the acquired transporters, Na-K-ATPase, a basolateral membrane (BLM) transporter, 
plays an important role in regulating ionic homeostasis, cell volume and maintaining membrane 
potential (Kay, 2017). Na-K-ATPase transports three Na+ out of the cell in exchange for two K+ 
into the cell, thus maintaining a high level of intracellular K+ and low intracellular Na+ 
concentration (Kaplan, 2002). This establishes a Na+ gradient that is responsible for driving other 
secondary transport processes across the brush border membrane (BBM). Transport of different 
ions (H+, Ca2+, Cl-, PO42-, SO42-), nutrients like glucose, amino acids and vitamins, certain 
nucleic acids, bile acids, and neurotransmitters across the plasma membrane are all dependent on 
Na-K-ATPase activity (Skou, 1990; Skou & Esmann, 1992). Previous studies have shown that 
Na-nutrient co-transport mechanisms in the BBM, namely Na-glucose (SGLT1), Na-alanine 
(NAcT), Na-glutamine (B0AT1), Na-bile acid (Apical sodium bile acid transporter (ASBT)) and 
Na-adenosine (Divalent metal transporter 1 (DMT1)) that depend on the BLM Na-K-ATPase for 
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their optimal activity, are inhibited. Further, their inhibition in villus cells in a rabbit model of 
inflammatory bowel disease (IBD) (Ejderhamn et al., 1989; Rachmilewitz et al., 1984; Sundaram 
& West, 1997) is at least in part secondary to altered Na extruding capacity of the cell from 
diminished Na-K-ATPase activity. Therefore, Na-K-ATPase plays a crucial role in nutrient 
absorption and maintenance of intestinal health. 
The Na-K-ATPase enzyme consists of various subunits: alpha (α), beta (β) and gamma 
(g) subunits (Kaplan, 2002). The α and β subunits are ubiquitously present and are important for 
the activity of Na-K-ATPase (G. E. Shull, Lane, & Lingrel, 1986; G. E. Shull, Schwartz, & 
Lingrel, 1985), while the g-subunit is an optional subunit and its expression is restricted to 
certain tissues (Beguin et al., 1997). Of these subunits, α subunit does the catalytic function of 
the transporter (G. E. Shull et al., 1985), whereas other subunits (β and g) are responsible for the 
regulatory function of the α subunit (Arystarkhova, Wetzel, Asinovski, & Sweadner, 1999; 
Geering, 2001). The α subunit is a transmembrane protein having intracellular Na+, ATP and 
phosphate binding sites, and extracellular K+ binding sites (Kaplan, 2002). The β subunit is 
important for the proper folding of the α subunit and its translocation to the plasma membrane 
(Ackermann & Geering, 1990; McDonough, Geering, & Farley, 1990). At least four isoforms of 
the α subunit (α1, α2, α3, and α4) and three isoforms of the β (β1, β2, and β3) subunit are known. 
These isoforms are expressed in a tissue-specific manner (Blanco, Melton, Sanchez, & Mercer, 
1999; Kaplan, 2002; Mercer, 1993). The combination of different isoforms of the α and β 
subunits make up a series of Na-K-ATPase isoenzymes (Blanco & Mercer, 1998b). Each 
isoenzyme has different functional properties and they are expressed differentially in tissue- and 
cell specific-manners (Jewell et al., 1992). Of these isoforms, α1 and β1 are ubiquitously present 
in epithelial cells and are also present in the mucosa of the intestine (Saha et al., 2015).  
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Na-K-ATPase activity is tailored to change according to the physiological requirements 
of the cell. There are several mechanisms that regulate Na-K-ATPase activities. For example, 
availability of the substrate (Na+, K+ and ATP), the amount of the enzyme at the plasma 
membrane, which can be modified by changes in the rate of synthesis or degradation of the 
individual Na pump polypeptide, and movement of the pump from cytoplasmic vesicles to the 
plasma membrane by exo/endocytotic vesicular transport (Blanco et al., 1998). Besides these 
mechanisms, Na-K-ATPase activities at the cell surface are directly regulated by direct 
phosphorylation and dephosphorylation by protein kinases and protein phosphatases (Bertorello 
& Katz, 1993; Ewart & Klip, 1995; McDonough & Farley, 1993). Alterations in the 
phosphorylation levels of the α and regulatory g subunits are known to change the affinity and 
therefore the activity of the transporter.  
As mentioned above, published studies using in vivo models have shown that the Na-K-
ATPase functional activity varies depending on the cell type and function: rabbit villus cells that 
have the primary function of sodium-dependent nutrient absorption have twice the amount of 
Na-K-ATPase function compared to the crypt cells that have minimal absorptive capacity (S. 
Singh et al., 2015). However, the mechanism(s) underlying the alteration of Na-K-ATPase 
function during maturation of crypt to villus cell is not known at this time. Therefore, the aim of 
this study is to explore the mechanism(s) underlying the alteration of Na-K-ATPase activity 






3.3. MATERIALS AND METHODS 
3.3.1. Cell culture 
 Rat small intestinal epithelial cells (IEC-18, American Type Culture Collection), between 
passages 5 and 20, were used for all of the experiments. Cells were maintained in Dulbecco’s 
modified Eagle’s medium (DMEM), supplemented with 10% (vol/vol) fetal bovine serum, 100 
U/l human insulin, 0.25 mM β-hydroxybutyric acid and 100 U/ml of penicillin and streptomycin. 
These cells were cultured in a humidified atmosphere of 10% CO2 at 37°C. The cells were fed 
with fresh medium every other day. When the cells reached 100% confluence, it was considered 
as 0 day, and cells were grown until 4 days post-confluence. Experiments were conducted in 0-
day, 1-day, 2-day, 3-day, and 4-day post-confluent cells. 
3.3.2. Alkaline phosphatase activity (ALP) assay 
The activities of ALP were determined using an enzyme assay kit, according to the 
manufacturer’s protocol (Abcam#83369, Alkaline phosphatase assay kit, colorimetric). ALP 
activity was calculated as picomole/min/ml from the cells that were harvested between 0 and 4-
day post-confluence.   
3.3.3. Na-dependent glucose uptake studies 
To determine the Na-dependent glucose transport in IEC-18 cells, glucose uptake studies 
were performed on cells grown on transwell inserts (0.4 µ , Thermoscientific #140620) in 24 
well plates. Cells were rinsed once with warm wash buffer (130 mM NaCl, 5mM KCl, 1mM 
MgSO4, 2 mM CaCl2, 20 mM HEPES and pH adjusted to 7.4) and incubated with the same 
buffer for 10 mins. After the incubation, wash buffer was removed from the wells and replaced 
with a reaction mixture containing a trace amount of [3H] OMG in Na-HEPES buffer with and 
without phlorizin (SGLT1 inhibitor). The reaction was stopped after two minutes with cold wash 
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buffer (130 mM NaCl, 5mM KCl, 1mM MgSO4, 2 mM CaCl2, 20 mM HEPES, 10mM D-
Glucose and pH adjusted to 7.4), and the cells were then washed twice with the same buffer. 
Cells were lysed by incubating them with 1M NaOH for 20 mins at 70°C. The lysed cells from 
each well were then mixed with 5 ml of Ecoscint A (National Diagnostics). The vials were kept 
in darkness overnight and radioactivity retained by the cells was determined in a Beckman 
Coulter 6500 scintillation counter. 
3.3.4. Crude plasma membrane isolation 
Plasma membrane (crude) was prepared from cells according to the method of 
Havrankova et al. (Havrankova, Roth, & Brownstein, 1978). Briefly, 100 mg cells were 
homogenized in 5ml of 1mM NaHCO3 and centrifuged at 600 x g for 30 min. The supernatant 
was collected and centrifuged for 30 min at 20,000 x g. The membrane pellets were washed 
twice with 1mM NaHCO3. The final pellets were resuspended in 0.04 M Tri-HCl buffer (pH 7.4) 
containing 0.1% BSA. All the procedures mentioned above were carried out at 4oC.  
3.3.5. Na-K-ATPase activity assay 
Na-K-ATPase activity was measured as Pi liberated in cellular homogenates and crude 
plasma membrane fractions from the cells that were harvested 0-4 days post-confluence 
according to the protocol of Forbush et al. (Forbush, 1983). Enzyme-specific activity was 
expressed as nanomoles of Pi released per milligram protein per minute.   
3.3.6. Determination of Na-K-ATPase activity and kinetics by 86Rb+ uptake 
Uptake studies were performed in cells grown on transwell inserts in 24 well plates. IEC-
18 cells were plated with approximately 1×105 cells. Uptake studies for Na-K-ATPase were 
done using radioactive Rubidium (86Rb+, Perkin Elmer). Cells were incubated for 1hr in serum-
free DMEM media at the aforementioned conditions. The cells were subsequently washed with 
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serum-free media and incubated for 10 min at 37°C with 20 μM monensin (in serum-free 
DMEM) added to both the apical and basolateral sides. The cells were then washed with serum-
free DMEM. Uptake of 86Rb+ was started by incubating the cells for 15 mins in a reaction 
mixture (Serum-free DMEM) containing ~1 μCi/ of 86Rb+ well added to the basolateral side of 
the cells in the presence and absence of ouabain (1mM).  
For Na-K-ATPase kinetics, after incubation with serum-free DMEM for 1hr, the cells 
were subsequently washed with an incubation buffer (130 mM NaCl, 5mM KCl, 1mM MgSO4, 2 
mM CaCl2 and 20 mM HEPES) and incubated for 10 min at 37°C in the incubation buffer with 
20μM monensin on both sides of the membrane. Then cells were washed with a wash buffer (130 
mM NaCl, 1mM MgSO4, 2 mM CaCl2, 20 mM HEPES and 5 mM mannitol) on both sides. Na-
K-ATPase kinetic studies were then performed in cells by incubating them for 30 secs with 
reaction mixtures (130 mM tetramethylammonium chloride, 1mM MgSO4, 2 mM CaCl2, 20 mM 
HEPES, 5 mM mannitol and 86Rb+ (~1 μCi/ well)) containing different concentrations (0.05-2 
mM) of RbCl added to the basolateral side of the membrane in the presence and absence of 
ouabain (1 mM).  
For both uptake and kinetics experiments, the reaction was then stopped by the addition 
of ice-cold MgCl2. The cells were then washed three times with MgCl2 and lysed with 800 μl of 
1N NaOH by incubating them for 30 min at 70°C. The lysed cells from each well were then 
mixed with 5 ml of Ecoscint A (National Diagnostics). The vials were kept in darkness overnight 
and radioactivity retained by the cells was determined in a Beckman Coulter 6500 scintillation 
counter. The absolute Na-K-ATPase activity was calculated by subtracting 86Rb+ uptake in the 
presence of ouabain from that in the absence of ouabain. 
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3.3.7. RNA isolation and qRT-PCR 
RNA was isolated from 0-4 days post-confluent cells by using the RNeasy mini kit 
obtained from Qiagen. The real-time quantitative PCR (qRT-PCR) was performed using an 
isolated total RNA by a two-step method. First, total RNA was used to synthesize 
complementary deoxyribonucleic acid (cDNA) using SuperScript III (Invitrogen Life 
Technologies). Then, newly synthesized cDNA was used as a template to perform real-time PCR 
using TaqMan universal PCR master mix from Applied Biosystems (Foster City, CA) according 
to the manufacturer’s protocol. Rat-specific Na-K-ATPase α1 and Na-K-ATPase β1 primers and 
probes were used for the qRT-PCR studies. In addition, the rat-specific β-actin primer was used 
to normalize the expression levels of mRNA in the samples. 
3.3.8. Immunoprecipitation 
Immunoprecipitation (IP) assays were conducted in order to investigate the 
phosphorylation level of Na-K-ATPase α1 present in the plasma membrane. Cells were first 
rinsed with PBS, scraped and collected in PBS, and pelleted by brief low-speed centrifugation 
(800 rpm). The collected pellet was further used for plasma membrane isolation as mentioned 
above. The prepared plasma membrane fraction was sonicated and dissolved in 200 ul of lysis 
buffer (T-per Buffer, Thermo scientific) with protease inhibitors (Thermo Scientific). Plasma 
membrane protein was further diluted to 1 μg/μl in a microcentrifuge tube with T-per buffer and 
placed on a rocking shaker at 4°C with 2 μg of Anti-Na-K-ATPase α1 antibody overnight. 
Antibody-protein complexes formed were captured by adding 50 μl of washed protein G agarose 
bead slurry (Thermo Scientific, Catalog # 16-266) with rotation at 4°C for 2 hours. The agarose 
beads with the protein-antibody complex were collected by centrifugation (14,000 x g) and 
washed three times with ice-cold lysis buffer. These agarose beads were resuspended in 2X 
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sample loading buffer and incubated at 37°C for 15 minutes. The beads in sample loading buffer 
were vortexed, and the supernatant was used for Western blot analysis.  
3.3.9. Western blot analysis 
Western blot analysis was performed in the whole cell lysate and plasma membrane 
preparations. An equal amount of protein (20 μg) was denatured in sample buffer (Laemmli 
sample buffer, BIO-RAD #3100010639) and separated by electrophoresis on a 8%-12% gradient 
gel. Proteins on the gel were transferred to a polyvinylidene fluoride membrane which was 
blocked with 5% dry milk or BSA in TBS (20 mM Tris pH 7.5, 150 mM NaCl) with 0.1% 
Tween-20 and then incubated with one of the following primary antibodies, overnight at 4°C: 
Na-K-ATPase α1 (Millipore, # 05-369); Na-K-ATPase β1 (Abcam, ab2873); p-Serine (Abcam, 
ab9332); p-Threonine (Abcam, ab179530); p-Tyrosine (Abcam, ab9337); p-Na-K-ATPase α1-
Ser23 (Cell Signaling Technology, #4006) and p-Na-K-ATPase α1-Ser16 (Cell Signaling 
Technology, #4020). The membrane was washed three times with TBST followed by TBS. The 
membrane was then incubated with secondary antibody for 1hr.  Enhanced chemiluminescence 
(ECL) western blotting detection reagent (GE Healthcare Bio-Sciences, Piscataway, NJ) was 
used to detect the immobilized protein. The chemiluminescence was detected using a FluorChem 
M instrument (Alpha Innotech, San Leandro, CA) and the intensity of the bands were analyzed 
by its software. β-actin was used to normalize the expression levels in cellular homogenate.  
3.3.10. Protein determination  
Total protein was measured by the Lowry method using the Bio-Rad protein assay kit 
(Hercules, CA). BSA was used as a standard. 
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3.3.11. Statistical analysis  
All groups presented have at least n=3 per group repeated with a different passage. The 
values are presented as mean ± SEM, and significant values of P<0.05 were taken to indicate 
statistical significance. All of the data were analyzed using one-way or two-way analysis of 




















3.4. RESULTS  
3.4.1. Alkaline phosphatase (ALP) levels during cell growth 
To confirm the cell growth and maturation in IEC-18 cells, alkaline phosphatase activity 
was measured from cells collected from 0-day to 4-day post confluence (Figure 9). The highest 
level of alkaline phosphatase activity was observed at 4-day post-confluence (1536±44.16 
picomole/min.ml), whereas the lowest level activity (1092±5.432 picomole/min.ml) was 
observed at 0-day post-confluence. This trend of increasing alkaline phosphatase activity 
demonstrates that cells mature as they grow from 0-day post confluence (crypt-like) to 4-day 
post confluence (villus-like). 
 
 
Figure 9. Alkaline phosphatase (ALP) activity to validate cell maturation as IEC-18 cells 
grow. Values are represented as means ± SEM, n=4. Values not sharing common superscripted 
letters are significantly different at P < 0.001. 
3.4.2. Na-dependent glucose uptake during cell growth 
As enterocytes mature from crypt to villus, physiological alterations are accompanied by 
the appearance of different transporters in the BBM. Specifically, the Na-glucose co-transporter 
SGLT1 appears as enterocytes mature from crypt to villus. Similar to in vivo observations 
(Hwang, Hirayama, & Wright, 1991), we also found that Na-dependent glucose uptake increased 
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almost three-fold as cells matured from crypt-like to villus-like. Figure 10 shows that minimal 
SGLT1 activity (92.53±13.35 picomole/mg protein.min) was at 0-day ost-confluence. There was 
a steady and robust increase in SGLT1 activity from 0 to 4-day post-confluence in IEC-18 cells 
(376± 57.71). This phenomenon of increasing SGLT1 activity may be due to increasing cellular 
maturation, cellular polarity and/or an increase in the number of transporters itself and is 
comparable to what is seen in vivo during crypt to villus maturation (Coon et al., 2005).  
 
Figure 10. Increase in Na-dependent glucose uptake as IEC-18 cells mature. Uptake was 
performed in the presence and absence of phlorizin (1 mM) in reaction medium containing [3H]-
OMG tracer. Values are represented as means ± SEM, n=6 independent experiments. Values not 
sharing common superscripted letters are significantly different at P < 0.001. 
3.4.3. Na-K-ATPase activity levels during cell growth 
As enterocytes mature, along with the appearance of BBM transporters, BLM Na-K-
ATPase activity increases to provide the favorable Na gradient necessary to absorb nutrients. 
Similar to the in vivo observation in rabbit intestine (S. Singh et al., 2015), Na-K-ATPase 
activity, as determined by inorganic phosphate (Pi) release increased gradually in IEC-18 
cellular homogenates from 0-4 days post-confluence (Figure 11A, 5.01±0.12 nanomole/mg 
protein.min in 0-day, 5.74±0.47 in 1-day, 14.48±1.07 in 2-day, 14.58±0.90 in 3-day, 13.72±0.23 
in 4-day). Since Na-K-ATPase is a membrane protein, plasma membrane fraction were prepared 
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from IEC-18 cells, and in these preparations, Na-K-ATPase activity also increased gradually 
from 0-day to 4-day (Figure 11B, 49.81±02.74 nanomole/mg protein.min in 0-day, 81.36±1.775 
in 1-day, 86.53±1.617 in 2-day, 102.8±4.01 in 3- day, 115.6±3.58 in 4-day). Finally, since 
radiolabeled rubidium (86Rb+) uptake is more a functional measure of Na-K-ATPase activity in 
live cells, it was measured. 86Rb+ uptake also increased gradually from 0-day to 4-day (Figure 
12, 649.2±6.95 nanomole/mg protein.min in 0-day, 958.6±32.52 in 1-day, 1285±22.28 in 2-day, 
1335±39.27 in 3-day, 1565±8,17 in 4-day). Thus, these data indicate that as IEC-18 cells mature 
from crypt-like at 0-day post-confluence to villus-like at 4-day post-confluence, Na-K-ATPase 
activity increased comparable to in vivo crypt and villus cells. 
 
Figure 11. Na-K-ATPase activity as measured by Pi release in IEC-18 cells. Na-K-ATPase 
activity was measured in the presence or absence of ouabain (1 mM). The absolute Na-K-
ATPase activity presented was calculated by subtracting Pi release in the presence of ouabain 
from that in the absence of ouabain. A. Cellular homogenates. B. Plasma membrane 
preparations. Values are represented as means  SEM, n=5. Values not sharing common 
superscripted letters are significantly different at P < 0.01. 
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Figure 12: Na-K-ATPase activity as measured by 86Rb+ uptake in IEC-18 cells. Values are 
represented as means SEM, n=5. Values not sharing common superscripted letters are 
significantly different at P < 0.01. 
3.4.4. Kinetic Studies during cell growth 
To determine the mechanism of the increase in Na-K-ATPase activity from 0-4 days 
post-confluence, we performed 86Rb+ kinetics in IEC-18 cells. As the concentration of 
extracellular Rb+ was increased, Rb+ uptake was stimulated and subsequently became saturated 
in all conditions. Kinetic parameters showed that there was no significant change in Vmax among 
the groups. However, there was a significant difference in Km from 0-4 days post-confluence 
(Table 5). Affinity (1/Km) of Na-K-ATPase increased gradually as the cells matured from 0-4 
days post-confluence as shown in Table 5. 
 0 Day 1 Day 2 Day 3 Day  4 Day 
Vmax 
(picomole/mg protein*30 Sec) 
742.5±62 714±83.5 718±58.4 713±27.9 733±44.8 
Km 
(mM) 
0.68±0.11a 0.61±0.15a 0.39±0.08b 0.37±0.04b 0.33±0.06b 
 
Table 5: Kinetic parameters of Na-K-ATPase transporters in IEC-18 Cells. Uptake of 86Rb+ 
as a function of varying concentration of extracellular Rb+ (Rubidium chloride (RbCl)). As 
extracellular Rb+ concentration was increased, uptake of 86Rb+ was stimulated and subsequently 
became saturated in all groups. Kinetic parameters [maximal uptake (Vmax) and affinity (1/Km)] 
were obtained after the analysis of data with GraphPad Prism software. Values are represented as 
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mean  SEM, n=6. Values not sharing common superscripted letters are significantly different 
at P < 0.01.  
3.4.5. Na-K-ATPase α1 and Na-K-ATPase β1 subunit mRNA abundance during cell growth  
The α subunit primarily provides Na-K-ATPase functional activity whereas the β subunit 
does not have pumping activity but contributes to proper transportation of the α subunit to the 
plasma membrane to make the entire protein fully functional. Therefore, to determine whether 
the change in Na-K-ATPase activity may be transcriptionally regulated, we performed qRT-
PCR. There was no significant difference in the relative expression of Na-K-ATPase α1 mRNA 
(Figure 13A) between different groups (0-4 days). Similarly, the Na-K-ATPase β1 subunit 
mRNA abundance (Figure 13B) was also not statistically different between the groups (0-4 
days).   
 
Figure 13. qRT-PCR analysis of IEC-18 cells on different days post confluence. Values are 
relative to 0-day and normalized to β-actin. A. Na-K-ATPase α1. B. Na-K-ATPase β1. Values 
are represented as mean  SEM, n=4.  
3.4.6. Na-K-ATPase α1 and Na-K-ATPase β1 subunit protein expression during cell growth  
Since mRNA levels of the Na-K-ATPase α1 and Na-K-ATPase β1 subunits do not 
always correlate with protein expression, Western blot analysis of protein expression of the Na-
K-ATPase α1 and Na-K-ATPase β1 subunits were performed. Immunoreactive protein levels of 
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Na-K-ATPase α1 and Na-K-ATPase β1 subunits were determined in cellular homogenates and 
plasma membrane fractions. Densitometric analysis of relative protein expression revealed that 
the level of Na-K-ATPase α1 protein expression was not statistically different in IEC-18 cells 
from 0-4 days post-confluence in cellular homogenates (Figure 14A) or plasma fractions (Figure 
15A). Similarly, there was also no significant difference in Na-K-ATPase β1 subunit protein 
expression among IEC-18 cells from 0-4 days post-confluence in cellular homogenates (Figure 
14B) and plasma membrane fractions (Figure 15B). Protein expression of Na-K-ATPase α1 and 
Na-K-ATPase β1 subunits correlates with mRNA expression of these subunits, respectively. 
Further, these studies are consistent with kinetic parameters determined above. Therefore, the 
expression of Na-K-ATPase α1 and Na-K-ATPase β1 subunits were unaltered in cellular 
homogenates and plasma membrane fractions in IEC-18 cells during maturation. Thus, the 
increase in Na-K-ATPase activity as IEC-18 cells mature from crypt-like to villus-like cells is 
secondary to increased affinity of the protein which may be due to altered phosphorylation of the 




Figure 14. Western blot analysis of different post confluence IEC-18 cells in cellular 
homogenates. A. Representative blot of Na-K-ATPase α1, Na-K-ATPase β1 and internal control 
β-actin. Densitometric quantitation of western blots. B. Na-K-ATPase α1 and C. Na-K-ATPase 
β1. Values are relative to 0-day and normalized to β-actin. Values are represented as mean  
SEM, n=4.  
 
Figure 15. Western blot analysis of different post confluence IEC-18 cells in plasma 
membrane fractions. A. Representative blots of Na-K-ATPase α1 and Na-K-ATPase β1. 
Densitometric quantitation of western blots. B. Na-K-ATPase α1 and C. Na-K-ATPase β1. Equal 
amount of proteins was loaded. Values are relative to 0-day and represented as mean  SEM, 
n=4.  
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3.4.7 Protein phosphorylation of Na-K-ATPase α1 subunit during cell growth  
To examine whether changes in Na-K-ATPase activity during different days of post 
confluence is due to phosphorylation of Na-K-ATPase α1 subunit, thus affecting its affinity, 
immunoprecipitation studies were performed. Na-K-ATPase α1 subunit was immunoprecipitated 
from the plasma membrane on different days of post-confluence and probed with antibodies 
specific for phosphorylated amino acids (serine, threonine, and tyrosine). As shown in the 
representative blot and densitometric analysis in Figure 16, immunoprecipitated Na-K-ATPase 
α1 subunit from different days of post confluence had a gradual increase in the levels of 
phosphorylated tyrosine (Figure 16B; 100% in 0-day and 170±21.41 in 4-day post-confluence). 
Similarly, phosphorylated serine levels also increased (Figure 16C; 100% in 0-day and 179±5.08 
in 4-day post confluence). However, phosphorylated threonine levels remained unchanged. To 
determine which specific residues might be the target of phosphorylation during maturation, 
proteins extracted from different days were probed with anti-p-Na-K-ATPase α1-Ser23 and anti-
p-Na-K-ATPase α1-Ser16 antibodies, the targets of which have been previously implicated in 
alterations in Na-K-ATPase activity. As shown in the representative blot and densitometric 
analysis in Figure 17, p-Na-K-ATPase α1-Ser23 had a gradual increase (100% in 0-day and 
241.3±5.5 in 4-day post-confluence) in its phosphorylation levels during IEC-18 cell growth. 
These data confirmed that a change in Na-K-ATPase activity during cell growth is likely due to 
changes in phosphorylation of Na-K-ATPase α1 subunit, specifically at serine and tyrosine 
amino acid residues and possibly involving p-Na-K-ATPase α1-Ser23 residue. 
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Figure 16. Western blot analysis of phosphorylation levels of Na-K-ATPase α1 during 
different days post confluence IEC-18 cells in plasma membrane fractions. A. Representative 
blot of p-tyrosine, p-serine, p-threonine and Na-K-ATPase α1 after immunoprecipitation with 
Na-K-ATPase α1. Densitometric quantitation of western blots. B. p-tyrosine. C. p-Serine. D. p-
Threonine. Values are relative to 0-day and normalized to Na-K-ATPase α1. Values are 
represented as mean  SEM, n=4. Values not sharing common superscripted letters are 
significantly different at P < 0.05. 
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Figure 17. Western blot analysis of Na-K-ATPase α1-Ser23 at different days post confluence 
IEC-18 cells in plasma membrane fractions. A. Representative blot of experiment done in 
triplicate. B. Densitometric analysis of western blots. Values are relative to 0-day and normalized 
to Na-K-ATPase α1. Values are represented as mean  SEM, n=3. Values not sharing common 












3.5. DISCUSSION  
Villus and crypt cells have been extensively investigated concerning absorption 
mechanisms of Na-dependent nutrient co-transporters at the level of the co-transporters in the 
BBM. At the cellular level, all of these Na-dependent co-transport processes may be regulated 
secondary to alterations in BLM Na-K-ATPase since it provides the necessary Na gradient for 
these secondary active transport processes. However, the Na-K-ATPase located in the BLM that 
drives these nutrient transporters has not been previously studied concerning its mechanism of 
adaption to support the increasing nutritional absorptive capacity during the growth and 
maturation of intestinal epithelial cells. Therefore, the present study was undertaken to 
understand the mechanism of Na-K-ATPase regulation during the maturation of intestinal 
epithelial cells from the crypt to villus.  
During the maturation of intestinal cells from the crypt to villus, significant 
morphological and physiological changes occur. Morphological changes include changes in 
composition and membrane surface area. Along with these changes, physiologically mature cells 
acquire more transporters and therefore, their capacity to absorb nutrients increases. A study of 
the crypt-villus axis of piglets has shown that there is upregulation of proteins associated with 
glycolysis/gluconeogenesis, fatty acid metabolism, amino acid metabolism, and the citrate cycle 
as cells mature from crypt to villus (Yang, Wang, Xiong, & Yin, 2016). Additionally, it has been 
reported that alkaline phosphatase (ALP), aminopeptidase, sucrose, lactase, and Na-K-ATPase 
activities increased along the crypt-villus axis in jejunum and ileum of neonatal pigs (Fan, Stoll, 
Jiang, & Burrin, 2001).  Similar to these results, our study has shown that there is an increase in 
ALP and SGLT1 activities as IEC-18 cells mature from crypt-like to villus-like cells in vitro. 
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There are conflicting reports in the literature addressing the levels of Na-K-ATPase 
activity during the maturation of cells (Blostein, Drapeau, Benderoff, & Weigensberg, 1983; 
Brugnara & de Franceschi, 1993; Furukawa, Bilezikian, & Loeb, 1981). For example, in one 
study a reduction in activity was found to be due to the shedding of Na-K-ATPase into exosomes 
or due to degradation (Mairbaurl, Schulz, & Hoffman, 2000). This study has shown that there is 
an increase in Na-K-ATPase activity as IEC-18 cells mature from crypt-like to villus-like cells.  
The increase or decrease in activity may be the result of various mechanisms: firstly, by 
increasing or decreasing the subunits α and β respectively (Erichsen, Zuo, Curtis, Rarey, & 
Hultcrantz, 1996; Vasarhelyi et al., 2000; Wang & Celsi, 1993; Wang, Yasui, & Celsi, 1994). 
The increased Na-K-ATPase activity could be, therefore, due to an increase in these subunits by 
increased mRNA and protein synthesis. Secondly, the translocation of α and β subunits from the 
cytoplasm to the plasma membrane (Bertorello & Katz, 1993; McDonough & Farley, 1993; 
Pedemont & Bertorello, 2001). The increased translocation of α and β subunit to the plasma 
membrane could, therefore, increase the Na-K-ATPase activity. Among different isoforms of α 
and β subunits, α1 and β1 isoforms are expressed ubiquitously and are observed to perform a 
housekeeping role in most epithelial cell types, including intestinal epithelial cells (Rajasekaran, 
Barwe, & Rajasekaran, 2005; Saha et al., 2015). During the development and maturation of 
erythrocytes, Na-K-ATPase enzyme activities were found to decrease with maturation, 
correlating with a decrease in the α1 subunit (Rosen & Sigstrom, 1978). Similarly, in conjunction 
with Na-K-ATPase activity, the α1 isoform also increases during the maturation of cochlea 
(Curtis, ten Cate, & Rarey, 1993). However, in the present study, we did not find any significant 
changes in mRNA expression of the α1 isoform or its protein levels though there was an increase 
in Na-K-ATPase activity.  
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For Na-K-ATPase to be fully functional as a transporting unit in the plasma membrane, 
assembly of the β subunit with the α subunit is essential. The association of the β subunit with 
the α subunit is required for maturation, membrane insertion and transport activity of the α 
subunit (Tokhtaeva, Clifford, Kaplan, Sachs, & Vagin, 2012). Na-K-ATPase α and β 
heterodimer are selective in their subunit isoform association, where the α1 subunit mostly 
assembles with the β1 isoform (Tokhtaeva et al., 2012). Although there was elevated Na-K-
ATPase activity, the expression level of β1 mRNA and protein in cellular homogenates remain 
unchanged during maturation. Therefore, the level of Na-K-ATPase α1 and β1 mRNA and 
protein in cellular homogenates confirmed that Na-K-ATPase is regulated post-translationally. 
Correspondingly, there was also no alteration in Na-K-ATPase α1 and β1 expression in the 
plasma membrane. Therefore, the unaltered level of Na-K-ATPase α1 and β1 protein expression 
in both cellular homogenate and plasma membrane also indicate that increased Na-K-ATPase 
activity during maturation is not likely due to altered intracellular trafficking.  
The increase in Na-K-ATPase activity could be due to a change in the affinity of the Na-
K-ATPase to Na+, K+ and ATP (Faleiros, Garcon, Lucena, McNamara, & Leone, 2018; 
Kristensen & Juel, 2010). In the present study, there was an increase in the affinity for K+ of Na-
K-ATPase during cell maturation. This change in affinity may be due to the level of the 
phosphorylation of the protein. Considerable evidence indicates that the Na-K-ATPase activity is 
regulated by phosphorylation of the Na-K-ATPase α1 subunit on serine, threonine (Beguin et al., 
1994; Bertorello et al., 1991; Chibalin, Vasilets, Hennekes, Pralong, & Geering, 1992; Fisone et 
al., 1994) and tyrosine residues (El-Beialy et al., 2010; Feraille et al., 1999). It has been reported 
that there are at least 21 phosphorylation sites in rat Na-K-ATPase α1 (Soltoff, Asara, & Hedden, 
2010), including 6 tyrosine, 1 threonine, and 14 serine phosphorylation sites. Protein kinases A 
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and C (PKA, PKC) have been reported to phosphorylate the α subunit specifically on serine and 
threonine residues (Beguin et al., 1994; Bertorello et al., 1991; Chibalin et al., 1992; Fisone et 
al., 1994) whereas various tyrosine kinases phosphorylate at tyrosine residues, thus, regulating 
Na-K-ATPase activity (El-Beialy et al., 2010; Feraille et al., 1999). Multiple studies have 
reported that the phosphorylation of the Na-K-ATPase α1 subunit on tyrosine residues causes 
different responses on Na-K-ATPase activity (Al-Khalili et al., 2004; El-Beialy et al., 2010; 
Feraille et al., 1999). While some reports have demonstrated that increased tyrosine 
phosphorylation of Na-K-ATPase α1 in rat kidney tubules (Feraille et al., 1999) and human 
skeletal muscle cells (Al-Khalili et al., 2004) increases the activity of the Na-K-ATPase, others 
have reported that increased tyrosine phosphorylation of Na-K-ATPase α1 in human and pig 
renal cells reduces the activity of Na-K-ATPase (El-Beialy et al., 2010). This differential 
regulation of Na-K-ATPase pump activity by tyrosine phosphorylation might be due to 
phosphorylation at different residues or due to the differences in both tissue and species. Our 
study demonstrates that there is an increase in Na-K-ATPase α1 tyrosine phosphorylation in 
conjunction with its increase in activity as cells mature. The different results suggest that 
depending on the tissue studied, and the experimental conditions, phosphorylation of serine and 
tyrosine leads to either activation or inhibition of Na-K-ATPase (Pedemont & Bertorello, 2001). 
However, in the present study, we observed that there was an increase in serine and tyrosine 
phosphorylation whereas there was no change in threonine phosphorylation as cells mature.  
Various studies have demonstrated that Ser16 and Ser23 on the N terminus of Na-K-
ATPase α1 are PKC phosphorylation sites (Beguin et al., 1994; Chibalin et al., 1992). Ser16 is 
well conserved among mammalian α1 isoforms but is weakly phosphorylated (Pierre, Duran, 
Carr, & Pressley, 2002), whereas Na-K-ATPase α1-Ser23 is the most extensively studied residue. 
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Furthermore, Na-K-ATPase α1-Ser23 phosphorylation either increases or decreases the activity of 
Na-K-ATPase activity depending on the tissue type and experimental conditions. However, in 
the present study, Na-K-ATPase α1-Ser23 phosphorylation increases as cells mature with 






















In summary, this study determined that as the intestinal epithelial cells mature from 
secretory crypt-like (0-day) to absorptive villus-like (4-day post confluence) cells, the Na-K-
ATPase activity also increases to support the increasing absorptive capacity of the enterocytes. 
Na-K-ATPase activity increased secondary to increases in affinity (1/Km) rather than an increase 
in transporter numbers as cells matured from crypt to villus. Specifically, altered affinity is likely 
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In the mammalian small intestinal epithelial cells, Na-K-ATPase provides a favorable 
transcellular Na gradient required for the functioning of Na-dependent nutrient transporters, thus 
enabling the assimilation of nutrients. Glutamine, the primary metabolite for enterocytes, is 
absorbed via Na-glutamine co-transporter (SN2) in intestinal crypt cells. SN2 is stimulated 
during chronic intestinal inflammation secondary at least in part to the stimulation of Na-K-
ATPase during chronic ileitis. Immune-inflammatory mediator Leukotriene D4 (LTD4) is known 
to be elevated in the mucosa during chronic enteritis, but how it may regulate Na-K-ATPase is 
not known. Therefore, this study aims to determine the effect of LTD4 on Na-K-ATPase in 
intestinal epithelial cells and define its mechanism of action. In an in vitro model of rat intestinal 
epithelial cells (IEC-18 cells), grown to confluence, Na-K-ATPase activity was significantly 
stimulated by LTD4 (1 μm) as measured by 86Rb+ uptake in cells and inorganic phosphate (Pi) 
release in the plasma membrane. Since LTD4 mediates its action via calcium-dependent protein 
kinase C (PKC), calcium levels were measured and were shown to be increased by LTD4. 
Phorbol 12-Myristate 13-Acetate (PMA), an activator of PKC, mediated stimulation of Na-K-
ATPase similar to LTD4, while BAPTA-AM (calcium chelator) and Calphostin-C (PKC 
inhibitor) reversed the stimulation of Na-K-ATPase activity by LTD4. LTD4 caused a significant 
increase in mRNA and plasma membrane protein expression of Na-K-ATPase α1, and β1 
subunits which were prevented by Calphostin-C. These studies demonstrate that LTD4 
stimulates Na-K-ATPase. The mechanism of stimulation is secondary to the transcriptional 
increase of Na-K-ATPase α1 and β1 subunits in the chronically inflamed intestine. Therefore, 
LTD4 mediates this transcriptional stimulation of Na-K-ATPase via Ca2+-activated PKC 
pathway in intestinal epithelial cells during chronic intestinal inflammation. 
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4.2. INTRODUCTION 
The primary function of the mammalian small intestine is an absorption of nutrients vital 
for the survival of the organism. The process of nutrient absorption occurs through a monolayer 
of epithelial cells (innermost layer of the mucosa), called enterocytes, present in the small 
intestine. These enterocytes are further divided into immature enterocytes (crypt cells) and 
mature enterocytes (villus cells). In the mammalian small intestine, the villus cells are generally 
considered to be absorptive thus possessing virtually all nutrient absorptive transport pathways. 
In contrast, crypt cells are typically considered to be secretory and not known to have any 
nutrient absorptive pathways except for Na-glutamine co-transport, SN2 in the brush border 
membrane (BBM).  
Crypt cell BBM SN2 requires a favorable Na-gradient which is established by Na-K-
ATPase, an integral transmembrane protein located on the basolateral membrane (BLM) of these 
cells. In an animal model of chronic intestinal inflammation, resembling human inflammatory 
bowel disease (IBD), it has been demonstrated that SN2 is stimulated in crypt cells, at least in 
part secondary to the stimulation of Na-K-ATPase (Arthur et al., 2012; Saha et al., 2012). 
Further, it has been shown that the immune inflammatory mediator, LTD4, is increased in the 
mucosa during chronic intestinal inflammation. Finally, it has also been shown that inhibition of 
the formation of leukotrienes in this animal model of IBD, reverses the stimulation of Na-K-
ATPase and subsequently SN2 in crypt cells (S. Singh et al., 2018). However, it is unknown how 
LTD4 may stimulate Na-K-ATPase in crypt cells during chronic intestinal inflammation. 
It is well established that various physiological and pathophysiological conditions alter 
Na-K-ATPase through numerous mechanisms. It has been reported that there is a reduction of 
Na-K-ATPase activity in several diseases such as chronic neurodegenerative disorder (Chauhan, 
69 
Lee, & Siegel, 1997), cardiovascular (Ziegelhoffer et al., 2000), or renal disease (Rose & Valdes, 
1994). Similarly, malabsorption of a variety of nutrients in IBD is partly due to altered Na-K-
ATPase activity (Arthur et al., 2012; Coon et al., 2010; Coon et al., 2005; Saha et al., 2012; 
Sundaram et al., 2007). For example, in the IBD intestine it has been shown that in villus cells, 
BBM Na-glucose co-transport (SGLT1), Na-alanine co-transport (NAcT), Na-bile acid 
cotransporter (ASBT) and Na-glutamine co-transport (B0AT1) are all inhibited. All of these co-
transporters are altered at the level of the co-transporter in the BBM in the IBD intestine. But at 
the cellular level, the down-regulation of these co-transporters is due to the down-regulation of 
BLM Na-K-ATPase leading to the loss of the intracellular Na+ gradient. However, interestingly 
only in crypt cells, Na-K-ATPase activity was upregulated during chronic intestinal 
inflammation with concurrent stimulation of BBM Na-glutamine co-transporter SN2 (Saha et al., 
2012). This new observation is made all the more critical because SN2 is the sole nutrient 
absorptive pathway in crypt cells in health and disease. Further, Na-K-ATPase activity and 
subsequently SN2 activity was reversed to normal levels by treatment with a corticosteroid, 
methylprednisolone (Saha et al., 2012; S. Singh et al., 2018; S. Singh et al., 2015). These studies 
establish that immune inflammatory mediators are responsible for altered BLM Na-K-ATPase as 
well as BBM SN2 in crypt cells during chronic intestinal inflammation.  
Arachidonic acid metabolites (AAMs) are prominent inflammatory mediators present in 
the mucosa of intestinal tissue from patients with IBD (Romero et al., 2008) and ulcerative 
colitis (Carty, Nickols, Feakins, & Rampton, 2002). AAMs, specifically prostaglandin E2 
(PGE2) and leukotriene D4 (LTD4) have been associated with the pathogenesis of several 
diseases including rheumatoid arthritis, asthma, psoriasis, multiple sclerosis, and IBD. It has 
been reported that LTD4  has also been associated with inflammatory processes (Ford-
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Hutchinson, Bray, Doig, Shipley, & Smith, 1980) as well as intestinal secretion (Musch et al., 
1982). LTD4 has also been involved in the stimulation of SN2 and Na-K-ATPase in IEC-18 cells 
(S. Singh & Sundaram, 2015). However, the molecular mechanisms responsible for the 
stimulation of Na-K-ATPase by LTD4 in crypt cells during IBD have not been determined. 
Na-K-ATPase is dynamically regulated to change its activity according to its 
physiological requirement. This holoenzyme is constituted of various subunits: alpha (α), beta 
(β) and gamma (g) subunits. Of these subunits, two dissimilar subunits, α and β, are required for 
the proper assembly and functioning of Na-K-ATPase (Li & Langhans, 2015; McDonough & 
Farley, 1993; Mercer, 1993). However, the g subunit is expressed in specific tissues and is 
optional for the functional activity of Na-K-ATPase (Kaplan, 2002). Of these subunits, the α 
subunit has the catalytic function: exchange of 2K+ inside the cells to 3Na+ outside the cells as 
well as cleaving of ATP (Pressley, Allen, Clarke, Odebunmi, & Higham, 1996). However, the β 
subunit facilitates maturation of the α subunit by the formation of α/β heterodimer and 
transporting this enzyme to the plasma membrane (Geering, 1991). Thus, both of these subunits 
are required for the efficient functioning of Na-K-ATPase hence generating optimum sodium 
gradient inside the cell. This sodium gradient actuates secondary transport processes on BBM, 
specifically Na-nutrient co-transporter, thus enabling intestinal epithelial cells to absorb nutrients 
efficiently. At least four isoforms of the α subunit (α1, α2, α3, and α4) and three isoforms of the 
β subunit (β1, β2, and β3) are reported to date. These isoforms are expressed in a tissue-specific 
manner (Blanco et al., 1999; Kaplan, 2002; Mercer, 1993). The combination of different 
isoforms of α and β subunits make up a series of Na-K-ATPase isoenzymes (Blanco & Mercer, 
1998a). Each isoenzyme has different functional properties and is expressed differentially in a 
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tissue- and cell-specific manner (Jewell et al., 1992). Of these isoforms, α1 and β1 are 
ubiquitously present in epithelial cells and are also present in the mucosa of the intestine.  
Na-K-ATPase activity is tailored to change according to the physiological requirements 
of the cell. There are several mechanisms that regulate Na-K-ATPase activity-for example, the 
availability of the substrates (Na+, K+, and ATP). Also, the amount of the enzyme at the plasma 
membrane can be modified by changes in the rate of synthesis or degradation of the individual 
Na pump polypeptide and movement of the pump from the cytoplasm to the plasma membrane 
by exo/endocytotic vesicular transport (Blanco et al., 1998). Apart from these mechanisms, Na-
K-ATPase activity at the cell surface is directly regulated by phosphorylation and 
dephosphorylation by protein kinases and protein phosphatases respectively (Bertorello & Katz, 
1993; Ewart & Klip, 1995; McDonough & Farley, 1993). Moreover, phosphorylation of 
transcription factors associated with Na-K-ATPase α and β subunits also changes the expression 
and activity of Na-K-ATPase (Li & Langhans, 2015; Serhan & Kreydiyyeh, 2011).  
Given this background, very little research has been conducted regarding the effect of 
LTD4 on Na-K-ATPase in crypt cells, although Na-K-ATPase is vital for the absorption of 
glutamine in crypt cells. Thus, this study aims to determine the molecular mechanism of 








4.3. MATERIALS AND METHODS 
4.3.1. Reagents  
All reagents were purchased from Cayman chemicals (Ann Arbor, Michigan, USA): 
Leukotrine D4 (LTD4) (Cat # 20310), REV 5901 (Cat #70600), Calphostin-C (Cat #15383), 
REV 5901 (Cat #70600), Phorbol 12-myristate 13-acetate (PMA, Cat# 10008014), BAPTA-AM 
(Cat# 15551), Amlodipine (Cat#14838) used in the experiments. All reagents were dissolved in 
DMSO except LTD4, which was dissolved in ethanol to make the stock solutions. The final 
working concentration of the solutions contained less than 0.5% of DMSO or ethanol. Toxicity 
of all the drugs was assessed, and the safe dose was used for further experiments (Supplementary 
Figures- Figure 39).  
4.3.2. Cell culture 
 The rat small intestine cells (IEC-18) (American Type Culture Collection), between 
passages 5 and 20, were used for all of the experiments. Cells were maintained in Dulbecco’s 
modified Eagle’s medium (DMEM), supplemented with 10% (vol/vol) fetal bovine serum, 100 
U/l human insulin, 0.25 mM b-hydroxybutyric acid, and 100 units/ml penicillin and 
streptomycin. These cells were cultured in a humidified atmosphere of 10% CO2 at 37°C. Cells 
were fed with fresh DMEM every other day. 
4.3.3. Cell viability assay 
For assessing the cell viability, the MTT (3-(4,5-dimethylthaizol-2-yl)-2,5-
diphenlytetrazolium bromide) assay was performed. Vybrant MTT cell proliferation kit (cat#V-
13154) was purchased from Thermofisher Scientific. To perform the MTT assay, cells were 
seeded with equal number of cells in 96 well plate and cultured until confluent, then treated with 
test chemicals for desired time. Then medium was then removed from the wells and replaced 
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with 100 µl of fresh medium. After that, 10 µl of 12 mM MTT solution (prepared in PBS) was 
added and incubated at 37°C for 2 hours. The whole medium was aspirated and replaced with 
100 µl of SDS-HCL solution to each well and mixed thoroughly. The cells were incubated in 
SDS-HCL solution overnight (~12 hrs) at 37°C. Then the solution was again mixed, and 
absorbance was read on the spectrophotometer at 570nm. Trypan blue exclusion assay was also 
performed to measure the cell viability. 
4.3.4. Crude plasma membrane preparation 
Plasma membrane (crude) was isolated from cells according to the method of 
Havrankova et al. (Havrankova et al., 1978). Subsequently, cells were mixed with 2.5-fold 
volume of 0.001 M NaHCO3 and homogenized 3 times (10 seconds each) with homogenizer 
(IKA, Cat# 823707, T25 S1c). These homogenized cells were centrifuged at 600 x g for 30 min. 
The resultant supernatant was centrifuged for 30 min at 20,000 x g. The membrane was washed 
twice with 0.001 M NaHCO3. The final pellet was resuspended in 0.04 M Tris-HCl buffer (pH 
7.4) containing 0.1% BSA. All procedures were carried out at 4oC.  
4.3.5. Na-K-ATPase activity assay 
Na-K-ATPase activity was measured as Pi liberated (Forbush, 1983) in plasma 
membrane fractions from cells. Enzyme-specific activity was expressed as nanomoles of Pi 
released per milligram protein per minute.  
4.3.6. RNA isolation and qRT-PCR 
RNA was isolated from different experimental groups by using RNeasy mini kit obtained 
from Qiagen. Real-time quantitative PCR (qRT-PCR) was performed using isolated total RNA 
by a two-step method. First, total RNA was used to synthesize cDNA using SuperScript III 
(Invitrogen, Life Technologies) and an equal mixture of oligo (dT) primer and random hexamers. 
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Second, newly synthesized cDNA was used as template to perform real-time PCR using TaqMan 
Universal PCR master mix from Applied Biosystems (Foster city, CA) according to 
manufacturer’s protocol. Rat specific Na-K-ATPase α1- and β1-specific primers and probe were 
used for the qRT-PCR studies. Rat specific β-actin primer and probe was used as housekeeping 
gene to normalize the expression of samples.  
4.3.7. 86Rb+ uptake for Na-K-ATPase activity  
IEC-18 cells uptake studies were grown in 24 well transwell inserts (Corning Transwell # 
29442, insert size 24 mm, pore size 0.4 µ). IEC-18 cells were plated with equal number of cells. 
Uptake studies for Na-K-ATPase were done using radioactive Rubidium (86Rb+, PerkinElmer). 
Cells were incubated for 1 hr in serum free DMEM (SFM). The cells were subsequently washed 
with SFM and incubated for 10 min at 37°C in SFM containing 20μM monensin on both sides of 
the membrane. Then cells were washed with SFM. Na-K-ATPase uptake studies were then 
performed by incubating cells for 15 min with reaction mixture [SFM and 86Rb+ (~1 μCi/well)] 
on the basolateral side of the membrane in presence and absence of ouabain (1 mM). The 
reaction was stopped by addition of ice-cold MgCl2, subsequently washed three times with 
MgCl2, and the cells were lysed with 800 μl of 1N NaOH and incubation for 30 min at 70°C, 
which was then mixed with 5 ml of Ecoscint A (National diagnostics). The vials were kept in 
darkness overnight and radioactivity retained by the cells was determined in a Beckman Coulter 
6500 scintillation counter.  
4.3.8. Calcium measurement  
Calcium measurement was performed using the Fluo-8 calcium flux assay kit (Abcam, 
cat# ab112129). Cells were seeded with equal number of cells in 96 well plate and cultured until 
confluent, then treated with test chemicals for desired time. Subsequently, the supernatant was 
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removed and replaced with 100 μl Fluo-8 dye-loading solution per well and incubated for 30 min 
at room temperature. Next, the fluorescence intensity was measured at Ex/Em of 490/525 nm 
using a fluorescence plate reader (Spectramax i3x, Molecular Devices). 
4.3.9. Immunocytochemistry (ICC) staining  
IEC-18 cells were grown on a coverslip until 4-day post-confluence. Cells were treated 
respectively as mentioned before. Following the treatment for 24 hours, cells were fixed with 
100% methanol (chilled at -20°C) at room temperature for 5 min. After cells were permeabilized 
with PBST (PBS + 0.5% Tween 20) for 10 min, cells were blocked with 3% BSA in PBST for 
30 min. Then the cells were incubated for an hour at room temperature with primary antibody 
Zonula occludens (ZO-1) (Anti-Rabbit; Invitrogen, cat# 40-2200), Na-K-ATPase (Anti-mouse; 
Millipore, cat# 05-369). The secondary antibody (Alexa Fluor; Invitrogen) was added, and the 
cells were incubated at 37°C for 1h. Cells were mounted with DAPI mounting medium and 
sealed with nail polish to prevent cells from drying. An EVOS microscope was used to capture 
images, and ImageJ was used for analysis.  
4.3.10. Western blot analysis 
Western blot analysis was performed on plasma membrane fractions prepared from 
different samples as described above. Equal amounts of protein were denatured in sample buffer 
(10 mM Tris-HCl pH 7,12% glycerol, 2% SDS, 0.01% bromophenol blue, and freshly added 
1mM Dithiothreitol) and separated by electrophoresis on an 8% polyacrylamide gel. Proteins on 
the gel were transferred to a polyvinylidene fluoride membrane which was blocked with 5% milk 
or BSA in TBS (20 mM Tris pH 7.5, 150 mM NaCl) with 0.1% Tween-20 and then incubated 
with primary antibody against Na-K-ATPase α1 (Millipore, cat# 05-369) or Na-K-ATPase β1 
(Abcam, cat# ab2873) overnight at 4°C. Membranes were washed three times each with TBS and 
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TBST, followed by incubation with secondary antibody for 1 hr. Membranes were washed again 
three times each with TBS and TBST. An ECL western blotting detection reagent (GE healthcare 
Bio-Sciences, Piscataway, NJ) was used to detect the immobilized protein. The 
chemiluminescence was detected using FluorChemM instrument (Alpha Innotech, San Leandro, 
CA) and analyzed with its software. Ezrin antibody (Abcam, cat#ab4069) was used to normalize 
the expression levels of proteins in plasma membrane.  
4.3.11. Protein determination  
Total protein was measured by the Lowry method using the Bio-Rad DCTM Protein 
Assay Kit (Hercules, CA, USA). Different concentrations of BSA were used as a standard. 
Samples were diluted to 200 µl with water. The diluted sample was mixed with 250 µl of DC 
Protein Assay reagent A (cat# 500-0113) and incubated for 2 minutes. Subsequently, the sample 
was incubated for another 15 minutes after the addition of 2 ml DC Protein Assay reagent B 
(cat# 500-0114). Finally, the sample was read at OD750nm using a spectrophotometer.  
4.3.12. Statistical analysis  
All groups presented have at least n=4 per group, repeated with different passages. The 
values are presented as mean ± SEM, and p-values of <0.05 were taken to indicate statistical 
significance. All of the data were analyzed using t- test, one-way or two-way analysis of variance 








4.4.1. Stimulation of Na-K-ATPase by LTD4 
It has been shown that Na-K-ATPase activity in crypt cells, as well as LTD4 in the 
mucosa is elevated in the chronically inflamed rabbit intestine (S. Singh et al., 2018). IEC-18 
cells grown till confluence, at 0-day post confluence physiologically behave like crypt cells (e.g., 
has SN2 but not SGLT1 or NHE3). Therefore, in order to determine whether the LTD4 is 
responsible for the stimulation of Na-K-ATPase, IEC-18 cells were treated with various 
concentrations of LTD4 and the activity of Na-K-ATPase was measured by 86Rb+ uptake. Our 
observations showed that Na-K-ATPase was significantly stimulated at 1µm of LTD4 
(674.2±45.19 picomole/mg protein/min) compared to control (334.8±73.8). However, lower 
amounts of LTD4 did not show any stimulation (0.1µm-399.4±59.46, 0.5µm-380.3±42.93p) and 
higher amounts of LTD4 than 1 µm also did not show any additional stimulation of Na-K-
ATPase (Figure 18A) The stimulation of Na-K-ATPase activity in plasma membrane by 1µm of 
LTD4 was further corroborated with Na-K-ATPase assay Pi  release (0µm-5.96±0.66, 1µm-
10.96±0.45 nanomole/mg protein/min; Figure 18B).  
 
Figure 18. Effect of LTD4 exposure for 24 hours on Na-K-ATPase activity in IEC-18 cells. 
A. Measurement of Na-K-ATPase activity by 86Rb+ uptake (n=6). B. Measurement of Na-K-
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ATPase activity by Pi release in plasma membrane (n=4). Values are represented as means ± 
SEM. **, P < 0.01 vs 0 µM or control. 
4.4.2. Effect of LTD4 exposure on cell viability 
To ensure that LTD4 did not negatively affect the viability of IEC-18 cells, MTT and 
trypan blue assays were performed. Cell viability was not significantly affected by LTD4 (Figure 
19A) below 2 µm, thus for all experiments, a concentration of 1 µm was subsequently used. This 
was also validated with the trypan blue exclusion assay (Figure 19B).  
 
Figure 19. Effect of LTD4 exposure for 24 hours on cell viability. A. Measurement of cell 
Viability by MTT assay. B. Measurement of cell viability by trypan blue assay. Values are 
represented as means ± SEM, n=6. *, P < 0.05 vs 0 µM. 
4.4.3. Leukotriene receptor antagonist inhibited LTD4 effect on Na-K-ATPase  
To determine whether the effect of LTD4 is mediated through its receptor, the effect of 
the LTD4 receptor antagonist, REV5901, was studied in IEC-18 cells. REV5901 is a competitive 
antagonist of peptidoleukotrienes and specifically blocks both receptors cysteinyl leukotriene 
receptors 1 and 2, CysLT1 and CysLT2 (Van Inwegen et al., 1987). It is known that IEC-18 cells 
have LTD4 receptors (CysLT1 and CysLT2) (Talukder et al., 2008) and these receptors are 
inhibited by the specific LTD4 receptor inhibitor REV5901 (5 uM) (Talukder et al., 2008). After 
the pretreatment with REV5901, cells were treated with or without LTD4 for 24 hours, followed 
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by a rubidium uptake assay. While LTD4 alone produced a significant increase in rubidium 
uptake, neither REV5901 alone nor REV5901+LTD4 affected rubidium uptake compared to the 
control, as seen in Figure 20. These data indicate that the stimulatory effect of LTD4 is mediated 
through its receptor activation in IEC-18 cells.  
 
Figure 20. Effect of LTD4 receptor inhibitor REV5901 (5 µM) on Na-K-ATPase activity in 
IEC-18 cells. Measurement of Na-K-ATPase activity by 86Rb+ uptake. Values are represented as 
means ± SEM, n=6. **, P < 0.01; n.s., not significant. 
4.4.4. Effect of LTD4 on intracellular calcium [Ca2+]i 
Ca2+ is a second messenger and plays an essential role in signal transduction by either 
activation through ion channels or by G-protein coupled receptors (Clapham, 2007). This cation 
is vital for many physiological processes, including muscle contraction, neuronal excitability, 
cellular motility, cell growth and apoptosis (Berridge, Lipp, & Bootman, 2000; Rash, Ackman, 
& Rakic, 2016). Therefore, we looked for the effect of LTD4 on [Ca2+]i levels. Calcium channels 
were blocked with amlodipine in IEC-18 cells and then cells treated with LTD4. The [Ca2+]i 
levels increased in cells treated with LTD4 as shown in Figure 21. Intracellular Ca2+ increased 
almost 2-fold within 5 minutes and peaked at 10 minutes (~ 3-fold) with LTD4. Levels reduced 
gradually at later time points (30 minutes: ~2.3 fold, 60 minutes: ~1.8 fold, 180 minutes: ~1.3 
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fold) but were still significantly higher than control. These data indicate that LTD4 increases 
intracellular calcium.  
 
Figure 21. Level of calcium at different time points during LTD4 treatment. Measurement of 
Ca2+ by Fluo-8 calcium flux assay. Values are relative to 1 min control and are represented as 
means ± SEM, n=8. *, P< 0.05, **, P< 0.01 and ***, P<0.001 vs Control. Control and 
Amlodipine (AML, calcium channel blocker) did not change significantly at different time 
points.  
4.4.5. Effect of calcium chelator on Na-K-ATPase activity in IEC-18 cells 
Since LTD4 treatment elevated the Ca2+ level as shown in Figure 21, to determine 
whether elevated intracellular Ca2+ is responsible for the stimulation of Na-K-ATPase, we used 
the Bapta-AM. IEC-18 cells were pretreated with calcium chelator (1 µM) Bapta-AM followed 
by measuring 86Rb+ uptake. Na-K-ATPase was found to be stimulated with LTD4 whereas 
Batpa-AM treatment inhibited LTD4 mediated stimulation of Na-K-ATPase as shown in Figure 
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22 (Control-381.6±50.54, LTD4-726.3±92.26, Bapta-AM-344±25.6, Bapta-AM+ LTD4-
326.5±46.8 picomole/mg protein/min). Bapta-AM alone had no effect (Figure 22). 
 
Figure 22. Effect of calcium chelator BAPTA-AM (1µM) on Na-K-ATPase activity in IEC-
18 cells. Measurement of Na-K-ATPase activity by 86Rb+ uptake. Values are represented as 
means ± SEM, n=6. **, P < 0.01; n.s., not significant. 
4.4.6. Effect of inhibition and activation of the PKC pathway on Na-K-ATPase activity in 
IEC-18 cells 
Previous studies have shown that PKC phosphorylates Na-K-ATPase subunits which 
subsequently affects the activity of Na-K-ATPase (Galuska et al., 2011). To see whether PKC 
mediates the LTD4 effect, the cells were pretreated with 0.1 µM calphostin-C (PKC inhibitor) 
for an hour. After pretreatment, cells were treated with LTD4 for 24 hours, subsequently 
followed by 86Rb+ uptake. Pretreatment with calphostin inhibited the LTD4-mediated stimulation 
of Na-K-ATPase (Control-317.3±42.8, LTD4-710.3±61.17, Cal-C-400.8±30.14, Cal-C+ LTD4-
452±28.31 picomole/mg protein/min; Figure 23A). Similarly, the PKC activator PMA also 
stimulated Na-K-ATPase comparable to LTD4 (Control-360.9±53.12, LTD4-636.9±65.51, 
PMA-659.3±39.74; Figure 23B). These data indicate that PKC mediates LTD4 stimulation of 
Na-K-ATPase in IEC-18 cells.  
82 
 
Figure 23. Effect of PKC inhibitor and activator on Na-K-ATPase activity in IEC-18 cells. 
A. PKC inhibitor calphostin-C (0.1 µM). B. PKC activator PMA (1 µM). Measurement of Na-K-
ATPase activity by 86Rb+ uptake. Values are represented as means ± SEM, n=6. **, P < 0.01 vs 
Control; n.s., not significant. 
4.4.7. Na-K-ATPase α1 and Na-K-ATPase β1 subunit mRNA abundance during LTD4 
treatment 
Na-K-ATPase functional activity is primarily due to its α subunit whereas the β subunit 
does not have pumping activity but provides proper transportation of the α subunit to plasma 
membrane making it fully functional. Therefore, to determine whether the change in Na-K-
ATPase activity is transcriptionally regulated, we performed qRT-PCR. There was a significant 
increase in mRNA level of Na-K-ATPase α1 and Na-K-ATPase β1 subunits when exposed with 
LTD4 by 160% and 180% respectively (Figure 24A and B). However, the Na-K-ATPase α1 and 
Na-K-ATPase β1 subunits mRNA level remain unaltered compared to control when cells were 
treated with Cal-C+ LTD4 (Figure 24A and B). This data indicated that Na-K-ATPase α1 and 
Na-K-ATPase β1 subunits were transcriptionally regulated when treated with LTD4. 
Additionally, the Na-K-ATPase α1 and Na-K-ATPase β1 subunits mRNA abundance returned 
back to control levels when treated with Cal-C+LTD4, state that PKC play an important role in 
LTD4 mediated regulation of Na-K-ATPase.  
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Figure 24. QRT-PCR analysis of IEC-18 cells. Values are relative to control and normalized to 
β-actin. A. Na-K-ATPase α1. B. Na-K-ATPase β1. Values are represented as mean  SEM, 
n=4. **, P < 0.01; n.s., not significant. 
4.4.8. Na-K-ATPase α1 and Na-K-ATPase β1 subunit protein expression during LTD4 
treatment 
To determine whether changes in Na-K-ATPase activities are due to altered transcription 
of the Na-K-ATPase α1 and β1 subunits protein, Western blot analysis of plasma membrane 
(Figure 25) and immunocytochemistry of IEC-18 cells (Figure 26) was performed. Densitometric 
analysis of relative protein expression revealed that the level of Na-K-ATPase α1 protein 
expression was significantly increased by LTD4 treatment, whereas it remained at control levels 
when treated with Cal-C+LTD4 (Figure 25B and 26). Similarly, there was also a significant 
increase in Na-K-ATPase β1 subunit protein expression in the plasma membrane (Figures 25A & 
C) when treated with LTD4, and this level reverted to normal when treated with Cal-C+LTD4 
(Figures 25A & C). Therefore, the expression of Na-K-ATPase α1 and Na-K-ATPase β1 
subunits mRNA expression correlated with its protein expression in the plasma membrane. This 
shows that LTD4 regulates Na-K-ATPase transcriptionally by increasing mRNA and protein 
levels of the α1 and β1 subunits.  
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Figure 25. Western blot analysis of IEC-18 cells when treated with LTD4 and Calphostin-C 
(PKC inhibitor). A. Representative western blots of Na-K-ATPase α1, Na-K-ATPase β1 and 
Ezrin (internal control). Densitometric quantitation of blots, B. Na-K-ATPase α1 and C. Na-K-
ATPase β1. Values are relative to control and normalized to Ezrin. Values are represented as 
mean  SEM, n=4. *, P < 0.05; n.s., not significant. 
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Figure 26. Immunocytochemistry of IEC-18 cells when treated with LTD4 and Calphostin 
C (PKC inhibitor). A. Representative images of Na-K-ATPase α1(green), and ZO-1(Red), 
(20X). B. (Quantification of Na-K-ATPaseα1 (green channel). Values are represented as mean 











4.5. DISCUSSION  
In the chronically inflamed intestine, Na-glutamine co-transport, mediated by SN2, is 
stimulated at the cellular level secondary to the stimulation of Na-K-ATPase. Immune-
inflammatory pathway inhibition indicated that these unique changes might mediate through the 
leukotriene pathway (S. Singh et al., 2018). Indeed, LTD4 was shown to be elevated in the 
chronically inflamed intestinal mucosa. These observations led to the hypothesis that LTD4 may 
stimulate Na-K-ATPase thereby facilitating the stimulation of SN2 in crypt cells during chronic 
intestinal inflammation. These studies for the first time provided the mechanism of stimulation of 
Na-K-ATPase by LTD4 in crypt cells during chronic intestinal inflammation.  
To explore the mechanism described above, Rat intestinal epithelial cells (IEC-18) were 
used. These cells at 0-day post-confluence phenotypically resemble intestinal crypt cells, and by 
day 4 post-confluence mature into villus like cells. Comparable to native crypt cells, IEC-18 cells 
at day 0, have SN2 on the BBM but not SGLT1, NHE3 or any other absorptive process (S. Singh 
& Sundaram, 2015). Also comparable to crypt cells, IEC-18 cells have Na-K-ATPase, located on 
the BLM, to provide the favorable Na gradient for SN2. Thus, these cells are an ideal in vitro 
model of intestinal crypt cells.  
Alterations in intestinal epithelial cell absorption and secretion are mediated by immune 
inflammatory mediators, known to be released in the chronically inflamed intestine (Arthur et al., 
2012; Coon et al., 2010; Coon et al., 2005; Saha et al., 2012). The alteration in absorptive 
mechanisms during intestinal inflammation may be due to many immune inflammatory 
mediators including prostaglandins, leukotrienes (LTs), chemokines, interleukins, and/or reactive 
nitrogen and oxygen species (Sartor & Powell, 1991). Indeed, many of these inflammatory 
mediators have been shown to regulate nutrient and electrolyte transport processes during 
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chronic intestinal inflammation (Manokas, Fromkes, & Sundaram, 2000; Sundaram & West, 
1997; Sundaram, Wisel, & Coon, 2005; Sundaram, Wisel, & Fromkes, 1998b; Sundaram, Wisel, 
Rajendren, & West, 1997).   
Of the arachidonic acid metabolites known to be increased in the chronically inflamed 
intestinal mucosa, there is a wealth of evidence that  LTs (LTB4, LTC4, LTD4, and LTE4) are 
involved in the alteration of intestinal electrolyte transport in IBD patients (Peskar et al., 1986).  
Other studies have shown that the LOX pathway is involved in the stimulation of Na-glutamine 
transporter (SN2) and Na-K-ATPase activity in crypt cells in the inflamed intestine of rabbits (S. 
Singh et al., 2018). Hence, it was reasonable to postulate that LTD4 mediates the stimulation of 
Na-K-ATPase in crypt cells and identify the specific mechanisms by which LTD4 stimulates Na-
K-ATPase.  
This study demonstrated that 1 µM LTD4 for 24 hours is both non-toxic and optimal for 
stimulation of Na-K-ATPase in IEC-18 cells. This stimulation of Na-K-ATPase is through LTD4 
receptor activation. At the level of the intracellular signaling, receptors CysLT1 and CystLT2 
mediate their action through various G-proteins that subsequently alter intracellular Ca2+ or 
cAMP (Bouchelouche, Ahnfelt-Ronne, & Thomsen, 1990; Chan et al., 1994; Gronroos, Thodeti, 
& Sjolander, 1998; Han, Park, Lee, Lee, & Park, 1999; Thodeti & Sjolander, 2002). This study 
demonstrated that LTD4 increased intracellular Ca2+ when exposed to LTD4; thus, when Ca was 
chelated, the reversal in the stimulation of Na-K-ATPase was observed; therefore, indicating that 
stimulation of Na-K-ATPase is mediated through increased [Ca2+]i.  
LTD4 mediated increase of  [Ca2+]i, may in-turn activate Ca2+dependent kinases and 
downstream signaling (Bouchelouche et al., 1990; Chan et al., 1994; Gronroos et al., 1998; Han 
et al., 1999; Thodeti & Sjolander, 2002). Based on the external stimulus, PKC has been shown to 
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be involved in the reduction or activation of Na-K-ATPase activity, depending upon species and 
tissues studied (Borghini, Geering, Gjinovci, Wollheim, & Pralong, 1994; Feschenko & 
Sweadner, 1995). Moreover, the stimulation of various isoforms of PKC can have a differential 
effect on Na-K-ATPase. Conventional PKC a and b are associated with decreased activity of 
Na-K-ATPase by endocytosis (Chibalin, Pedemonte, et al., 1998; Feraille & Doucet, 2001), 
whereas other isoforms of PKC (e and d) have been shown to stimulate Na-K-ATPase activity 
through the ERK1/2 pathway (Galuska et al., 2011; Zhong et al., 2005). In the present study, the 
PKC pathway was activated by LTD4. When calphostin-c inhibited PKC, LTD4-mediated 
stimulation of Na-K-ATPase was attenuated, thus indicating that Ca2+ activated PKC is 
responsible for stimulation of Na-K-ATPase. Future studies will need to identify the exact PKC 
isoform responsible for the LTD4-mediated stimulation of Na-K-ATPase.  
Upon activation of PKC, its modulation of Na-K-ATPase might be due to 1) direct 
phosphorylation of Na-K-ATPase a and g subunits, or 2) alteration in transcription factors 
associated with various subunits of Na-K-ATPase (Li & Langhans, 2015). In the present study, 
LTD4 increased the transcription of the message for the α1 and β1 subunits of Na-K-ATPase and 
subsequently the protein levels of these subunits in the plasma membrane. Transcription factors 
such specific protein (Sp); Sp1, Sp2, and Sp3 are ubiquitously expressed whereas Sp4 is mainly 
confined to neurons and testis (Li & Langhans, 2015). Among these, Sp1 and Sp3 found to 
increase the transcription of the α1 and β1subunits by binding to the promoter region of these 
subunits (Johar et al., 2012; Kobayashi et al., 1997). Similarly, phosphorylation of transcription 
factor CREB induces the increased α1 mRNA level without altering β1subuint mRNA level 
(Dagenais et al., 2001). Also, the binding of ZEB1 (AREB6) to the promoter region of the α1 
subunit increases the protein level of the α1 subunit in skeletal muscle (Galuska et al., 2011). 
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Future studies will decipher the potential transcription factor via which LTD4 may stimulate Na-
























In conclusion, as shown in Figure 27, LTD4-mediated stimulation of Na-K-ATPase in 
intestinal crypt cells is due to activation of Ca-mediated PKC, which in-turn activates different 
transcription factors regulating expression of α1 and β1 subunits of Na-K-ATPase. Thus, in the 
chronically inflamed intestine, LTD4 mediated stimulation of crypt cell Na-K-ATPase which 
facilitates the stimulation of the lone nutrient absorptive pathway of these cells, namely SN2, is 
via PKC and subsequently enhanced transcription of α1 and β1 subunits of Na-K-ATPase. 
 
Figure 27. Proposed mechanism of LTD4–mediated regulation of Na-K-ATPase in 
intestinal epithelial cells. LTD4-Leukotriene-D4, LTR-Leukotriene receptor, PKC-Protein 







4.7. SUPPLEMENTARY FIGURES 
 
Figure 28. Effect of different concentration of reagents (drugs) exposure for 24 hours on cell 
viability. A. REV5901. B. calphostin-C. C. PMA (Phorbol 12-myristate 13-acetate). D. BAPTA-
AM. E. Amlodipine. Measurement of cell Viability by MTT assay. Values are relative to 0 µM 
and are represented as means ± SEM, n=6. *, P < 0.05 vs 0 µM, **, P < 0.01 vs 0 µM, ***, P < 
0.001 vs 0 µM. 
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In the mammalian small intestine, villus cells absorb nutrients, electrolytes, and water. 
The primary means of absorption of nutrients by villus cells is via Na-dependent nutrient co-
transporters located in brush border membrane (BBM) of villus cells. These secondary active co-
transport processes require a favorable transcellular Na gradient that is provided by Na-K-
ATPase, an integral basolateral membrane (BLM). Thus, inhibition of villus cell Na-K-ATPase 
during chronic intestinal inflammation results in the malabsorption of essential nutrients (e.g., 
amino acids, glucose) via Na-nutrient co-transport pathways. Glutamine is the preferred 
metabolite of intestinal epithelial cells. Its villus cell absorption is via Na-glutamine co-transport, 
B0AT1. During chronic intestinal inflammation, B0AT1 is inhibited in villus cells, at least 
partially secondary to an inhibition of Na-K-ATPase in these cells. Further, specific immune 
inflammatory mediators (e.g., PGE2) are elevated in the inflamed intestinal mucosa. But how 
PGE2 may mediate the inhibition of Na-K-ATPase in the chronically inflamed intestine is not 
known. Therefore, this study aims to determine the effect of PGE2 on Na-K-ATPase in intestinal 
epithelial cells and define its mechanism of action. An in vitro model of rat intestinal epithelial 
cells (IEC-18 cells line), was used, which resemble villus cells 4-days post-confluence.  In IEC-
18 cells, PGE2 (0.1 μm) significantly reduced Na-K-ATPase activity, as measured by 86Rb+ 
uptake and Pi release in the plasma membrane, without affecting cell viability. Since PGE2 
mediates its action via cAMP-dependent protein kinase A (PKA), cAMP levels were measured 
and shown to be increased by PGE2. 8-Bromo-cAMP (cAMP analog) acted similarly to PGE2, 
while Rp-cAMP (PKA inhibitor) reversed the PGE2-mediated reduction of Na-K-ATPase 
activity. PGE2 caused a significant decrease in mRNA and plasma membrane protein expression 
of the Na-K-ATPase α1 and β1 subunits, while Rp-cAMP prevented this inhibition by PGE2. 
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These studies demonstrated that the PGE2-mediated reduction of Na-K-ATPase is through the 
cAMP-activated PKA pathway in intestinal epithelial cells. The mechanism of inhibition is 
secondary to a transcriptional reduction in Na-K-ATPase α1 and β1 subunits. Thus, in an in vitro 
model of intestinal inflammation, PGE2 inhibits Na-K-ATPase activity through PKA by 





















Na-K-ATPase is an integral plasma membrane protein specifically present in the 
basolateral membrane (BLM) of epithelial cells that transports 3 Na+ out of and 2 K+ into the cell 
by utilizing one ATP per each transport cycle. Consequently, pumping Na+ out of the cell, Na-K-
ATPase generates a favorable transcellular Na+ gradient required for nutrient absorption in 
mammalian intestinal cells. Thus, Na-K-ATPase drives transporters, specifically Na-dependent 
transporters present on the brush border membrane (BBM) in absorptive intestinal villus cells.  
Three distinct subunits, alpha (α), beta (β) and gamma (g) subunits constitute a fully 
functional Na-K-ATPase enzyme. Of these subunits, α and β subunits are crucial for the proper 
functioning of the Na-K-ATPase, whereas the g subunit is not essential for its function (Blanco et 
al., 1999; Geering, 1991; Kaplan, 2002). The catalytic α subunit that does the pumping function 
can be found in four different isoforms (α1, α2, α3, and α4) and is reported to be expressed in a 
tissue-specific manner (Blanco et al., 1999; Kaplan, 2002; Mercer, 1993). However, the 
regulatory β subunit facilitates maturation of the α subunit by forming an α/β heterodimer and 
transporting this enzyme to the plasma membrane (Geering, 1991). The activity of Na-K-ATPase 
can be regulated by various mechanisms: 1) trafficking of pump from cytoplasm to the plasma 
membrane (Blanco et al., 1998), 2) transcriptional regulation of subunits (Musch et al., 1982; 
Serhan & Kreydiyyeh, 2011), and 3) phosphorylation and dephosphorylation of subunits 
(Bertorello & Katz, 1993; Ewart & Klip, 1995; McDonough & Farley, 1993).  
Inflammatory bowel disease (IBD) is characterized by the malabsorption of nutrients and 
electrolytes, resulting in severe weight loss and malnutrition. Previous studies have shown that 
Na-nutrient co-transport pathways in the BBM, namely Na-glucose (SGLT1), Na-alanine 
(NAcT), Na-glutamine (B0AT1), Na-bile acid cotransporter (ASBT) and Na-adenosine (DMT1), 
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which all depend on the BLM Na-K-ATPase for their optimal activities, are inhibited in villus 
cells in a rabbit model of IBD (Ejderhamn et al., 1989; Rachmilewitz et al., 1984; Sundaram & 
West, 1997; Sundaram, Wisel, & Fromkes, 1998b). In these cases, it has been reported that there 
is decreased Na-K-ATPase activity in villus cells, which implies that Na-K-ATPase might be at 
least in part responsible for the improper functioning of those transporters, thus leading to the 
malabsorption. 
It has been well established that during IBD, various immune inflammatory mediators are 
produced endogenously in the intestine (Stadnyk, 2002). These immune inflammatory mediators 
work solely or synergistically with one another to affect electrolyte and nutrient transport 
pathways (Castro, 1991; Hinterleitner & Powell, 1991; Sartor, 1991). Furthermore, immune 
inflammatory mediators such as arachidonic acid metabolites (AAMs) are prominent in the 
mucosa of patients with IBD. Specifically, prostaglandin E2 (PGE2) and leukotriene D4 (LTD4) 
have been associated with the pathogenesis of IBD and several other diseases including 
rheumatoid arthritis, asthma, psoriasis, and multiple sclerosis. PGE2 has been shown to affect 
numerous biological activities like water and electrolyte transport in the gut, have vasoactive 
effects, and induce smooth muscle contraction (Rachmilewitz et al., 1984). Moreover, the 
cyclooxygenase pathway is also responsible for the reduction of B0AT1 and Na-K-ATPase in 
villus cells of IBD-induced rabbits (Arthur et al., 2018). However, the molecular mechanisms 
responsible for PGE2-mediated reduction of Na-K-ATPase activity have not been determined. 
Therefore, this work aims to address the mechanism(s) of PGE2-mediated reduction of Na-K-




5.3. MATERIALS AND METHODS  
5.3.1. Reagents  
All reagents were purchased from Cayman chemicals (Ann Arbor, Michigan, USA): 
Prostaglandin E2 (PGE2, Cat# 14010), AH6809 (Cat# 14050), Rp-cAMP (Cat# 16985), and 8-
bromo-Cyclic AMP (Cat# 14431) were used in the experiments. All reagents were dissolved in 
DMSO to make the stock solutions. Final working concentrations of solutions contained less 
than 0.5% DMSO. Toxicity of all the drugs was assessed, and the safe dose was used for further 
experiments (Supplementary Figures- Figure 39). 
5.3.2. Cell culture 
 The cells used in experiments were rat intestinal epithelial cells (IEC-18, American Type 
Culture Collection), between passages 5 and 20. IEC-18 cells are a non-transformed, polarized 
rat epithelial cell line that maintains its integrity and biochemical properties that are similar to in 
vivo mammalian intestinal epithelial cells. Cells were maintained in Dulbecco’s modified Eagle’s 
medium (DMEM), supplemented with 10% (vol/vol) fetal bovine serum, 100 U/l human insulin, 
0.25 mM B-hydroxybutyric acid, and 100 units/ml penicillin and streptomycin. These cells were 
cultured in a humidified atmosphere of 10% CO2 at 37°C. Cells were fed with fresh DMEM 
every other day. When the cells reached 100% confluence, it was considered as 0 day and cells 
were grown until 4 days post confluence. All of the experiments were conducted on 4 days post 
confluence when they exhibit villus-like features of small intestine.  
5.3.3. Cell viability assays 
For assessing the cell viability, the MTT (3-(4,5-dimethylthaizol-2-yl)-2,5-
diphenlytetrazolium bromide) assay was performed. Vybrant MTT cell proliferation kit (cat#V-
13154) was purchased from Thermofisher Scientific. To perform MTT assay, cells were seeded 
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with an equal number of cells in 96 well plate and cultured, then treated with test chemicals for 
desired time. The medium was then removed from the wells and replaced with 100 µl of fresh 
medium. After that, 10 µl of 12 mM MTT solution (prepared in PBS) was added and incubated 
at 37°C for 2 hours. The whole medium was aspirated and replaced with 100 µl of SDS-HCL 
solution to each well and mixed thoroughly. The cells were incubated in SDS-HCL solution 
overnight (~12 hrs) at 37°C. Then the solution was again mixed, and absorbance was read on the 
spectrophotometer at 570nm. Trypan blue exclusion assay was also performed to measure the 
cell viability. 
5.3.4. Crude plasma membrane preparation 
Crude plasma membrane was prepared from IEC-18 cells following the method of 
Havrankova et al.(Havrankova et al., 1978). Cells were well mixed with 2.5-fold 0.001 M 
NaHCO3 and homogenized 3 times (10 seconds each) with homogenizer (IKA, Cat# 823707, 
T25 S1). These homogenized cells were centrifuged at 600 x g for 30 min. The resultant 
supernatant was centrifuged for 30 min at 20,000 x g. The membrane was washed twice with 
0.001 M NaHCO3. The final pellet was resuspended in 0.04 M Tris-HCl buffer (pH 7.4) 
containing 0.1% BSA. All procedures were carried out at 4oC.  
5.3.5. Na-K-ATPase activity assay 
Na-K-ATPase activity was measured as Pi liberated in plasma membrane fractions from 
IEC-18 cells according to protocol of Forbush (Forbush, 1983). Enzyme-specific activity was 
expressed as nanomoles of Pi released per milligram protein per minute.  
5.3.6. RNA isolation and qRT-PCR 
RNA was isolated from different experimental groups by using RNeasy mini kit obtained 
from Qiagen. Real-time quantitative PCR (qRT-PCR) was performed using isolated total RNA 
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by a two-step method. First, total RNA was used to synthesize cDNA using SuperScript III kit 
(Invitrogen, Life Technologies). Second, newly synthesized cDNA was used as template to 
perform real-time PCR using TaqMan Universal PCR master mix from Applied Biosystems 
(Foster city, CA) according to manufacturer’s protocol. Rat specific Na-K-ATPase α1- and β1-
specific primers and probe were used for the qRT-PCR studies. Rat specific β-actin primer and 
probe was used as a housekeeping gene to normalize the expression of samples. 
5.3.7. 86Rb+ uptake for Na-K-ATPase activity  
For uptake studies, IEC-18 cells were grown on transwell inserts (Corning Transwell # 
29442, insert size 24 mm, pore size 0.4 µ) in 24 well plates. IEC-18 cells were plated with equal 
number of cells. Uptake studies for Na-K-ATPase were done using radioactive Rubidium (86Rb+, 
PerkinElmer). Cells were incubated for 1 hr in serum free DMEM (SFM). The cells were 
subsequently washed with SFM and incubated for 10 min at 37°C in SFM containing 20 μM 
monensin on both sides of the membrane. Then cells were washed with SFM. Na-K-ATPase 
uptake studies were then performed by incubating cells for 15 min with reaction mixture [SFM 
and 86Rb+ (~1 μCi/well)] on the basolateral side of the membrane in presence and absence of 
ouabain (1 mM). The reaction was stopped by addition of ice-cold MgCl2, subsequently washed 
three times with MgCl2, and the cells were lysed with 800 μl of 1N NaOH and incubation for 30 
min at 70°C, which was then mixed with 5 ml of Ecoscint A (National diagnostics). The vials 
were kept in darkness overnight and radioactivity retained by the cells was determined in a 
Beckman Coulter 6500 scintillation counter.  
5.3.8. cAMP measurement  
Calcium measurement was performed using the cAMP Direct immunoassay kit (Abcam, 
cat# ab65355). Cells were seeded with an equal number of cells in 35 cm2 dish and cultured until 
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4-day post confluent, then treated with test chemicals for desired time. The medium was 
aspirated followed by addition of 282 μl of 0.1 M HCl. The suspension was homogenized by 
pipetting up and down several times. Then the suspension was centrifuged for 10 minutes at 
14,000 rpm. The resultant supernatant collected was used for further experiments. Next the 
sample was diluted and mixed with acetylating reagents. After that, the samples were loaded in 
96 well plates and incubated with cAMP antibody for an hour; cAMP-HRP was added to each 
well and incubated for another hour and washed 3 times with wash buffer. Subsequently, HRP 
developer was added and incubated for 1 hr. The reaction was stopped by 1M HCl and the color 
developed was read at OD450nm using a plate reader (Spectramax i3x, Molecular Devices). 
5.3.9. Western blot analysis 
Western blot analysis was performed on plasma membrane fractions prepared from 
different samples as described above. Equal amounts of protein (10 μg) were denatured in 
sample buffer (10 mM Tris-HCl pH 7, 12% glycerol, 2% SDS, 0.01% bromophenol blue, and 
freshly added 1 mM Dithiothreitol) and separated by electrophoresis on a 8% polyacrylamide 
gel. Proteins on the gel were transferred to a polyvinylidene fluoride membrane which was 
blocked with 5% milk or BSA in TBS (20 mM Tris pH 7.5, 150 mM NaCl) with 0.1% Tween-20 
and then incubated with primary antibody against Na-K-ATPase α1 (Millipore, cat# 05-369) or 
Na-K-ATPase β1 (Abcam, cat# ab2873) overnight at 4°C. Membranes were washed three times 
each with TBS and TBST, followed by incubation with secondary antibody for 1 hr. Membranes 
were washed again three times each with TBS and TBST. ECL western blotting detection 
reagent (GE healthcare Bio-Sciences, Piscataway, NJ) was used to detect the immobilized 
protein. The chemiluminescence was detected using FluorChem instrument (Alpha Innotech, San 
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Leandro, CA) and analyzed with its software. Ezrin (Abcam, cat#ab4069) antibody was used to 
normalize the expression levels of proteins in plasma membrane fractions.  
5.3.10. Immunocytochemistry (ICC) staining  
IEC-18 cells were grown on coverslip to 4-day post confluence. Cells were treated with 
PGE2 or Rp-cAMP and as mentioned before. Following the treatment for 24 hours, cells were 
fixed with 100% methanol (chilled at -20°C) at room temperature for 5 min. After cells were 
permeabilized with PBST (PBS + 0.5% Tween 20) for 10 min, cells were blocked with 3% BSA 
in PBST for 30 min. Then the cells were incubated for an hour at room temperature with primary 
antibodies ZO-1 (Anti-Rabbit; Invitrogen cat# 40-2200), and Na-K-ATPase (Anti-mouse; 
Millipore cat# 05-369). Alexa Fluor secondary antibodies (Invitrogen) were added, and the cells 
were incubated at room temperature for an hour. Cells were mounted with DAPI-containing 
mounting medium (Abcam) and sealed with nail polish to prevent cells from drying. An EVOS 
microscope (Invitrogen) was used to capture images and ImageJ software was used for analysis.  
5.3.11. Protein determination  
Total protein was measured by Lowry method using the DC Protein Assay Kit (Bio-Rad, 
Hercules, CA). Different concentrations of BSA were used as standards. Samples were diluted to 
200 µl with water. The diluted sample was mixed with 250 µl of DC Protein Assay reagent A 
(cat# 500-0113) and incubated for 2 minutes. Subsequently, the sample was incubated for 
another 15 minutes after the addition of 2 ml DC Protein Assay reagent B (cat# 500-0114). 
Finally, the sample was read at OD750nm using a spectrophotometer.  
5.3.12. Statistical analysis  
All groups presented have at least n=4 per group, repeated with a different passage. The 
values are presented as mean ± SEM, and p-values of <0.05 were taken to indicate statistical 
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significance. All of the data were analyzed using t-test, one-way or two-way analysis of variance 
























5.4.1. Effect of PGE2 on Na-K-ATPase in IEC-18 cells 
IEC-18 cells were treated with various concentrations of PGE2 for 24 hours (two 
treatments 12 hours apart), and the activity of Na-K-ATPase was measured by 86Rb+ uptake.  
The lowest dose of PGE2 at which Na-K-ATPase activity was significantly diminished was at 
0.1 µm of PGE2 (792±53.2 picomole/mg protein/min) compared to control (1656±95.6) (Figure 
29A). The reduction of Na-K-ATPase activity in the plasma membrane by 0.1 µm of PGE2 was 
further corroborated by the Na-K-ATPase inorganic phosphate (Pi) release assay (Control-
18.9±1.64, PGE2, 1 µm-9.36±1.22 nanomole/mg protein/min; Figure 29B).  
 
Figure 29. Effect of PGE2 exposure for 24 hours on Na-K-ATPase activity in IEC-18 cells. 
A. Measurement of Na-K-ATPase activity by 86Rb+ uptake (n=6). B. Measurement of Na-K-
ATPase activity by Pi release in plasma membrane preparations (n=4). Values are represented as 
means ± SEM. **, P < 0.01 and ***, P<0.001 vs 0 µM or control. 
5.4.2. Effect of PGE2 on cell viability 
To ensure that a given dose of PGE2 did not affect the viability of IEC-18 cells, MTT and 
trypan blue assays were performed. Cell viability was not significantly altered with 0.25 µm or 
less concentration of PGE2 (Figure 30A). However, there was decreased cell viability in IEC-18 
cells with 1 µm or higher concentration of PGE2. |erefore, the concentration we used for our 
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experiments (0.1 µm) did not cause any cell death, which was also validated with the trypan blue 
exclusion assay (Figure 30B).  
 
Figure 30. Effect of PGE2 exposure for 24 hours on cell viability. A. Measurement of cell 
viability by MTT assay. B. Measurement of cell viability by trypan blue assay. Values are 
represented as means ± SEM, n=6. *, P < 0.05, **, P < 0.01 vs 0 µM. 
5.4.3. Prostaglandin receptor antagonist blocked PGE2 effect on Na-K-ATPase  
The PGE2 receptor antagonist AH6809 was used to determine if the PGE2 effect is specifically 
mediated through its receptor in IEC-18 cells. AH6809 is an EP and DP receptor antagonist which blocks 
EP1, EP2, EP3, EP4 and DP1 receptors present in cells (Abramovitz et al., 2000). Previous studies from 
our laboratory have shown that EP2 and EP4 receptors are present in IEC-18 cells (data not shown). In 
this study, IEC-18 cells were pretreated with 5 µM of AH6809 for an hour followed by PGE2 treatment 
for 24 hours (two treatments 12 hours apart). As shown in Figure 31, PGE2 significantly inhibited Na-
K-ATPase, however, pretreatment with AH6089 followed by PGE2 treatment prevented the inhibition 
produced by PGE2 (Control-1690±111.1, PGE2-792±81.1, AH6089-1645±115, AH6089+PGE2-
1528±85.4 picomole/mg protein/min). This indicates that the inhibitory effect of PGE2 is mediated 
through its receptors EP2 and/or EP4 in IEC-18 cells.  
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Figure 31. Effect of PGE2 receptor inhibitor AH6809 (5 µM) on Na-K-ATPase activity in 
IEC-18 cells. Measurement of Na-K-ATPase activity by 86Rb+ uptake. Values are represented as 
means ± SEM, n=6. ***, P < 0.001; n.s., not significant. 
5.4.4. Effect of PGE2 on intracellular cAMP 
In many systems, PGE2 is known to mediate its action via cAMP. This second messenger 
is involved in various physiological and pathophysiological processes (Rahman, Buck, & Levin, 
2013). Thus, measurement of cAMP was conducted. PGE2 treatment increased the cAMP levels 
in IEC-18 cells as shown in Figure 32. cAMP increased 2.4-fold (Control-11.4±2.3, PGE2-
27.09±3.1 picomole/mg protein) within 2 minutes and peaked at 10 minutes (4.3-fold, Control-
10.1±0.5, PGE2-43.2±3.3 picomole/mg protein) with PGE2. Levels reduced gradually at later 
time points (30 minutes, 3.3-fold; Control-11.4±2.9, PGE2-37.7±2.4, 60 minutes, 1.9-fold; 
Control-12.9±2.2, PGE2-25±2.8, 180 minutes, 1.8-fold; Control-12.5±4,6, PGE2-22.3±0.6 
picomole/mg protein) but were still significantly higher than control. Thus, these data indicate 
that PGE2 increased cAMP levels in IEC-18.    
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Figure 32. Level of cAMP at different time points during PGE2 treatment. Measurement of 
cAMP by cAMP Elisa kit. Values are represented as means ± SEM, n=8. *, P< 0.05, **, P< 0.01 
and ***, P<0.001 vs Control. Control did not change significantly at different time points.  
5.4.5. Effect of an analogue of cAMP on Na-K-ATPase activity in IEC-18 cells 
To know whether increased cAMP is responsible for the reduction of Na-K-ATPase, we 
used an analog of cAMP: 8-Bromo-cAMP. IEC-18 cells were treated with 0.1 µM 8-Bromo-
cAMP for 24 hours (two treatments 12 hours apart) followed by 86Rb+ uptake. The Na-K-
ATPase activity was found to be diminished with 8-bromo-cAMP treatment comparable to PGE2 




Figure 33. Effect of cAMP analogue 8-Bromo-cAMP (0.1 µm) on Na-K-ATPase activity in 
IEC-18 cells. Measurement of Na-K-ATPase activity by 86Rb+ uptake. Values are represented as 
means ± SEM, n=6. ***, P < 0.001 vs Control. 
5.4.6. Effect of PKA pathway inhibition on Na-K-ATPase activity in IEC-18 cells 
It has been demonstrated that cAMP mediates its effects via protein kinase A (PKA) and 
subsequent phosphorylation of many proteins (Walsh & Van Patten, 1994). To see whether PKA 
plays an active role in the regulation of Na-K-ATPase by PGE2, cells were pretreated with 10 
µM of the PKA inhibitor Rp-cAMP for an hour. After pretreatment, cells were treated with 
PGE2 for 24 hours (two treatments 12 hours apart) and cellular uptakes for 86Rb+ were 
performed. Pretreatment with Rp-cAMP prevented the PGE2-mediated reduction of Na-K-
ATPase (Control-1592±100.9, PGE2-746±75.3, Rp-cAMP-1596±67.3, Rp-cAMP+PGE2-1455± 
113.5 picomole/mg protein/min; Figure 34). 
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Figure 34. Effect of PKA inhibitor Rp-cAMP (10 µM) on Na-K-ATPase activity in IEC-18 
cells. Measurement of Na-K-ATPase activity by 86Rb+ uptake. Values are represented as means ± 
SEM, n=6. ***, P < 0.001; n.s., not significant. 
5.4.7. Na-K-ATPase α1 and Na-K-ATPase β1 subunit mRNA abundance after PGE2 
treatment 
Gene and protein expression levels of Na-K-ATPase subunits, specifically α and β, are 
correlated with its functional activity. While the α subunit is accountable for Na-K-ATPase 
pumping activity, the β subunit does not contribute any pumping activity directly but instead 
supports α subunit by proper folding and transporting α subunit from the cytoplasm to the plasma 
membrane. Therefore, to determine whether changes in Na-K-ATPase activity mediated by 
PGE2 are transcriptionally regulated, we performed qRT-PCR analysis. Na-K-ATPase α1 
subunit mRNA was significantly decreased when exposed to PGE2, while Rp-cAMP 
pretreatment prevented the reduction of Na-K-ATPase α1 subunit (Figure 35A, control-1.00X, 
PGE2-0.65X±0.04, Rp-cAMP-0.88X±0.13, PGE2+Rp-cAMP-0.93X±0.09). Similarly, there was 
a decrease in Na-K-ATPase β1subunit level when treated with PGE2, but the reduction was 
partially abolished when pretreated with Rp-cAMP (Figure 35B, control-1.00X, PGE2-
0.55X±0.06, Rp-cAMP-1.01X±0.16, PGE2+Rp-cAMP-0.85X±0.05). These data indicate that 
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Na-K-ATPase α1 and β1 subunits were transcriptionally downregulated when treated with 
PGE2. Additionally, the PGE2-mediated decrease in Na-K-ATPase α1 and β1 subunit mRNA 
abundance was prevented with Rp-cAMP+ PGE2, indicating that the PKA pathway is 
responsible for PGE2-mediated regulation of Na-K-ATPase.  
 
Figure 35. qRT-PCR analysis of IEC-18 cells. Values are relative to control and normalized to 
β-actin. A. Na-K-ATPase α1. B. Na-K-ATPase β1. Values are represented as mean  SEM, 
n=4. *, P < 0.05, **, P < 0.01; n.s., not significant. 
5.4.8. Na-K-ATPase α1 and Na-K-ATPase β1 subunit protein expression after PGE2 
treatment 
Protein levels of Na-K-ATPase α1 and Na-K-ATPase β1 subunits were determined by 
performing immunocytochemistry of cell monolayers and Western blots analysis on plasma 
membrane fractions for all experimental conditions. Immunocytochemistry (Figure 36) and 
Western blot analysis (Figure 37) showed that relative levels of Na-K-ATPase α1 protein 
expression were significantly lowered after PGE2 treatment, whereas this reduction was blocked 
when treated with Rp-cAMP+PGE2 (Figure 37A and B, control-1.00, PGE2-0.56±0.26, Rp-
cAMP-1.02±0.19, PGE2+Rp-cAMP-0.93±0.21). Similarly, there was also a significant decrease 
in Na-K-ATPase β1 subunit protein expression in plasma membrane fractions when treated with 
111 
PGE2, and this was reversed when treated with Rp-cAMP+ PGE2 (Figure 37A and C, control-
1.00, PGE2-0.73±0.1, Rp-cAMP-1.06±0.1, PGE2+Rp-cAMP-1.04±0.08). Therefore, the 
expression of Na-K-ATPase α1 and β1 subunits mRNA correlated with its protein expression in 
plasma membrane fractions. These data indicate that PGE2 regulates Na-K-ATPase 
transcriptionally through the cAMP-activated PKA pathway. 
 
Figure 36. Immunocytochemistry of IEC-18 cells treated with PGE2 and Rp-cAMP (PKA 
inhibitor). A. Representative images of Na-K-ATPase α1(green), and ZO-1(red), (20X). B. 
Quantification of Na-K-ATPase α1 fluorescence. Values are represented as mean  SEM, n=6. 
**, P < 0.01 vs Control. 
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Figure 37. Western blot analysis of IEC-18 cells treated with PGE2 and Rp-cAMP (PKA 
inhibitor). A. Representative western blots of Na-K-ATPase α1, Na-K-ATPase β1 and Ezrin 
(internal control). Densitometric quantitation of blots, B. Na-K-ATPase α1 and C. Na-K-ATPase 
β1. Values are relative to control and normalized to Ezrin. Values are represented as mean  












Prostaglandins play an essential role in maintaining normal physiological processes such 
as intestinal secretion, motility, mucosal protection (Mohajer & Ma, 2000). However, they have 
also been seen to be increased in the mucosa during chronic enteritis (Ligumsky et al., 1981; 
Sharon, Ligumsky, Rachmilewitz, & Zor, 1978). PGE2 has been extensively studied in the 
various process such as apoptosis (Huang et al., 2009), and inflammatory processes (Mohajer & 
Ma, 2000). Regarding intestinal absorption, PGE2 has been shown to decrease active sodium and 
chloride absorption and increase chloride secretion in in vitro studies (Ligumsky et al., 1981; 
Sharon et al., 1978). PGE2 has also been involved in the regulation of intestinal epithelial 
transporters including Na-glucose (SGLT1) (Hyun, Arai, Onaga, & Kato, 1997; Talukder et al., 
2014), Na/H exchanger (Hodeify & Kreydiyyeh, 2007; Moeser, Nighot, Ryan, Wooten, & 
Blikslager, 2006), Na-K-ATPase (Markossian & Kreydiyyeh, 2005) and Cl-/HCO3- (Fujii et al., 
2016). Moreover, our laboratory has also shown that the cyclooxygenase pathway, which 
produces prostaglandins, has been involved in the reduction of Na-glutamine uptake (B0AT1) 
and Na-K-ATPase activity in villus cells in the inflamed intestine of rabbits (Arthur et al., 2012). 
Given this background, it is evident that PGE2 plays a crucial role in transporters involved in 
intestinal epithelial cell absorptive pathways, perhaps including Na-K-ATPase during chronic 
enteritis. However, the mechanism of regulation of Na-K-ATPase by PGE2 in intestinal 
epithelial cells during chronic intestinal inflammation is not known.  
In the present study, we demonstrated the mechanisms of regulation of Na-K-ATPase by 
the inflammatory mediator PGE2 which in turn regulates several secondary active Na-dependent 
nutrient and electrolyte transporters. This work revealed that PGE2 reduces Na-K-ATPase 
activity through the PKA-mediated pathway in rat intestinal epithelial cells (IEC-18 cells), which 
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physiologically behave like absorptive villus cells when grown four days post-confluent (Saha et 
al., 2015).  
PGE2 is a well-known regulator of Na-K-ATPase activity in numerous tissue types. A 
PGE2-mediated inhibitory effect has been seen in various organs including heart (Skayian & 
Kreydiyyeh, 2006), liver (Kreydiyyeh, Riman, Serhan, & Kassardjian, 2007; Seven, Turkozkan, 
& Cimen, 2005), and kidney (Cimen, Turkozkan, Seven, Unlu, & Karasu, 2004). Similar to other 
findings, our data also demonstrates that 0.1 µM of PGE2 for 24 hours is optimal for reduction of 
Na-K-ATPase in IEC-18 cells. Our qRT-PCR data showed that PGE2 transcriptionally reduces 
Na-K-ATPase a1 and b1, which led to a decrease in plasma membrane protein expression of 
both subunits as demonstrated by western blot analysis.  
Previously, our laboratory has shown that IEC-18 cells have PGE2 receptors (EP1, EP2, 
EP3, and EP4). The specific inhibitor AH6809 is an EP and DP receptor antagonist and inhibits 
these receptors with equal affinity (Abramovitz et al., 2000). When IEC-18 cells were pretreated 
with AH6809, the reduction of Na-K-ATPase due to PGE2 treatment was prevented. These data 
demonstrate that the decrease of Na-K-ATPase activity is mediated through PGE2 receptors. 
These receptors mediate their action through secondary messengers such as Ca2+ or cAMP 
(Funk et al., 1993; Woodward, Pepperl, Burkey, & Regan, 1995). We observed that PGE2 
increases the intracellular cAMP levels. Therefore, to demonstrate the role of cAMP in the 
reduction of Na-K-ATPase, we treated cells with a cAMP analog (8-Bromo-cAMP). There was a 
similar effect produced by 8-Bromo-cAMP comparable to PGE2.  
PGE2 has been shown to activate signaling pathways through PKA or PKC, downstream 
of the second messenger cAMP or Ca2+ in various cell types (Sachs, Villarreal, Cunha, Parada, 
& Ferreira, 2009; Sawasdikosol, Pyarajan, Alzabin, Matejovic, & Burakoff, 2007). PKA has 
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been shown to have differential regulation (activation, inhibition, or no effect) of Na-K-ATPase 
based on the tissue types. The discrepancy in the regulation of Na-K-ATPase by PKA might be 
due to phosphorylation of different isoforms of Na-K-ATPase subunits (Blanco et al., 1998). 
Oliveira et al. reported that short-term treatment of PGE2 has a PKA-mediated inhibitory effect 
on Na-K-ATPase hippocampal tissue likely due to phosphorylation of the Ser943 residue of the 
α subunit (Oliveira et al., 2009). On the other hand, cAMP-mediated PKA has also been shown 
to regulate Na-K-ATPase transcriptionally. Dagenais et al. reported that activation of PKA by a 
cAMP analog subsequently phosphorylates transcription factor CREB and eventually increased 
the synthesis of mRNA of the a1 subunit but not the b1subunit after 8 hours treatment in isolated 
rat alveolar epithelial cells (Dagenais et al., 2001). However, there was no significant change in 
a1 mRNA level after 24 hours of treatment. Additionally, three prostaglandin response elements 
(PGRE) have been identified in the b1subunit, which in response to PGE1 (4 hours treatment) 
increased the transcription of the b1subunit by activating transcription factors CRE and CREB 
(Matlhagela et al., 2005; Matlhagela & Taub, 2006a, 2006b). Contrary to this finding, in our 
study, we found that a cAMP-mediated PKA is responsible for inhibition of Na-K-ATPase. The 
discrepancy in the results may be due to the different tissues of origin that we used, the 
concentration of the PGE2, and/or the exposure time. Another possible reason for this 
discrepancy might be the observed effect might be an early response.  
However, in a study  by Mony et.al,  in the hypoxic condition in cancer, transcription 
factors hypoxia inducing factor (HIF-1a) and Smad3 bind to the b1 subunit and likely repress 
the expression of beta-subunit (Mony et al., 2013). Therefore, the prolonged treatment with 
PGE2 might result in transcription repression of b1 subunit by transcription factors like (HIF-1a) 
and Smad3.  
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5.6. CONCLUSION 
The current study indicates that the mechanism by which PGE2 reduces Na-K-ATPase 
activity is via the cAMP-mediated PKA pathway, as shown in Figure 38. The mechanism 
involves binding of PGE2 to prostaglandin receptors, leading to subsequent activation of the 
PKA pathway through increased intracellular cAMP which eventually leads to a decrease in Na-
K-ATPase activity. The reduction in activity is most likely due to transcriptional repression of 
genes encoding various subunits of Na-K-ATPase.  
 
 
Figure 38. Proposed mechanism of PGE2-mediated regulation of Na-K-ATPase in intestinal 







5.7. SUPPLEMENTARY FIGURES 
 
Figure 39. Effect of different concentration of reagents (drugs) exposure for 24 hours on cell 
viability. A. AH6809. B. Rp-cAMP. C. 8-Bromo-cAMP. Measurement of cell Viability by MTT 
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CHAPTER 6: DISCUSSION AND FUTURE DIRECTIONS 
6.1. DISCUSSION 
The incidence of IBD has been seen to be increasing in the Western world since the 
1950s (Lakatos, 2006). Various factors contribute to the pathogenesis of IBD including genetic 
heterogeneity, intestinal microbiome, and several environmental factors, thus generating 
complexity in the prognosis of the disease (K. L. Wallace, Zheng, Kanazawa, & Shih, 2014). 
Individuals suffering from IBD, and specifically with Crohn’s disease, are likely to have 
nutritional deficiency because of chronic diarrhea leading to malabsorption of electrolytes and 
nutrients (Massironi et al., 2013). Additionally, increased energy expenditure and decreased 
nutrient uptake during IBD are known to further worsen the disease condition. Among various 
factors that cause diarrhea in IBD, the effects of inflammation on muscular tone and intestinal 
transport remain the prominent ones (Wenzl, 2012). The most common treatment to overcome 
chronic inflammation and nutrient loss during diarrhea to date are enteral nutrition or steroid 
therapy. However, steroids are the first line of treatment in adults with enteral nutrition as 
supportive therapy, whereas enteral nutrition remains the preferred treatment in children 
(Massironi et al., 2013). Though steroids improve or put the disease in remission, they have been 
reported to have numerous side effects causing additional discomfort to the patients. Therefore, it 
becomes crucial to identify the immune components that might interfere with the absorption of 
specific nutrients in the intestine so that drugs can be developed against them to replace steroids 
for IBD treatment. 
A comprehensive understanding of nutrient and electrolyte transport during IBD is of 
utmost relevance to developing better treatments of IBD. Over the past two decades, there have 
been extensive studies on nutrient transporters in a rabbit model of chronic intestinal 
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inflammation resembling IBD (Coon et al., 2010; Saha et al., 2012; Sundaram, Wisel, & 
Fromkes, 1998a; Sundaram et al., 1997). A series of studies done in this in vivo rabbit model of 
IBD have reported that various nutrient transporters, namely Na-glucose (SGLT1), Na-amino 
acid [-alanine (ATB0), -glutamine (B0AT1)], Na-bile acid (ASBT), and Na-adenosine 
cotransport are significantly reduced in villus cells (Coon et al., 2010; Saha et al., 2012; 
Sundaram et al., 1998a; Sundaram et al., 1997). All these studies indicated that along with 
decreased nutrient absorption, there was also a decrease in sodium absorption, since all the above 
indicated cotransporters of different nutrients are sodium-dependent. Additionally, in this animal 
model of IBD, Na-K-ATPase activity was also significantly decreased in villus cells, indicating 
decreased transcellular sodium transport, which may be partially responsible for the decreased 
nutrient at the brush border membrane. On the contrary, it has also been reported that in crypt 
cells there is increased glutamine absorption mediated by the Na-glutamine cotransporter (SN2) 
along with increased Na-K-ATPase activity during chronic enteritis in the rabbit model (Saha et 
al., 2012). The discrepancy in glutamine absorption between villus and crypt cells during 
inflammation of the intestine might be due to villus atrophy and crypt hypertrophy, and the crypt 
cells trying to compensate for the loss of glutamine absorption by the villus cells (Saha et al., 
2012). However, this increased glutamine absorption in crypts did not compensate for the loss of 
villus cell glutamine absorption, resulting in a net decrease in glutamine absorption across the 
villus-crypt axis. 
 A net decrease in Na and water absorption in the intestine rather than increased anion 
secretion resulting in watery stool, has also been reported by other studies in IBD (Hawker, 
McKay, & Turnberg, 1980; Sandle, 2005). The net reduction of Na absorption is likely due to 
decreased Na-K-ATPase activity (and expression) observed in IBD samples and IBD models 
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(Tables 3, 4, and 5). The outcome of decreased Na-K-ATPase activity may result in an elevation 
of intracellular Na level, thus reducing the Na and Na-dependent nutrient absorption capacity of 
the enterocytes.     
Given this background, it becomes important to understand the intracellular signaling and 
molecular mechanisms responsible for the alteration of sodium absorptive processes in the 
intestine during IBD. However, in vivo systems do not facilitate effective manipulation and 
dissection of specific cellular processes and protein targets due to their physiological complexity. 
Therefore, there was a need to develop an in vitro model, which could behave like either crypt or 
villus cells under defined culture conditions. To date, the majority of investigations related to 
absorptive and inflammatory mechanisms were done in colon cancer cell lines (Caco-2 or T-84), 
which do not represent the small intestinal enterocytes well (Table 3). Additionally, the 
complexity generated by the effects of oncogenesis on these cell lines makes them less ideal for 
studying effects mediated by immune-inflammatory mediators. However, a rat small intestine-
derived normal intestinal epithelial cell line called IEC-18 has been successfully used as an in 
vitro model to study enterocytes at the level of either immature crypt-like cells and mature villus-
like cells. 
Based on this background, the objective of the current study was to dissect the specific 
molecular mechanisms responsible for the modulation of sodium-dependent nutrient transporters 
and Na-K-ATPase by specific immune inflammatory mediators in villus and crypt cells. To 
accomplish this objective, this study was divided into different sub-projects. The first study was 
to characterize the in vitro model (IEC-18) so it could be used as a cell model comparable to both 
crypt and villus enterocytes. Once establishing IEC-18 as an appropriate in vitro system to study 
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both crypt and villus cells, we then studied the effect of specific immune inflammatory mediators 
on Na-K-ATPase activity. Our findings are summarized below. 
6.1.1. Maturation of IEC-18 cells 
During the maturation of intestinal absorptive cells from crypt to villus, significant 
morphological and physiological changes occur. Morphological changes include changes in 
membrane composition and surface area, so that physiologically mature cells acquire more 
transporters and therefore increased capacity to absorb nutrients. A study of the crypt-villus axis 
of piglets has shown that there is upregulation of proteins associated with 
glycolysis/gluconeogenesis, fatty acid metabolism, amino acid metabolism, and citrate cycle as 
cells mature from crypt to villus (Yang et al., 2016). Additionally, it has been reported that ALP, 
aminopeptidase, sucrose, lactase and Na-K-ATPase activities increased along the crypt-villus 
axis in jejunum and ileum of neonatal pigs (Fan et al., 2001). Similar to these results, our study 
has shown that there is an increase in ALP and SGLT1 activities as IEC-18 cells mature from 
crypt-like to villus-like in culture. 
6.1.2. Regulation of Na-K-ATPase during intestinal cell maturation 
There are contradictory reports in the literature addressing the levels of Na-K-ATPase 
activity during the maturation of intestinal epithelial cells (Blostein et al., 1983; Brugnara & de 
Franceschi, 1993; Furukawa et al., 1981). The mechanism involved in the reduction of activity 
was found to be due to the shedding of Na-K-ATPase into exosomes or due to degradation by 
energy-dependent mechanisms (Mairbaurl et al., 2000). Moreover, studies from our lab have 
demonstrated that the activity of Na-K-ATPase is elevated in villus cells compared to the crypt 
cells (Saha et al., 2012). In these studies, Na-K-ATPase activity varied depending upon the 
physiological nutritional demand of the intestinal epithelial cells during the maturation process. 
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Supporting this notion, the present study has shown that there is an increase in Na-K-ATPase 
activity as IEC-18 cells mature from crypt-like to villus-like.  
While intestinal epithelial cells mature from crypt to villus, Na-K-ATPase activity also 
increases to support the increasing absorptive capacity of the enterocytes. The results of this 
study showed that the increased Na-K-ATPase activity in villus-like cells compared to crypt-like 
cells is likely due to the change in the affinity of the transporter rather than an elevated 
expression of Na-K-ATPase. Moreover, the differences in affinity are due to changes in 
phosphorylation of the α1 subunit of Na-K-ATPase, specifically at serine and tyrosine residues. 
6.1.3. Regulation of Na-K-ATPase during induced inflammatory condition (LTD4 
treatment) in crypt-like cells 
Various inflammatory mediators such as prostaglandins, leukotrienes, chemokines, 
interleukins, and/or reactive nitrogen and oxygen species are known to modulate intestinal 
nutrient and electrolyte transporters (Sartor & Powell, 1991). The mechanisms of modulation by 
these factors are unique to the transporters during chronic intestinal inflammation  (Manokas et 
al., 2000; Sundaram & West, 1997; Sundaram et al., 2005; Sundaram et al., 1998b; Sundaram et 
al., 1997). Previously, our laboratory has shown that the LOX pathway, which produces 
leukotrienes, is involved in the stimulation of Na-glutamine transporter (SN2) and Na-K-ATPase 
activity in crypt cells in the inflamed intestine of rabbits (S. Singh et al., 2018). In agreement 
with this study, the present study also demonstrates that there is increased Na-K-ATPase activity 
during LTD4 exposure to crypt-like cells. Subsequently, the LTD4-mediated stimulation of Na-
K-ATPase in intestinal epithelial cells is due to Ca-mediated activation of the PKC (Figure 40), 
which in turn may activate different transcription factors upregulating the expression of the Na-
K-ATPase a1 and b1 subunits. 
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6.1.4. Regulation of Na-K-ATPase during induced inflammatory condition (PGE2 
treatment) in villus-like cells 
PGE2-mediated inhibitory effect on transporter has been seen in various organs including 
the heart (Skayian & Kreydiyyeh, 2006), liver (Kreydiyyeh et al., 2007; Seven et al., 2005), and 
kidney (Cimen et al., 2004). Additionally, our laboratory has also shown that the cyclooxygenase 
pathway, which produces various prostaglandins, has been involved in the reduction of Na-
glutamine (B0AT1) and Na-K-ATPase activity in villus cells in the inflamed intestine of rabbits 
(Arthur et al., 2018). Similar to these findings, the present study also demonstrates that PGE2 
reduces the activity of Na-K-ATPase in villus-like cells in vitro. Moreover, the mechanism of 
inhibition of Na-K-ATPase in intestinal epithelial cells is due to cAMP-mediated activation of 
the PKA pathway (Figure 40), which in turn may be modulating the transcription factors 
downregulating the expression of the Na-K-ATPase a1 and b1 subunits. 
 
Figure 40. Schematic representation of mechanisms of alteration of Na-K-ATPase activity 
by inflammatory mediators (LTD4 and PGE2) during intestinal inflammation. 
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6.2. FUTURE DIRECTIONS 
6.2.1. Regulation of Na-K-ATPase during maturation of intestinal cells 
The present study provides the potential regulation of Na-K-ATPase during the 
maturation of intestinal cells. While the study is novel, the limitation of this study is that the 
model is in vitro, and further studies need to be done ex vivo or in vivo to support the current 
findings. For example, we can sequentially isolate cells from the immature crypt base to the 
mature villus tips in rabbit or rat intestine and determine if comparable changes occur in vivo as 
it pertains to Na-K-ATPase. In addition to investigating the molecular mechanisms involved in 
the altered activity of Na-K-ATPase during the maturation process, further studies need to be 
done to decipher external cellular factors that bring about these alterations. As was demonstrated, 
PGE2 and LTD4 have very different effects on Na-K-ATPase in crypt-like and villus-like states 
of IEC-18 cells. Thus, such external mediators may regulate Na-K-ATPase during maturation. 
6.2.1.1. Locating the phosphorylation residues involved in modulation of Na-K-
ATPase during maturation 
Our data revealed that there is alteration of phosphorylation levels of serine and tyrosine 
residues in the Na-K-ATPase α1 subunit during the maturation of intestinal epithelial cells from 
crypt to villus. There are several phosphorylation targets in Na-K-ATPase α1, which are known 
to modulate the activity of the enzyme depending on the tissue type and experimental conditions 
(Beguin et al., 1994; Chibalin et al., 1992). Additionally, we observed in this study that Na-K-
ATPase α1-Ser23 phosphorylation increases as cells mature, along with increases in Na-K-
ATPase activity. Besides Ser23, there are phosphorylation sites at Tyr5 and Ser943 in the α1 
subunit that are also known to modulate the activity of Na-K-ATPase (Beguin et al., 1994; 
Efendiev et al., 2000). Thus, further studies with point mutations of potential serine and tyrosine 
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phosphorylation sites will help to decipher and understand the mechanisms of regulation of Na-
K-ATPase during maturation.  
6.2.1.2. Finding the role of FXYD subunit  
There are 12 different members of the FXYD protein family that are known to be  
expressed differentially in cells and tissues (J. Y. Cheung et al., 2010). A specific domain at the 
N terminus of FXYD is known to interact with Na-K-ATPase thereby regulating the activity of 
Na-K-ATPase, whereas the C terminus consists of phosphorylation sites that could be potential 
targets of activation by kinases (Dey et al., 2013). In the present study, we did not explore the 
role of FXYD in the regulation of Na-K-ATPase. Therefore, future studies should be conducted 
to explore the potential role of FXYD in the modulation of Na-K-ATPase activity during the 
maturation of intestinal epithelial cells.  
6.2.2. Regulation of Na-K-ATPase by inflammatory mediators (LTD4 and PGE2 
treatment) 
In addition to investigating the mechanism of how inflammatory mediators LTD4 and 
PGE2 works in crypt and villus, we also treated crypt cells with PGE2 and villus cells with 
LTD4 (Figure 41). We observed that PGE2 and LTD4 did not have any effect on Na-K-ATPase 
activities in crypt and villus cells, respectively. However, the question remains on the fact that 
the epithelial cells lose their sensitivity to LTD4 treatment and acquire PGE2 sensitivity. To 
explore this interesting phenomenon, further studies need to be conducted to investigate the 
LTD4 and PGE2 receptor development/transition during the maturation of intestinal epithelial 
cells. Changes subsequent to agonist-receptor interaction, specifically at the G protein level is 
another possibility which needs to be explored as well.  
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Figure 41. Effect of LTD4 and PGE2 exposure for 24 hours on Na-K-ATPase activity in 
IEC-18 cells. A. Crypt-like cells (0-day confluence). B. Villus-like cells (4-day confluence). 
Measurement of Na-K-ATPase activity by 86Rb+ uptake. Values are represented as means ± 
SEM, n=6. **, P < 0.01 Vs Control, ***, P < 0.001 Vs Control. 
6.2.2.1. Exploring the role of different PKC isoforms during LTD4-mediated 
stimulation of Na-K-ATPase 
Based on the external stimulus, PKC has been involved in reduction or activation of Na-
K-ATPase activity depending upon species and tissues (Borghini et al., 1994; Feschenko & 
Sweadner, 1995). Moreover, the stimulation of various isoforms of PKC can have a differential 
effect on Na-K-ATPase. Conventional PKC a and b are associated with decrease in activity of 
Na-K-ATPase by endocytosis (Chibalin, Pedemonte, et al., 1998; Feraille & Doucet, 2001), 
whereas other isoforms of PKC, e and d have been shown to stimulate Na-K-ATPase activity 
through the ERK1/2 pathway (Galuska et al., 2011; Zhong et al., 2005). In the present study, we 
used calphostin-c, a non-isoform specific PKC inhibitor. Therefore, using specific isoform 
inhibitors will further dissect the mechanism of LTD4-mediated stimulation in intestinal 
epithelial cells.  
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6.2.2.2. Exploring the role of transcriptional factors during LTD4-mediated 
stimulation of Na-K-ATPase 
We observed the transcriptional activation of the Na-K-ATPase α1 and β1 subunits 
during LTD4 treatment in crypt-like cells. Transcription factors such as Sp1 and Sp3 are known 
to increase the transcription of the α1 and β1 subunits by binding to the promoter region of these 
subunit genes (Johar et al., 2012; Kobayashi et al., 1997). Similarly, phosphorylation of 
transcription factor CREB is known to induce the increased α1 mRNA level (Dagenais et al., 
2001). Also, the binding of ZEB1 (AREB6) to the promoter region of the α1 subunit gene 
increases the protein level of the α1 subunit in skeletal muscle (Galuska et al., 2011). Therefore, 
future studies observing the role of these transcription factors might be helpful in understanding 
the transcriptional modulation of LTD4-mediated stimulation of Na-K-ATPase in intestinal 
epithelial cells. 
6.2.2.3. Exploring the role of transcriptional factors during PGE2-mediated 
reduction of Na-K-ATPase 
In the present study, we observed the transcriptional repression of the Na-K-ATPase α1 
and β1 subunits during PGE2 treatment in villus-like cells. It has been reported that TGF-β2 
reduces the mRNA level of the β1 subunit through transcription factors HIF and Smad3 (Mony 
et al., 2013). Therefore, these transcription factors might play a potential role in the PGE2-
mediated reduction of Na-K-ATPase activity and hence need to be studied. However, there is no 
report suggesting a potential transcription repressor for the α1 subunit; therefore, further studies 





Abram, C. L., & Courtneidge, S. A. (2000). Src family tyrosine kinases and growth factor 
signaling. Exp Cell Res, 254(1), 1-13. doi:10.1006/excr.1999.4732 
Abramovitz, M., Adam, M., Boie, Y., Carriere, M., Denis, D., Godbout, C., . . . Metters, K. M. 
(2000). The utilization of recombinant prostanoid receptors to determine the affinities and 
selectivities of prostaglandins and related analogs. Biochim Biophys Acta, 1483(2), 285-
293.  
Ackermann, U., & Geering, K. (1990). Mutual dependence of Na,K-ATPase alpha- and beta-
subunits for correct posttranslational processing and intracellular transport. FEBS Lett, 
269(1), 105-108.  
Al-Khalili, L., Kotova, O., Tsuchida, H., Ehren, I., Feraille, E., Krook, A., & Chibalin, A. V. 
(2004). ERK1/2 mediates insulin stimulation of Na(+),K(+)-ATPase by phosphorylation 
of the alpha-subunit in human skeletal muscle cells. J Biol Chem, 279(24), 25211-25218. 
doi:10.1074/jbc.M402152200 
Albers, R. W. (1967). Biochemical aspects of active transport. Annu Rev Biochem, 36, 727-756. 
doi:10.1146/annurev.bi.36.070167.003455 
Alberts, B., Johnson, S., & Lewis, J. (2007). Proteins. In Molecular biology of cells. New York: 
Garland Science. 
Allgayer, H., Kruis, W., & Erdmann, E. (1988). Human colonic (Na+ + K+)-ATPase and 
specific ouabain binding are not influenced by lipoxygenase products or superoxide 
radicals. Klin Wochenschr, 66(13), 599-600.  
Allgayer, H., Kruis, W., Paumgartner, G., Wiebecke, B., Brown, L., & Erdmann, E. (1988). 
Inverse relationship between colonic (Na+ + K+)-ATPase activity and degree of mucosal 
inflammation in inflammatory bowel disease. Dig Dis Sci, 33(4), 417-422.  
Anderson, J. M., & Van Itallie, C. M. (1995). Tight junctions and the molecular basis for 
regulation of paracellular permeability. Am J Physiol, 269(4 Pt 1), G467-475. 
doi:10.1152/ajpgi.1995.269.4.G467 
Aperia, A. C. (1995). Regulation of sodium transport. Curr Opin Nephrol Hypertens, 4(5), 416-
420.  
130 
Apodaca, G. (2001). Endocytic traffic in polarized epithelial cells: role of the actin and 
microtubule cytoskeleton. Traffic, 2(3), 149-159.  
Arthur, S., Saha, P., Sundaram, S., Kekuda, R., & Sundaram, U. (2012). Regulation of sodium-
glutamine cotransport in villus and crypt cells by glucocorticoids during chronic enteritis. 
Inflamm Bowel Dis, 18(11), 2149-2157. doi:10.1002/ibd.22924 
Arthur, S., Singh, S., & Sundaram, U. (2018). Cyclooxygenase pathway mediates the inhibition 
of Na-glutamine co-transporter B0AT1 in rabbit villus cells during chronic intestinal 
inflammation. PLoS One, 13(9), e0203552. doi:10.1371/journal.pone.0203552 
Arystarkhova, E., Wetzel, R. K., Asinovski, N. K., & Sweadner, K. J. (1999). The gamma 
subunit modulates Na(+) and K(+) affinity of the renal Na,K-ATPase. J Biol Chem, 
274(47), 33183-33185.  
Babula, P., Masarik, M., Adam, V., Provaznik, I., & Kizek, R. (2013). From Na+/K+-ATPase 
and cardiac glycosides to cytotoxicity and cancer treatment. Anticancer Agents Med 
Chem, 13(7), 1069-1087.  
Babyastsky, M. W., & Podolsky, D. K. (1999). Growth and development of the gastrointestinal 
tract. In Gastroenterology (pp. 547-584). Philadelphia, PA, USA: Lippincott, J. 
Balsinde, J., Winstead, M. V., & Dennis, E. A. (2002). Phospholipase A(2) regulation of 
arachidonic acid mobilization. FEBS Lett, 531(1), 2-6.  
Barker, N., & Clevers, H. (2010). Leucine-rich repeat-containing G-protein-coupled receptors as 
markers of adult stem cells. Gastroenterology, 138(5), 1681-1696. 
doi:10.1053/j.gastro.2010.03.002 
Barker, N., van de Wetering, M., & Clevers, H. (2008). The intestinal stem cell. Genes Dev, 
22(14), 1856-1864. doi:10.1101/gad.1674008 
Barnard, M. L., Ridge, K. M., Saldias, F., Friedman, E., Gare, M., Guerrero, C., . . . Sznajder, J. 
I. (1999). Stimulation of the dopamine 1 receptor increases lung edema clearance. Am J 
Respir Crit Care Med, 160(3), 982-986. doi:10.1164/ajrccm.160.3.9812003 
Beguin, P., Beggah, A. T., Chibalin, A. V., Burgener-Kairuz, P., Jaisser, F., Mathews, P. M., . . . 
Geering, K. (1994). Phosphorylation of the Na,K-ATPase alpha-subunit by protein kinase 
131 
A and C in vitro and in intact cells. Identification of a novel motif for PKC-mediated 
phosphorylation. J Biol Chem, 269(39), 24437-24445.  
Beguin, P., Wang, X., Firsov, D., Puoti, A., Claeys, D., Horisberger, J. D., & Geering, K. (1997). 
The gamma subunit is a specific component of the Na,K-ATPase and modulates its 
transport function. EMBO J, 16(14), 4250-4260.  
Bell, J. R., Kennington, E., Fuller, W., Dighe, K., Donoghue, P., Clark, J. E., . . . Shattock, M. J. 
(2008). Characterization of the phospholemman knockout mouse heart: depressed left 
ventricular function with increased Na-K-ATPase activity. Am J Physiol Heart Circ 
Physiol, 294(2), H613-621. doi:10.1152/ajpheart.01332.2007 
Bennett, A., & Fleshler, B. (1970). Prostaglandins and the gastrointestinal tract. 
Gastroenterology, 59(5), 790-800.  
Berridge, M. J., Lipp, P., & Bootman, M. D. (2000). The versatility and universality of calcium 
signalling. Nat Rev Mol Cell Biol, 1(1), 11-21. doi:10.1038/35036035 
Bertorello, A. M., Aperia, A., Walaas, S. I., Nairn, A. C., & Greengard, P. (1991). 
Phosphorylation of the catalytic subunit of Na+,K(+)-ATPase inhibits the activity of the 
enzyme. Proc Natl Acad Sci U S A, 88(24), 11359-11362.  
Bertorello, A. M., & Katz, A. I. (1993). Short-term regulation of renal Na-K-ATPase activity: 
physiological relevance and cellular mechanisms. Am J Physiol, 265(6 Pt 2), F743-755. 
doi:10.1152/ajprenal.1993.265.6.F743 
Bertorello, A. M., Ridge, K. M., Chibalin, A. V., Katz, A. I., & Sznajder, J. I. (1999). 
Isoproterenol increases Na+-K+-ATPase activity by membrane insertion of alpha-
subunits in lung alveolar cells. Am J Physiol, 276(1), L20-27. 
doi:10.1152/ajplung.1999.276.1.L20 
Bhattacharya, M., Peri, K. G., Almazan, G., Ribeiro-da-Silva, A., Shichi, H., Durocher, Y., . . . 
Chemtob, S. (1998). Nuclear localization of prostaglandin E2 receptors. Proc Natl Acad 
Sci U S A, 95(26), 15792-15797.  
Bjarnason, I., Fehilly, B., Smethurst, P., Menzies, I. S., & Levi, A. J. (1991). Importance of local 
versus systemic effects of non-steroidal anti-inflammatory drugs in increasing small 
intestinal permeability in man. Gut, 32(3), 275-277.  
132 
Bjarnason, I., & Peters, T. J. (1989). Intestinal permeability, non-steroidal anti-inflammatory 
drug enteropathy and inflammatory bowel disease: an overview. Gut, 30 Spec No, 22-28.  
Bjarnason, I., & Thjodleifsson, B. (1999). Gastrointestinal toxicity of non-steroidal anti-
inflammatory drugs: the effect of nimesulide compared with naproxen on the human 
gastrointestinal tract. Rheumatology (Oxford), 38 Suppl 1, 24-32.  
Blanco, G., Melton, R. J., Sanchez, G., & Mercer, R. W. (1999). Functional characterization of a 
testes-specific alpha-subunit isoform of the sodium/potassium adenosinetriphosphatase. 
Biochemistry, 38(41), 13661-13669.  
Blanco, G., & Mercer, R. W. (1998a). Isozymes of the Na-K-ATPase: heterogeneity in structure, 
diversity in function. Am J Physiol, 275(5 Pt 2), F633-650.  
Blanco, G., & Mercer, R. W. (1998b). Isozymes of the Na-K-ATPase: heterogeneity in structure, 
diversity in function. Am J Physiol, 275(5), F633-650. 
doi:10.1152/ajprenal.1998.275.5.F633 
Blanco, G., Sanchez, G., Melton, R. J., Tourtellotte, W. G., & Mercer, R. W. (2000). The alpha4 
isoform of the Na,K-ATPase is expressed in the germ cells of the testes. J Histochem 
Cytochem, 48(8), 1023-1032. doi:10.1177/002215540004800801 
Blanco, G., Sanchez, G., & Mercer, R. W. (1995). Comparison of the enzymatic properties of the 
Na,K-ATPase alpha 3 beta 1 and alpha 3 beta 2 isozymes. Biochemistry, 34(31), 9897-
9903.  
Blanco, G., Sanchez, G., & Mercer, R. W. (1998). Differential regulation of Na,K-ATPase 
isozymes by protein kinases and arachidonic acid. Arch Biochem Biophys, 359(2), 139-
150. doi:10.1006/abbi.1998.0904 
Blaustein, M. P. (1993). Physiological effects of endogenous ouabain: control of intracellular 
Ca2+ stores and cell responsiveness. Am J Physiol, 264(6 Pt 1), C1367-1387. 
doi:10.1152/ajpcell.1993.264.6.C1367 
Blikslager, A. T., Roberts, M. C., Rhoads, J. M., & Argenzio, R. A. (1997). Prostaglandins I2 
and E2 have a synergistic role in rescuing epithelial barrier function in porcine ileum. J 
Clin Invest, 100(8), 1928-1933. doi:10.1172/JCI119723 
133 
Blostein, R., Drapeau, P., Benderoff, S., & Weigensberg, A. M. (1983). Changes in Na+-ATPase 
and Na,K-pump during maturation of sheep reticulocytes. Can J Biochem Cell Biol, 
61(1), 23-28.  
Borghini, I., Geering, K., Gjinovci, A., Wollheim, C. B., & Pralong, W. F. (1994). In vivo 
phosphorylation of the Na,K-ATPase alpha subunit in sciatic nerves of control and 
diabetic rats: effects of protein kinase modulators. Proc Natl Acad Sci U S A, 91(13), 
6211-6215.  
Bos, C. L., Richel, D. J., Ritsema, T., Peppelenbosch, M. P., & Versteeg, H. H. (2004). 
Prostanoids and prostanoid receptors in signal transduction. Int J Biochem Cell Biol, 
36(7), 1187-1205. doi:10.1016/j.biocel.2003.08.006 
Boscher, C., & Nabi, I. R. (2012). Caveolin-1: role in cell signaling. Adv Exp Med Biol, 729, 29-
50. doi:10.1007/978-1-4614-1222-9_3 
Bouchelouche, P. N., Ahnfelt-Ronne, I., & Thomsen, M. K. (1990). LTD4 increases cytosolic 
free calcium and inositol phosphates in human neutrophils: inhibition by the novel LTD4 
receptor antagonist, SR2640, and possible relation to modulation of chemotaxis. Agents 
Actions, 29(3-4), 299-307.  
Brown, M. T., & Cooper, J. A. (1996). Regulation, substrates and functions of src. Biochim 
Biophys Acta, 1287(2-3), 121-149.  
Brugnara, C., & de Franceschi, L. (1993). Effect of cell age and phenylhydrazine on the cation 
transport properties of rabbit erythrocytes. J Cell Physiol, 154(2), 271-280. 
doi:10.1002/jcp.1041540209 
Bukhave, K., Rask-Madsen, J., Hogan, D. L., Koss, M. A., & Isenberg, J. I. (1990). Proximal 
duodenal prostaglandin E2 release and mucosal bicarbonate secretion are altered in 
patients with duodenal ulcer. Gastroenterology, 99(4), 951-955.  
Burakoff, R., Nastos, E., & Won, S. (1990). Effects of PGF2 alpha and of indomethacin on 
rabbit small and large intestinal motility in vivo. Am J Physiol, 258(2 Pt 1), G231-237. 
doi:10.1152/ajpgi.1990.258.2.G231 
Capdevila, J. H., Wei, S., Yan, J., Karara, A., Jacobson, H. R., Falck, J. R., . . . DuBois, R. N. 
(1992). Cytochrome P-450 arachidonic acid epoxygenase. Regulatory control of the renal 
epoxygenase by dietary salt loading. J Biol Chem, 267(30), 21720-21726.  
134 
Carty, E., Nickols, C., Feakins, R. M., & Rampton, D. S. (2002). Thromboxane synthase 
immunohistochemistry in inflammatory bowel disease. J Clin Pathol, 55(5), 367-370.  
Castro, G. A. (1991). Immunological regulation of electrolyte transport In E. Labenthal & M. E. 
Duffey (Eds.), Text-book of secretory Diarrhea (pp. 456). New York city, New York: 
Raven. 
Chan, C. C., Ecclestone, P., Nicholson, D. W., Metters, K. M., Pon, D. J., & Rodger, I. W. 
(1994). Leukotriene D4-induced increases in cytosolic calcium in THP-1 cells: 
dependence on extracellular calcium and inhibition with selective leukotriene D4 receptor 
antagonists. J Pharmacol Exp Ther, 269(3), 891-896.  
Chauhan, N. B., Lee, J. M., & Siegel, G. J. (1997). Na,K-ATPase mRNA levels and plaque load 
in Alzheimer's disease. J Mol Neurosci, 9(3), 151-166. doi:10.1007/BF02800498 
Cheung, J. Y., Zhang, X. Q., Song, J., Gao, E., Rabinowitz, J. E., Chan, T. O., & Wang, J. 
(2010). Phospholemman: a novel cardiac stress protein. Clin Transl Sci, 3(4), 189-196. 
doi:10.1111/j.1752-8062.2010.00213.x 
Cheung, L. Y. (1980). Topical effects of 16,16-dimethyl prostaglandin E2 on gastric blood flow 
in dogs. Am J Physiol, 238(6), G514-519. doi:10.1152/ajpgi.1980.238.6.G514 
Chibalin, A. V., Katz, A. I., Berggren, P. O., & Bertorello, A. M. (1997). Receptor-mediated 
inhibition of renal Na(+)-K(+)-ATPase is associated with endocytosis of its alpha- and 
beta-subunits. Am J Physiol, 273(5 Pt 1), C1458-1465.  
Chibalin, A. V., Kovalenko, M. V., Ryder, J. W., Feraille, E., Wallberg-Henriksson, H., & 
Zierath, J. R. (2001). Insulin- and glucose-induced phosphorylation of the Na(+),K(+)-
adenosine triphosphatase alpha-subunits in rat skeletal muscle. Endocrinology, 142(8), 
3474-3482. doi:10.1210/endo.142.8.8294 
Chibalin, A. V., Ogimoto, G., Pedemonte, C. H., Pressley, T. A., Katz, A. I., Feraille, E., . . . 
Bertorello, A. M. (1999). Dopamine-induced endocytosis of Na+,K+-ATPase is initiated 
by phosphorylation of Ser-18 in the rat alpha subunit and Is responsible for the decreased 
activity in epithelial cells. J Biol Chem, 274(4), 1920-1927.  
Chibalin, A. V., Pedemonte, C. H., Katz, A. I., Feraille, E., Berggren, P. O., & Bertorello, A. M. 
(1998). Phosphorylation of the catalyic alpha-subunit constitutes a triggering signal for 
Na+,K+-ATPase endocytosis. J Biol Chem, 273(15), 8814-8819.  
135 
Chibalin, A. V., Vasilets, L. A., Hennekes, H., Pralong, D., & Geering, K. (1992). 
Phosphorylation of Na,K-ATPase alpha-subunits in microsomes and in homogenates of 
Xenopus oocytes resulting from the stimulation of protein kinase A and protein kinase C. 
J Biol Chem, 267(31), 22378-22384.  
Chibalin, A. V., Zierath, J. R., Katz, A. I., Berggren, P. O., & Bertorello, A. M. (1998). 
Phosphatidylinositol 3-kinase-mediated endocytosis of renal Na+, K+-ATPase alpha 
subunit in response to dopamine. Mol Biol Cell, 9(5), 1209-1220.  
Cimen, B., Turkozkan, N., Seven, I., Unlu, A., & Karasu, C. (2004). Impaired Na+,K+-ATPase 
activity as a mechanism of reactive nitrogen species-induced cytotoxicity in guinea pig 
liver exposed to lipopolysaccharides. Mol Cell Biochem, 259(1-2), 53-57.  
Clapham, D. E. (2007). Calcium signaling. Cell, 131(6), 1047-1058. 
doi:10.1016/j.cell.2007.11.028 
Cochrane, D. R., Jacobsen, B. M., Connaghan, K. D., Howe, E. N., Bain, D. L., & Richer, J. K. 
(2012). Progestin regulated miRNAs that mediate progesterone receptor action in breast 
cancer. Mol Cell Endocrinol, 355(1), 15-24. doi:10.1016/j.mce.2011.12.020 
Contreras, R. G., Shoshani, L., Flores-Maldonado, C., Lazaro, A., & Cereijido, M. (1999). 
Relationship between Na(+),K(+)-ATPase and cell attachment. J Cell Sci, 112 ( Pt 23), 
4223-4232.  
Coon, S., Kekuda, R., Saha, P., & Sundaram, U. (2010). Glucocorticoids differentially regulate 
Na-bile acid cotransport in normal and chronically inflamed rabbit ileal villus cells. Am J 
Physiol Gastrointest Liver Physiol, 298(5), G675-682. doi:10.1152/ajpgi.00176.2009 
Coon, S., Kim, J., Shao, G., & Sundaram, U. (2005). Na-glucose and Na-neutral amino acid 
cotransport are uniquely regulated by constitutive nitric oxide in rabbit small intestinal 
villus cells. Am J Physiol Gastrointest Liver Physiol, 289(6), G1030-1035. 
doi:10.1152/ajpgi.00124.2005 
Cornelius, F., & Logvinenko, N. (1996). Functional regulation of reconstituted Na,K-ATPase by 
protein kinase A phosphorylation. FEBS Lett, 380(3), 277-280.  
Cornelius, F., & Mahmmoud, Y. A. (2007). Modulation of FXYD interaction with Na,K-ATPase 
by anionic phospholipids and protein kinase phosphorylation. Biochemistry, 46(9), 2371-
2379. doi:10.1021/bi062239j 
136 
Cortes, V. F., Ribeiro, I. M., Barrabin, H., Alves-Ferreira, M., & Fontes, C. F. (2011). 
Regulatory phosphorylation of FXYD2 by PKC and cross interactions between FXYD2, 
plasmalemmal Ca-ATPase and Na,K-ATPase. Arch Biochem Biophys, 505(1), 75-82. 
doi:10.1016/j.abb.2010.09.017 
Csupor, D., Csorba, A., & Hohmann, J. (2016). Recent advances in the analysis of 
flavonolignans of Silybum marianum. J Pharm Biomed Anal, 130, 301-317. 
doi:10.1016/j.jpba.2016.05.034 
Cui, X., & Xie, Z. (2017). Protein Interaction and Na/K-ATPase-Mediated Signal Transduction. 
Molecules, 22(6). doi:10.3390/molecules22060990 
Curtis, L. M., ten Cate, W. J., & Rarey, K. E. (1993). Dynamics of Na,K-ATPase sites in lateral 
cochlear wall tissues of the rat. Eur Arch Otorhinolaryngol, 250(5), 265-270.  
Dagenais, A., Denis, C., Vives, M. F., Girouard, S., Masse, C., Nguyen, T., . . . Berthiaume, Y. 
(2001). Modulation of alpha-ENaC and alpha1-Na+-K+-ATPase by cAMP and 
dexamethasone in alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol, 281(1), 
L217-230. doi:10.1152/ajplung.2001.281.1.L217 
de Santa Barbara, P., van den Brink, G. R., & Roberts, D. J. (2003). Development and 
differentiation of the intestinal epithelium. Cell Mol Life Sci, 60(7), 1322-1332. 
doi:10.1007/s00018-003-2289-3 
Delamere, N. A., & Tamiya, S. (2009). Lens ion transport: from basic concepts to regulation of 
Na,K-ATPase activity. Exp Eye Res, 88(2), 140-143. doi:10.1016/j.exer.2008.05.005 
Deng, W. B., Tian, Z., Liang, X. H., Wang, B. C., Yang, F., & Yang, Z. M. (2013). Progesterone 
regulation of Na/K-ATPase beta1 subunit expression in the mouse uterus during the peri-
implantation period. Theriogenology, 79(8), 1196-1203. 
doi:10.1016/j.theriogenology.2013.02.018 
Dennis, E. A. (1994). Diversity of group types, regulation, and function of phospholipase A2. J 
Biol Chem, 269(18), 13057-13060.  
Derfoul, A., Robertson, N. M., Lingrel, J. B., Hall, D. J., & Litwack, G. (1998). Regulation of 
the human Na/K-ATPase beta1 gene promoter by mineralocorticoid and glucocorticoid 
receptors. J Biol Chem, 273(33), 20702-20711.  
137 
Dey, K., Chakraborti, T., Roy, S., Ghosh, B., Kar, P., & Chakraborti, S. (2010). Identification, 
purification and partial characterization of a 70kDa inhibitor protein of Na(+)/K(+)-
ATPase from cytosol of pulmonary artery smooth muscle. Life Sci, 86(13-14), 473-481. 
doi:10.1016/j.lfs.2010.02.002 
Dey, K., Rahaman, S. M., Chakraborti, T., & Chakraborti, S. (2013). Role of phospholemman 
and the 70 kDa inhibitor protein in regulating Na+/K+ ATPase activity in pulmonary 
artery smooth muscle cells under U46619 stimulation. FEBS Lett, 587(21), 3535-3540. 
doi:10.1016/j.febslet.2013.09.011 
Diener, M., Bridges, R. J., Knobloch, S. F., & Rummel, W. (1988a). Indirect effects of 
bradykinin on ion transport in rat colon descendens: mediated by prostaglandins and 
enteric neurons. Naunyn Schmiedebergs Arch Pharmacol, 337(1), 69-73.  
Diener, M., Bridges, R. J., Knobloch, S. F., & Rummel, W. (1988b). Neuronally mediated and 
direct effects of prostaglandins on ion transport in rat colon descendens. Naunyn 
Schmiedebergs Arch Pharmacol, 337(1), 74-78.  
Dore, M. (2011). Cyclooxygenase-2 expression in animal cancers. Vet Pathol, 48(1), 254-265. 
doi:10.1177/0300985810379434 
DuBois, R. N., Eberhart, C. F., & Williams, C. S. (1996). Introduction to eicosanoids and the 
gastroenteric tract. Gastroenterol Clin North Am, 25(2), 267-277.  
Efendiev, R., Bertorello, A. M., & Pedemonte, C. H. (1999). PKC-beta and PKC-zeta mediate 
opposing effects on proximal tubule Na+,K+-ATPase activity. FEBS Lett, 456(1), 45-48.  
Efendiev, R., Bertorello, A. M., Pressley, T. A., Rousselot, M., Feraille, E., & Pedemonte, C. H. 
(2000). Simultaneous phosphorylation of Ser11 and Ser18 in the alpha-subunit promotes 
the recruitment of Na(+),K(+)-ATPase molecules to the plasma membrane. Biochemistry, 
39(32), 9884-9892.  
Ehrenpreis, S. (1981). Prostaglandin as a modulator of acetylcholine release in guinea pig 
myenteric plexus. Prog Lipid Res, 20, 505-509.  
Ejderhamn, J., Finkel, Y., & Strandvik, B. (1989). Na,K-ATPase activity in rectal mucosa of 
children with ulcerative colitis and Crohn's disease. Scand J Gastroenterol, 24(9), 1121-
1125.  
138 
El-Beialy, W., Galal, N., Deyama, Y., Yoshimura, Y., Suzuki, K., Tei, K., & Totsuka, Y. (2010). 
Regulation of human and pig renal Na(+),K (+)-ATPase activity by tyrosine 
phosphorylation of their alpha(1)-subunits. J Membr Biol, 233(1-3), 119-126. 
doi:10.1007/s00232-010-9231-z 
Erichsen, S., Zuo, J., Curtis, L., Rarey, K., & Hultcrantz, M. (1996). Na,K-ATPase alpha- and 
beta-isoforms in the developing cochlea of the mouse. Hear Res, 100(1-2), 143-149.  
Espineda, C. E., Chang, J. H., Twiss, J., Rajasekaran, S. A., & Rajasekaran, A. K. (2004). 
Repression of Na,K-ATPase beta1-subunit by the transcription factor snail in carcinoma. 
Mol Biol Cell, 15(3), 1364-1373. doi:10.1091/mbc.e03-09-0646 
Ewart, H. S., & Klip, A. (1995). Hormonal regulation of the Na(+)-K(+)-ATPase: mechanisms 
underlying rapid and sustained changes in pump activity. Am J Physiol, 269(2 Pt 1), 
C295-311. doi:10.1152/ajpcell.1995.269.2.C295 
Faleiros, R. O., Garcon, D. P., Lucena, M. N., McNamara, J. C., & Leone, F. A. (2018). Short- 
and long-term salinity challenge, osmoregulatory ability, and (Na(+), K(+))-ATPase 
kinetics and alpha-subunit mRNA expression in the gills of the thinstripe hermit crab 
Clibanarius symmetricus (Anomura, Diogenidae). Comp Biochem Physiol A Mol Integr 
Physiol, 225, 16-25. doi:10.1016/j.cbpa.2018.06.016 
Fambrough, D. M., Lemas, M. V., Hamrick, M., Emerick, M., Renaud, K. J., Inman, E. M., . . . 
Takeyasu, K. (1994). Analysis of subunit assembly of the Na-K-ATPase. Am J Physiol, 
266(3 Pt 1), C579-589. doi:10.1152/ajpcell.1994.266.3.C579 
Fan, M. Z., Stoll, B., Jiang, R., & Burrin, D. G. (2001). Enterocyte digestive enzyme activity 
along the crypt-villus and longitudinal axes in the neonatal pig small intestine. J Anim 
Sci, 79(2), 371-381.  
Feng, J., Orlowski, J., & Lingrel, J. B. (1993). Identification of a functional thyroid hormone 
response element in the upstream flanking region of the human Na,K-ATPase beta 1 
gene. Nucleic Acids Res, 21(11), 2619-2626.  
Feraille, E., Carranza, M. L., Buffin-Meyer, B., Rousselot, M., Doucet, A., & Favre, H. (1995). 
Protein kinase C-dependent stimulation of Na(+)-K(+)-ATP epsilon in rat proximal 
convoluted tubules. Am J Physiol, 268(5 Pt 1), C1277-1283. 
doi:10.1152/ajpcell.1995.268.5.C1277 
139 
Feraille, E., Carranza, M. L., Gonin, S., Beguin, P., Pedemonte, C., Rousselot, M., . . . Favre, H. 
(1999). Insulin-induced stimulation of Na+,K(+)-ATPase activity in kidney proximal 
tubule cells depends on phosphorylation of the alpha-subunit at Tyr-10. Mol Biol Cell, 
10(9), 2847-2859. doi:10.1091/mbc.10.9.2847 
Feraille, E., & Doucet, A. (2001). Sodium-potassium-adenosinetriphosphatase-dependent sodium 
transport in the kidney: hormonal control. Physiol Rev, 81(1), 345-418. 
doi:10.1152/physrev.2001.81.1.345 
Feschenko, M. S., & Sweadner, K. J. (1994). Conformation-dependent phosphorylation of Na,K-
ATPase by protein kinase A and protein kinase C. J Biol Chem, 269(48), 30436-30444.  
Feschenko, M. S., & Sweadner, K. J. (1995). Structural basis for species-specific differences in 
the phosphorylation of Na,K-ATPase by protein kinase C. J Biol Chem, 270(23), 14072-
14077.  
Field, M. (2003). Intestinal ion transport and the pathophysiology of diarrhea. J Clin Invest, 
111(7), 931-943. doi:10.1172/JCI18326 
Fisone, G., Cheng, S. X., Nairn, A. C., Czernik, A. J., Hemmings, H. C., Jr., Hoog, J. O., . . . et 
al. (1994). Identification of the phosphorylation site for cAMP-dependent protein kinase 
on Na+,K(+)-ATPase and effects of site-directed mutagenesis. J Biol Chem, 269(12), 
9368-9373.  
Forbush, B., 3rd. (1983). Assay of Na,K-ATPase in plasma membrane preparations: increasing 
the permeability of membrane vesicles using sodium dodecyl sulfate buffered with 
bovine serum albumin. Anal Biochem, 128(1), 159-163.  
Ford-Hutchinson, A. W., Bray, M. A., Doig, M. V., Shipley, M. E., & Smith, M. J. (1980). 
Leukotriene B, a potent chemokinetic and aggregating substance released from 
polymorphonuclear leukocytes. Nature, 286(5770), 264-265.  
Fowles, J. R., Green, H. J., & Ouyang, J. (2004). Na+-K+-ATPase in rat skeletal muscle: 
content, isoform, and activity characteristics. J Appl Physiol (1985), 96(1), 316-326. 
doi:10.1152/japplphysiol.00745.2002 
Fujii, S., Suzuki, K., Kawamoto, A., Ishibashi, F., Nakata, T., Murano, T., . . . Watanabe, M. 
(2016). PGE2 is a direct and robust mediator of anion/fluid secretion by human intestinal 
epithelial cells. Sci Rep, 6, 36795. doi:10.1038/srep36795 
140 
Funk, C. D., Furci, L., FitzGerald, G. A., Grygorczyk, R., Rochette, C., Bayne, M. A., . . . 
Metters, K. M. (1993). Cloning and expression of a cDNA for the human prostaglandin E 
receptor EP1 subtype. J Biol Chem, 268(35), 26767-26772.  
Furukawa, H., Bilezikian, J. P., & Loeb, J. N. (1981). Potassium fluxes in the rat reticulocyte. 
Ouabain sensitivity and changes during maturation. Biochim Biophys Acta, 649(3), 625-
632.  
Gaginella, T. S. (1990). Eicosanoid-mediated intestinal secretion. In D. Labenthal (Ed.), 
Textbook of secretory diarrhea (pp. 15-30). New York Raven Press  
Galuska, D., Pirkmajer, S., Barres, R., Ekberg, K., Wahren, J., & Chibalin, A. V. (2011). C-
peptide increases Na,K-ATPase expression via PKC- and MAP kinase-dependent 
activation of transcription factor ZEB in human renal tubular cells. PLoS One, 6(12), 
e28294. doi:10.1371/journal.pone.0028294 
Gatto, C., McLoud, S. M., & Kaplan, J. H. (2001). Heterologous expression of Na(+)-K(+)-
ATPase in insect cells: intracellular distribution of pump subunits. Am J Physiol Cell 
Physiol, 281(3), C982-992. doi:10.1152/ajpcell.2001.281.3.C982 
Geering, K. (1988). Biosynthesis, membrane insertion and maturation of Na, K-ATPase. Prog 
Clin Biol Res, 268B, 19-33.  
Geering, K. (1991). The functional role of the beta-subunit in the maturation and intracellular 
transport of Na,K-ATPase. FEBS Lett, 285(2), 189-193.  
Geering, K. (2001). The functional role of beta subunits in oligomeric P-type ATPases. J 
Bioenerg Biomembr, 33(5), 425-438.  
Geering, K. (2006). FXYD proteins: new regulators of Na-K-ATPase. Am J Physiol Renal 
Physiol, 290(2), F241-250. doi:10.1152/ajprenal.00126.2005 
Geering, K. (2008). Functional roles of Na,K-ATPase subunits. Curr Opin Nephrol Hypertens, 
17(5), 526-532. doi:10.1097/MNH.0b013e3283036cbf 
Gerbe, F., Legraverend, C., & Jay, P. (2012). The intestinal epithelium tuft cells: specification 
and function. Cell Mol Life Sci, 69(17), 2907-2917. doi:10.1007/s00018-012-0984-7 
141 
Gerstle, J. T., Seaton, J., Kauffman, G. L., & Colony, P. C. (1994). The association between 
PGE2 activity and mucosal permeability in proximal small bowel. J Surg Res, 57(5), 579-
583. doi:10.1006/jsre.1994.1186 
Giepmans, B. N. (2004). Gap junctions and connexin-interacting proteins. Cardiovasc Res, 
62(2), 233-245. doi:10.1016/j.cardiores.2003.12.009 
Goldschmidt, I., Grahammer, F., Warth, R., Schulz-Baldes, A., Garty, H., Greger, R., & Bleich, 
M. (2004). Kidney and colon electrolyte transport in CHIF knockout mice. Cell Physiol 
Biochem, 14(1-2), 113-120. doi:10.1159/000076932 
Greig, E. R., Boot-Handford, R. P., Mani, V., & Sandle, G. I. (2004). Decreased expression of 
apical Na+ channels and basolateral Na+, K+-ATPase in ulcerative colitis. J Pathol, 
204(1), 84-92. doi:10.1002/path.1613 
Gronroos, E., Thodeti, C. K., & Sjolander, A. (1998). Leukotriene D4 induces a rapid increase in 
cAMP in the human epithelial cell line, Int 407: a potential role for this signal in the 
regulation of calcium influx through the plasma membrane. Cell Calcium, 24(1), 9-16.  
Guth, P. H. (1986). Gastric blood flow in ethanol injury and prostaglandin cytoprotection. Scand 
J Gastroenterol Suppl, 125, 86-91.  
Han, H. J., Park, S. H., Lee, J. C., Lee, H. B., & Park, H. S. (1999). Leukotriene D4 inhibits Na+ 
uptake through cAMP and PLC pathways in primary cultured renal proximal tubular 
cells. Kidney Blood Press Res, 22(3), 106-113. doi:10.1159/000025915 
Harizi, H., Corcuff, J. B., & Gualde, N. (2008). Arachidonic-acid-derived eicosanoids: roles in 
biology and immunopathology. Trends Mol Med, 14(10), 461-469. 
doi:10.1016/j.molmed.2008.08.005 
Harizi, H., & Gualde, N. (2005). The impact of eicosanoids on the crosstalk between innate and 
adaptive immunity: the key roles of dendritic cells. Tissue Antigens, 65(6), 507-514. 
doi:10.1111/j.1399-0039.2005.00394.x 
Havrankova, J., Roth, J., & Brownstein, M. (1978). Insulin receptors are widely distributed in the 
central nervous system of the rat. Nature, 272(5656), 827-829.  
142 
Hawker, P. C., McKay, J. S., & Turnberg, L. A. (1980). Electrolyte transport across colonic 
mucosa from patients with inflammatory bowel disease. Gastroenterology, 79(3), 508-
511.  
Hawkey, C. J., Dube, L. M., Rountree, L. V., Linnen, P. J., & Lancaster, J. F. (1997). A trial of 
zileuton versus mesalazine or placebo in the maintenance of remission of ulcerative 
colitis. The European Zileuton Study Group For Ulcerative Colitis. Gastroenterology, 
112(3), 718-724.  
Hawkey, C. J., Karmeli, F., & Rachmilewitz, D. (1983). Imbalance of prostacyclin and 
thromboxane synthesis in Crohn's disease. Gut, 24(10), 881-885.  
Hawkey, C. J., Karrasch, J. A., Szczepanski, L., Walker, D. G., Barkun, A., Swannell, A. J., & 
Yeomans, N. D. (1998). Omeprazole compared with misoprostol for ulcers associated 
with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-
induced Ulcer Management (OMNIUM) Study Group. N Engl J Med, 338(11), 727-734. 
doi:10.1056/NEJM199803123381105 
He, S., Shelly, D. A., Moseley, A. E., James, P. F., James, J. H., Paul, R. J., & Lingrel, J. B. 
(2001). The alpha(1)- and alpha(2)-isoforms of Na-K-ATPase play different roles in 
skeletal muscle contractility. Am J Physiol Regul Integr Comp Physiol, 281(3), R917-
925. doi:10.1152/ajpregu.2001.281.3.R917 
Hendel, J., & Nielsen, O. H. (1997). Expression of cyclooxygenase-2 mRNA in active 
inflammatory bowel disease. Am J Gastroenterol, 92(7), 1170-1173.  
Hilton, W. A. (1902). The morphology and development of intestinal folds and villi in 
vertibrates. American journal of Anatomy(1), 459-505.  
Hinterleitner, T. A., & Powell, D. W. (1991). Immune system control of intestinal ion transport. 
Proc Soc Exp Biol Med, 197(3), 249-260.  
Hirai, H., Tanaka, K., Yoshie, O., Ogawa, K., Kenmotsu, K., Takamori, Y., . . . Nagata, K. 
(2001). Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, 
eosinophils, and basophils via seven-transmembrane receptor CRTH2. J Exp Med, 
193(2), 255-261.  
Hirota, C. L., & McKay, D. M. (2009). Loss of Ca-mediated ion transport during colitis 
correlates with reduced ion transport responses to a Ca-activated K channel opener. Br J 
Pharmacol, 156(7), 1085-1097. doi:10.1111/j.1476-5381.2009.00122.x 
143 
Hodeify, R. F., & Kreydiyyeh, S. I. (2007). PGE2 reduces net water and chloride absorption 
from the rat colon by targeting the Na+/H+ exchanger and the Na+ K+ 2Cl- 
cotransporter. Prostaglandins Leukot Essent Fatty Acids, 76(5), 285-292. 
doi:10.1016/j.plefa.2007.02.002 
Huang, S. K., White, E. S., Wettlaufer, S. H., Grifka, H., Hogaboam, C. M., Thannickal, V. J., . . 
. Peters-Golden, M. (2009). Prostaglandin E(2) induces fibroblast apoptosis by 
modulating multiple survival pathways. FASEB J, 23(12), 4317-4326. doi:10.1096/fj.08-
128801 
Hudson, N., Balsitis, M., Everitt, S., & Hawkey, C. J. (1993). Enhanced gastric mucosal 
leukotriene B4 synthesis in patients taking non-steroidal anti-inflammatory drugs. Gut, 
34(6), 742-747.  
Hundal, H. S., Marette, A., Ramlal, T., Liu, Z., & Klip, A. (1993). Expression of beta subunit 
isoforms of the Na+,K(+)-ATPase is muscle type-specific. FEBS Lett, 328(3), 253-258.  
Hwang, E. S., Hirayama, B. A., & Wright, E. M. (1991). Distribution of the SGLT1 Na+/glucose 
cotransporter and mRNA along the crypt-villus axis of rabbit small intestine. Biochem 
Biophys Res Commun, 181(3), 1208-1217.  
Hyun, H. S., Arai, S., Onaga, T., & Kato, S. (1997). PGE2 inhibits glucose uptake in isolated 
villous epithelial cells of the ovine small intestine. Zentralbl Veterinarmed A, 44(7), 443-
447.  
Ikehata, A., Hiwatashi, N., Kinouchi, Y., Yamazaki, H., Ito, K., & Toyota, T. (1995). Altered 
leukotriene B4 metabolism in colonic mucosa with inflammatory bowel disease. Scand J 
Gastroenterol, 30(1), 44-49.  
Jewell, E. A., & Lingrel, J. B. (1991). Comparison of the substrate dependence properties of the 
rat Na,K-ATPase alpha 1, alpha 2, and alpha 3 isoforms expressed in HeLa cells. J Biol 
Chem, 266(25), 16925-16930.  
Jewell, E. A., Shamraj, O. I., & Lingrel, J. B. (1992). Isoforms of the alpha subunit of Na,K-
ATPase and their significance. Acta Physiol Scand Suppl, 607, 161-169.  
Johar, K., Priya, A., & Wong-Riley, M. T. (2012). Regulation of Na(+)/K(+)-ATPase by nuclear 
respiratory factor 1: implication in the tight coupling of neuronal activity, energy 
generation, and energy consumption. J Biol Chem, 287(48), 40381-40390. 
doi:10.1074/jbc.M112.414573 
144 
Jones, D. H., Davies, T. C., & Kidder, G. M. (1997). Embryonic expression of the putative 
gamma subunit of the sodium pump is required for acquisition of fluid transport capacity 
during mouse blastocyst development. J Cell Biol, 139(6), 1545-1552.  
Jones, D. H., Li, T. Y., Arystarkhova, E., Barr, K. J., Wetzel, R. K., Peng, J., . . . Kidder, G. M. 
(2005). Na,K-ATPase from mice lacking the gamma subunit (FXYD2) exhibits altered 
Na+ affinity and decreased thermal stability. J Biol Chem, 280(19), 19003-19011. 
doi:10.1074/jbc.M500697200 
Jorgensen, P. L., Hakansson, K. O., & Karlish, S. J. (2003). Structure and mechanism of Na,K-
ATPase: functional sites and their interactions. Annu Rev Physiol, 65, 817-849. 
doi:10.1146/annurev.physiol.65.092101.142558 
Kanaoka, Y., & Boyce, J. A. (2004). Cysteinyl leukotrienes and their receptors: cellular 
distribution and function in immune and inflammatory responses. J Immunol, 173(3), 
1503-1510.  
Kaplan, J. H. (2002). Biochemistry of Na,K-ATPase. Annu Rev Biochem, 71, 511-535. 
doi:10.1146/annurev.biochem.71.102201.141218 
Karim, S. M., & Filshie, G. M. (1970). Therapeutic abortion using prostaglandin F2alpha. 
Lancet, 1(7639), 157-159.  
Kaufmann, H. J., & Taubin, H. L. (1987). Nonsteroidal anti-inflammatory drugs activate 
quiescent inflammatory bowel disease. Ann Intern Med, 107(4), 513-516.  
Kay, A. R. (2017). How Cells Can Control Their Size by Pumping Ions. Front Cell Dev Biol, 5, 
41. doi:10.3389/fcell.2017.00041 
Keast, J. R. (1987). Mucosal innervation and control of water and ion transport in the intestine. 
Rev Physiol Biochem Pharmacol, 109, 1-59.  
Kiela, P. R., & Ghishan, F. K. (2016). Physiology of Intestinal Absorption and Secretion. Best 
Pract Res Clin Gastroenterol, 30(2), 145-159. doi:10.1016/j.bpg.2016.02.007 
Klodos, I., & Ottolenghi, P. (1975). Large-scale preparation of Na, K-ATPase from ox brain. 
Anal Biochem, 67(2), 397-403.  
145 
Kobayashi, M., & Kawakami, K. (1995). ATF-1CREB heterodimer is involved in constitutive 
expression of the housekeeping Na,K-ATPase alpha 1 subunit gene. Nucleic Acids Res, 
23(15), 2848-2855.  
Kobayashi, M., Shimomura, A., Hagiwara, M., & Kawakami, K. (1997). Phosphorylation of 
ATF-1 enhances its DNA binding and transcription of the Na,K-ATPase alpha 1 subunit 
gene promoter. Nucleic Acids Res, 25(4), 877-882.  
Kolla, V., Robertson, N. M., & Litwack, G. (1999). Identification of a 
mineralocorticoid/glucocorticoid response element in the human Na/K ATPase alpha1 
gene promoter. Biochem Biophys Res Commun, 266(1), 5-14. 
doi:10.1006/bbrc.1999.1765 
Kreydiyyeh, S. I., & Al-Sadi, R. (2002a). Interleukin-1beta increases urine flow rate and inhibits 
protein expression of Na(+)/K(+)-ATPase in the rat jejunum and kidney. J Interferon 
Cytokine Res, 22(10), 1041-1048. doi:10.1089/107999002760624279 
Kreydiyyeh, S. I., & Al-Sadi, R. (2002b). The mechanism by which interleukin-1 beta reduces 
net fluid absorption from the rat colon. Eur Cytokine Netw, 13(3), 358-363.  
Kreydiyyeh, S. I., Riman, S., Serhan, M., & Kassardjian, A. (2007). TNF-alpha modulates 
hepatic Na+-K+ ATPase activity via PGE2 and EP2 receptors. Prostaglandins Other 
Lipid Mediat, 83(4), 295-303. doi:10.1016/j.prostaglandins.2007.02.003 
Kristensen, M., & Juel, C. (2010). Na+,K+-ATPase Na+ affinity in rat skeletal muscle fiber 
types. J Membr Biol, 234(1), 35-45. doi:10.1007/s00232-010-9237-6 
Kumral, D., & Zfass, A. M. (2018). Gut Movements: A Review of the Physiology of 
Gastrointestinal Transit. Dig Dis Sci, 63(10), 2500-2506. doi:10.1007/s10620-018-5259-1 
Lakatos, P. L. (2006). Recent trends in the epidemiology of inflammatory bowel diseases: up or 
down? World J Gastroenterol, 12(38), 6102-6108.  
Laubitz, D., Larmonier, C. B., Bai, A., Midura-Kiela, M. T., Lipko, M. A., Thurston, R. D., . . . 
Ghishan, F. K. (2008). Colonic gene expression profile in NHE3-deficient mice: evidence 
for spontaneous distal colitis. Am J Physiol Gastrointest Liver Physiol, 295(1), G63-G77. 
doi:10.1152/ajpgi.90207.2008 
146 
Laughery, M. D., Todd, M. L., & Kaplan, J. H. (2003). Mutational analysis of alpha-beta subunit 
interactions in the delivery of Na,K-ATPase heterodimers to the plasma membrane. J 
Biol Chem, 278(37), 34794-34803. doi:10.1074/jbc.M302899200 
Leung, F. W., Miller, J. C., Reedy, T. J., & Guth, P. H. (1989). Exogenous prostaglandin protects 
against acid-induced deep mucosal injury by stimulating alkaline secretion in rat 
duodenum. Dig Dis Sci, 34(11), 1686-1691.  
Lewis, R. A., Austen, K. F., & Soberman, R. J. (1990). Leukotrienes and other products of the 5-
lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N 
Engl J Med, 323(10), 645-655. doi:10.1056/NEJM199009063231006 
Li, Z., & Langhans, S. A. (2015). Transcriptional regulators of Na,K-ATPase subunits. Front 
Cell Dev Biol, 3, 66. doi:10.3389/fcell.2015.00066 
Ligumsky, M., Karmeli, F., Sharon, P., Zor, U., Cohen, F., & Rachmilewitz, D. (1981). 
Enhanced thromboxane A2 and prostacyclin production by cultured rectal mucosa in 
ulcerative colitis and its inhibition by steroids and sulfasalazine. Gastroenterology, 81(3), 
444-449.  
Lingrel, J. B. (2010). The physiological significance of the cardiotonic steroid/ouabain-binding 
site of the Na,K-ATPase. Annu Rev Physiol, 72, 395-412. doi:10.1146/annurev-physiol-
021909-135725 
Liu, B., & Gick, G. (1992). Characterization of the 5' flanking region of the rat Na+/K(+)-
ATPase beta 1 subunit gene. Biochim Biophys Acta, 1130(3), 336-338.  
Liu, B., Qu, L., & Yan, S. (2015). Cyclooxygenase-2 promotes tumor growth and suppresses 
tumor immunity. Cancer Cell Int, 15, 106. doi:10.1186/s12935-015-0260-7 
Lubarski, I., Pihakaski-Maunsbach, K., Karlish, S. J., Maunsbach, A. B., & Garty, H. (2005). 
Interaction with the Na,K-ATPase and tissue distribution of FXYD5 (related to ion 
channel). J Biol Chem, 280(45), 37717-37724. doi:10.1074/jbc.M506397200 
Lugea, A., Salas, A., Guarner, F., Azpiroz, F., & Malagelada, J. R. (1992). Duodenal mucosal 
resistance to intraluminal acid in the rat: role of adaptive cytoprotection. 
Gastroenterology, 102(4 Pt 1), 1129-1135.  
147 
Ma, T. Y. (1997). Intestinal epithelial barrier dysfunction in Crohn's disease. Proc Soc Exp Biol 
Med, 214(4), 318-327.  
Madara, J. L. (1989). Loosening tight junctions. Lessons from the intestine. J Clin Invest, 83(4), 
1089-1094. doi:10.1172/JCI113987 
Magalhaes, D., Cabral, J. M., Soares-da-Silva, P., & Magro, F. (2016). Role of epithelial ion 
transports in inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol, 
310(7), G460-476. doi:10.1152/ajpgi.00369.2015 
Magro, F., Fraga, S., Ribeiro, T., & Soares-da-Silva, P. (2004). Intestinal Na+-K+-ATPase 
activity and molecular events downstream of interferon-gamma receptor stimulation. Br J 
Pharmacol, 142(8), 1281-1292. doi:10.1038/sj.bjp.0705895 
Magro, F., Fraga, S., Ribeiro, T., & Soares-da-Silva, P. (2005). Regional intestinal adaptations in 
Na+,K+-ATPase in experimental colitis and the contrasting effects of interferon-gamma. 
Acta Physiol Scand, 183(2), 191-199. doi:10.1111/j.1365-201X.2004.01388.x 
Magro, F., Fraga, S., & Soares-da-Silva, P. (2005). Signaling of short- and long-term regulation 
of intestinal epithelial type 1 Na+/H+ exchanger by interferon-gamma. Br J Pharmacol, 
145(1), 93-103. doi:10.1038/sj.bjp.0706167 
Mairbaurl, H., Schulz, S., & Hoffman, J. F. (2000). Cation transport and cell volume changes in 
maturing rat reticulocytes. Am J Physiol Cell Physiol, 279(5), C1621-1630. 
doi:10.1152/ajpcell.2000.279.5.C1621 
Manokas, T., Fromkes, J. J., & Sundaram, U. (2000). Effect of chronic inflammation on ileal 
short-chain fatty acid/bicarbonate exchange. Am J Physiol Gastrointest Liver Physiol, 
278(4), G585-590. doi:10.1152/ajpgi.2000.278.4.G585 
Marchiando, A. M., Graham, W. V., & Turner, J. R. (2010). Epithelial barriers in homeostasis 
and disease. Annu Rev Pathol, 5, 119-144. doi:10.1146/annurev.pathol.4.110807.092135 
Markossian, S., & Kreydiyyeh, S. I. (2005). TNF-alpha down-regulates the Na+-K+ ATPase and 
the Na+-K+-2Cl-cotransporter in the rat colon via PGE2. Cytokine, 30(6), 319-327. 
doi:10.1016/j.cyto.2004.11.009 
148 
Massey-Harroche, D. (2000). Epithelial cell polarity as reflected in enterocytes. Microsc Res 
Tech, 49(4), 353-362. doi:10.1002/(SICI)1097-0029(20000515)49:4<353::AID-
JEMT4>3.0.CO;2-8 
Massironi, S., Rossi, R. E., Cavalcoli, F. A., Della Valle, S., Fraquelli, M., & Conte, D. (2013). 
Nutritional deficiencies in inflammatory bowel disease: therapeutic approaches. Clin 
Nutr, 32(6), 904-910. doi:10.1016/j.clnu.2013.03.020 
Matchkov, V. V., & Krivoi, II. (2016). Specialized Functional Diversity and Interactions of the 
Na,K-ATPase. Front Physiol, 7, 179. doi:10.3389/fphys.2016.00179 
Matlhagela, K., Borsick, M., Rajkhowa, T., & Taub, M. (2005). Identification of a prostaglandin-
responsive element in the Na,K-ATPase beta 1 promoter that is regulated by cAMP and 
Ca2+. Evidence for an interactive role of cAMP regulatory element-binding protein and 
Sp1. J Biol Chem, 280(1), 334-346. doi:10.1074/jbc.M411415200 
Matlhagela, K., & Taub, M. (2006a). Prostaglandins regulate transcription by means of 
prostaglandin response elements located in the promoters of mammalian Na,K-ATPase 
beta 1 subunit genes. Ann N Y Acad Sci, 1091, 233-243. doi:10.1196/annals.1378.070 
Matlhagela, K., & Taub, M. (2006b). Regulation of the Na-K-ATPase beta(1)-subunit promoter 
by multiple prostaglandin-responsive elements. Am J Physiol Renal Physiol, 291(3), 
F635-646. doi:10.1152/ajprenal.00452.2005 
McDonough, A. A., & Farley, R. A. (1993). Regulation of Na,K-ATPase activity. Curr Opin 
Nephrol Hypertens, 2(5), 725-734.  
McDonough, A. A., Geering, K., & Farley, R. A. (1990). The sodium pump needs its beta 
subunit. FASEB J, 4(6), 1598-1605.  
McKee, M., Scavone, C., & Nathanson, J. A. (1994). Nitric oxide, cGMP, and hormone 
regulation of active sodium transport. Proc Natl Acad Sci U S A, 91(25), 12056-12060.  
Mercer, R. W. (1993). Structure of the Na,K-ATPase. Int Rev Cytol, 137C, 139-168.  
Milton-Thompson, G. J., Cummings, J. H., Newman, A., Billings, J. A., & Misiewicz, J. J. 
(1975). Colonic and small intestinal response to intravenous prostaglandin F2 alpha and 
E2 in man. Gut, 16(1), 42-46.  
149 
Mitchell, J. A., & Evans, T. W. (1998). Cyclooxygenase-2 as a therapeutic target. Inflamm Res, 
47 Suppl 2, S88-92.  
Moeser, A. J., Nighot, P. K., Ryan, K. A., Wooten, J. G., & Blikslager, A. T. (2006). 
Prostaglandin-mediated inhibition of Na+/H+ exchanger isoform 2 stimulates recovery of 
barrier function in ischemia-injured intestine. Am J Physiol Gastrointest Liver Physiol, 
291(5), G885-894. doi:10.1152/ajpgi.00380.2005 
Mohajer, B., & Ma, T. Y. (2000). Eicosanoids and the small intestine. Prostaglandins Other 
Lipid Mediat, 61(3-4), 125-143.  
Monneret, G., Gravel, S., Diamond, M., Rokach, J., & Powell, W. S. (2001). Prostaglandin D2 is 
a potent chemoattractant for human eosinophils that acts via a novel DP receptor. Blood, 
98(6), 1942-1948.  
Mony, S., Lee, S. J., Harper, J. F., Barwe, S. P., & Langhans, S. A. (2013). Regulation of Na,K-
ATPase beta1-subunit in TGF-beta2-mediated epithelial-to-mesenchymal transition in 
human retinal pigmented epithelial cells. Exp Eye Res, 115, 113-122. 
doi:10.1016/j.exer.2013.06.007 
Moskowitz, N., Shapiro, L., Schook, W., & Puszkin, S. (1983). Phospholipase A2 modulation by 
calmodulin, prostaglandins and cyclic nucleotides. Biochem Biophys Res Commun, 
115(1), 94-99.  
Mounsey, J. P., John, J. E., 3rd, Helmke, S. M., Bush, E. W., Gilbert, J., Roses, A. D., . . . 
Moorman, J. R. (2000). Phospholemman is a substrate for myotonic dystrophy protein 
kinase. J Biol Chem, 275(30), 23362-23367. doi:10.1074/jbc.M000899200 
Musch, M. W., Miller, R. J., Field, M., & Siegel, M. I. (1982). Stimulation of colonic secretion 
by lipoxygenase metabolites of arachidonic acid. Science, 217(4566), 1255-1256.  
Narkar, V., Hussain, T., & Lokhandwala, M. (2002). Role of tyrosine kinase and p44/42 MAPK 
in D(2)-like receptor-mediated stimulation of Na(+), K(+)-ATPase in kidney. Am J 
Physiol Renal Physiol, 282(4), F697-702. doi:10.1152/ajprenal.00126.2001 
Narumiya, S., & FitzGerald, G. A. (2001). Genetic and pharmacological analysis of prostanoid 
receptor function. J Clin Invest, 108(1), 25-30. doi:10.1172/JCI13455 
150 
Nathanson, J. A., Scavone, C., Scanlon, C., & McKee, M. (1995). The cellular Na+ pump as a 
site of action for carbon monoxide and glutamate: a mechanism for long-term modulation 
of cellular activity. Neuron, 14(4), 781-794.  
Nguyen, A. N., Wallace, D. P., & Blanco, G. (2007). Ouabain binds with high affinity to the 
Na,K-ATPase in human polycystic kidney cells and induces extracellular signal-regulated 
kinase activation and cell proliferation. J Am Soc Nephrol, 18(1), 46-57. 
doi:10.1681/ASN.2006010086 
Oliveira, M. S., Furian, A. F., Rambo, L. M., Ribeiro, L. R., Royes, L. F., Ferreira, J., . . . Mello, 
C. F. (2009). Prostaglandin E2 modulates Na+,K+-ATPase activity in rat hippocampus: 
implications for neurological diseases. J Neurochem, 109(2), 416-426. 
doi:10.1111/j.1471-4159.2009.05961.x 
Pedemont, C. H., & Bertorello, A. M. (2001). Short-term regulation of the proximal tubule 
Na+,K+-ATPase: increased/decreased Na+,K+-ATPase activity mediated by protein 
kinase C isoforms. J Bioenerg Biomembr, 33(5), 439-447.  
Pedemonte, C. H., Pressley, T. A., Cinelli, A. R., & Lokhandwala, M. F. (1997). Stimulation of 
protein kinase C rapidly reduces intracellular Na+ concentration via activation of the Na+ 
pump in OK cells. Mol Pharmacol, 52(1), 88-97.  
Pedemonte, C. H., Pressley, T. A., Lokhandwala, M. F., & Cinelli, A. R. (1997). Regulation of 
Na,K-ATPase transport activity by protein kinase C. J Membr Biol, 155(3), 219-227.  
Peskar, B. M., Dreyling, K. W., Peskar, B. A., May, B., & Goebell, H. (1986). Enhanced 
formation of sulfidopeptide-leukotrienes in ulcerative colitis and Crohn's disease: 
inhibition by sulfasalazine and 5-aminosalicylic acid. Agents Actions, 18(3-4), 381-383.  
Pierre, S. V., Duran, M. J., Carr, D. L., & Pressley, T. A. (2002). Structure/function analysis of 
Na(+)-K(+)-ATPase central isoform-specific region: involvement in PKC regulation. Am 
J Physiol Renal Physiol, 283(5), F1066-1074. doi:10.1152/ajprenal.00153.2002 
Post, R. L., Sen, A. K., & Rosenthal, A. S. (1965). A Phosphorylated Intermediate in Adenosine 
Triphosphate-Dependent Sodium and Potassium Transport across Kidney Membranes. J 
Biol Chem, 240, 1437-1445.  
Powell, D. W. (1986). Ion and Water transport in the intestine In T. E. Andersen, Hoffman, J. G., 
Fanestil, D. D., Schultz, S. G,. (Ed.), Physiology of membrane disorders (pp. 559-596). 
New York: Plenum Publishing Corp. 
151 
Pressley, T. A., Allen, J. C., Clarke, C. H., Odebunmi, T., & Higham, S. C. (1996). Amino-
terminal processing of the catalytic subunit from Na(+)-K(+)-ATPase. Am J Physiol, 
271(3 Pt 1), C825-832. doi:10.1152/ajpcell.1996.271.3.C825 
Rachmilewitz, D., Karmeli, F., & Sharon, P. (1984). Decreased colonic Na-K-ATPase activity in 
active ulcerative colitis. Isr J Med Sci, 20(8), 681-684.  
Rachmilewitz, D., Ligumsky, M., Haimovitz, A., & Treves, A. J. (1982). Prostanoid synthesis by 
cultured peripheral blood mononuclear cells in inflammatory diseases of the bowel. 
Gastroenterology, 82(4), 673-679.  
Racusen, L. C., & Binder, H. J. (1980). Effect of prostaglandin on ion transport across isolated 
colonic mucosa. Dig Dis Sci, 25(12), 900-904.  
Rahman, N., Buck, J., & Levin, L. R. (2013). pH sensing via bicarbonate-regulated "soluble" 
adenylyl cyclase (sAC). Front Physiol, 4, 343. doi:10.3389/fphys.2013.00343 
Rajasekaran, S. A., Barwe, S. P., & Rajasekaran, A. K. (2005). Multiple functions of Na,K-
ATPase in epithelial cells. Semin Nephrol, 25(5), 328-334. 
doi:10.1016/j.semnephrol.2005.03.008 
Rampton, D. S., & Sladen, G. E. (1981). Prostaglandin synthesis inhibitors in ulcerative colitis: 
flurbiprofen compared with conventional treatment. Prostaglandins, 21(3), 417-425.  
Rash, B. G., Ackman, J. B., & Rakic, P. (2016). Bidirectional radial Ca(2+) activity regulates 
neurogenesis and migration during early cortical column formation. Sci Adv, 2(2), 
e1501733. doi:10.1126/sciadv.1501733 
Rask-Madsen, J., Bukhave, K., & Lauritsen, K. (1988). Functional role of eicosanoids in the 
gastrointestinal tract. Acta Gastroenterol Belg, 51(6), 439-449.  
Repke, K. R., & Schon, R. (1973). Flip-flop model of (NaK)-ATPase function. Acta Biol Med 
Ger, 31(4), Suppl:K19-30.  
Robert, A. (1976). Antisecretory, antiulcer, cytoprotective and diarrheogenic properties of 
prostaglandins. Adv Prostaglandin Thromboxane Res, 2, 507-520.  
152 
Robert, A. (1981). Prostaglandins and the gastrointestinal tract In L. R. Johnson (Ed.), 
Physiology of the gastrointestinal tract (Vol. 2, pp. 1407-1434). New York: Raven. 
Robert, A., Nezamis, J. E., Lancaster, C., Hanchar, A. J., & Klepper, M. S. (1976). 
Enteropooling assay: a test for diarrhea produced by prostaglandins. Prostaglandins, 
11(5), 809-828.  
Roberts, W. G., Simon, T. J., Berlin, R. G., Haggitt, R. C., Snyder, E. S., Stenson, W. F., . . . 
Berger, M. L. (1997). Leukotrienes in ulcerative colitis: results of a multicenter trial of a 
leukotriene biosynthesis inhibitor, MK-591. Gastroenterology, 112(3), 725-732.  
Romero, M., Artigiani, R., Costa, H., Oshima, C. T., Miszputen, S., & Franco, M. (2008). 
Evaluation of the immunoexpression of COX-1, COX-2 and p53 in Crohn's disease. Arq 
Gastroenterol, 45(4), 295-300.  
Rose, A. M., & Valdes, R., Jr. (1994). Understanding the sodium pump and its relevance to 
disease. Clin Chem, 40(9), 1674-1685.  
Rosen, K. G., & Sigstrom, L. (1978). The influence of age on Na-K-ATP-ase activity in 
erythrocytes in fetal and newborn guinea pigs. J Perinat Med, 6(3), 154-159.  
Ruwart, M. J., Klepper, M. S., & Rush, B. D. (1979). Ionic composition of small intestinal 
secretion induced by PGE2. Prostaglandins Med, 2(4), 285-291.  
Sachs, D., Villarreal, C., Cunha, F., Parada, C., & Ferreira, S. (2009). The role of PKA and 
PKCepsilon pathways in prostaglandin E2-mediated hypernociception. Br J Pharmacol, 
156(5), 826-834. doi:10.1111/j.1476-5381.2008.00093.x 
Saha, P., Arthur, S., Kekuda, R., & Sundaram, U. (2012). Na-glutamine co-transporters B(0)AT1 
in villus and SN2 in crypts are differentially altered in chronically inflamed rabbit 
intestine. Biochim Biophys Acta, 1818(3), 434-442. doi:10.1016/j.bbamem.2011.11.005 
Saha, P., Manoharan, P., Arthur, S., Sundaram, S., Kekuda, R., & Sundaram, U. (2015). 
Molecular mechanism of regulation of villus cell Na-K-ATPase in the chronically 
inflamed mammalian small intestine. Biochim Biophys Acta, 1848(2), 702-711. 
doi:10.1016/j.bbamem.2014.11.005 
Sandle, G. I. (2005). Pathogenesis of diarrhea in ulcerative colitis: new views on an old problem. 
J Clin Gastroenterol, 39(4 Suppl 2), S49-52.  
153 
Sandle, G. I., Higgs, N., Crowe, P., Marsh, M. N., Venkatesan, S., & Peters, T. J. (1990). 
Cellular basis for defective electrolyte transport in inflamed human colon. 
Gastroenterology, 99(1), 97-105.  
Sartor, R. B. (1991). Pathogenetic and clinical relevance of cytokines in inflammatory bowel 
disease. Immunol Res, 10(3-4), 465-471.  
Sartor, R. B., & Powell, D. W. (1991). Mechanisms of Diarrhea in inflammation and 
hypersensitivity: current Topic in Gastroenterology. In M. Field (Ed.), Diarrheal 
Diseases (pp. 75-114). New York, N.Y., USA.: Elsevier Science. 
Sawasdikosol, S., Pyarajan, S., Alzabin, S., Matejovic, G., & Burakoff, S. J. (2007). 
Prostaglandin E2 activates HPK1 kinase activity via a PKA-dependent pathway. J Biol 
Chem, 282(48), 34693-34699. doi:10.1074/jbc.M707425200 
Scavone, C., Scanlon, C., McKee, M., & Nathanson, J. A. (1995). Atrial natriuretic peptide 
modulates sodium and potassium-activated adenosine triphosphatase through a 
mechanism involving cyclic GMP and cyclic GMP-dependent protein kinase. J 
Pharmacol Exp Ther, 272(3), 1036-1043.  
Scheurlen, C., Allgayer, H., Hardt, M., & Kruis, W. (1998). Effect of short-term topical 
corticosteroid treatment on mucosal enzyme systems in patients with distal inflammatory 
bowel disease. Hepatogastroenterology, 45(23), 1539-1545.  
Schneeberger, K., Roth, S., Nieuwenhuis, E. E. S., & Middendorp, S. (2018). Intestinal epithelial 
cell polarity defects in disease: lessons from microvillus inclusion disease. Dis Model 
Mech, 11(2). doi:10.1242/dmm.031088 
Schror, K. (1985). Prostaglandins, other eicosanoids and endothelial cells. Basic Res Cardiol, 
80(5), 502-514.  
Schultheiss, G., Lan Kocks, S., & Diener, M. (2005). Stimulation of colonic anion secretion by 
monochloramine: action sites. Pflugers Arch, 449(6), 553-563. doi:10.1007/s00424-004-
1365-3 
Serhan, M. F., & Kreydiyyeh, S. I. (2011). Insulin targets the Na(+)/K(+) ATPase in enterocytes 
via PI3K, PKC, and MAPKS. J Recept Signal Transduct Res, 31(4), 299-306. 
doi:10.3109/10799893.2011.587821 
154 
Seven, I., Turkozkan, N., & Cimen, B. (2005). The effects of nitric oxide synthesis on the Na+ 
,K(+)-ATPase activity in guinea pig kidney exposed to lipopolysaccharides. Mol Cell 
Biochem, 271(1-2), 107-112.  
Shamraj, O. I., & Lingrel, J. B. (1994). A putative fourth Na+,K(+)-ATPase alpha-subunit gene 
is expressed in testis. Proc Natl Acad Sci U S A, 91(26), 12952-12956.  
Shapiro, J. I., & Tian, J. (2011). Signaling through the Na/K-ATPase: implications for cardiac 
fibrosis. Am J Physiol Heart Circ Physiol, 300(1), H29-30. 
doi:10.1152/ajpheart.01038.2010 
Sharon, P., Ligumsky, M., Rachmilewitz, D., & Zor, U. (1978). Role of prostaglandins in 
ulcerative colitis. Enhanced production during active disease and inhibition by 
sulfasalazine. Gastroenterology, 75(4), 638-640.  
Sharon, P., & Stenson, W. F. (1984). Enhanced synthesis of leukotriene B4 by colonic mucosa in 
inflammatory bowel disease. Gastroenterology, 86(3), 453-460.  
Shinoda, T., Ogawa, H., Cornelius, F., & Toyoshima, C. (2009). Crystal structure of the sodium-
potassium pump at 2.4 A resolution. Nature, 459(7245), 446-450. 
doi:10.1038/nature07939 
Shull, G. E., Lane, L. K., & Lingrel, J. B. (1986). Amino-acid sequence of the beta-subunit of the 
(Na+ + K+)ATPase deduced from a cDNA. Nature, 321(6068), 429-431. 
doi:10.1038/321429a0 
Shull, G. E., Schwartz, A., & Lingrel, J. B. (1985). Amino-acid sequence of the catalytic subunit 
of the (Na+ + K+)ATPase deduced from a complementary DNA. Nature, 316(6030), 
691-695.  
Shull, M. M., Pugh, D. G., & Lingrel, J. B. (1990). The human Na, K-ATPase alpha 1 gene: 
characterization of the 5'-flanking region and identification of a restriction fragment 
length polymorphism. Genomics, 6(3), 451-460.  
Shyjan, A. W., Cena, V., Klein, D. C., & Levenson, R. (1990). Differential expression and 
enzymatic properties of the Na+,K(+)-ATPase alpha 3 isoenzyme in rat pineal glands. 
Proc Natl Acad Sci U S A, 87(3), 1178-1182.  
155 
Shyjan, A. W., & Levenson, R. (1989). Antisera specific for the alpha 1, alpha 2, alpha 3, and 
beta subunits of the Na,K-ATPase: differential expression of alpha and beta subunits in 
rat tissue membranes. Biochemistry, 28(11), 4531-4535.  
Singer, II, Kawka, D. W., Schloemann, S., Tessner, T., Riehl, T., & Stenson, W. F. (1998). 
Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease. 
Gastroenterology, 115(2), 297-306.  
Singh, S., Arthur, S., & Sundaram, U. (2018). Unique regulation of Na-glutamine cotransporter 
SN2/SNAT5 in rabbit intestinal crypt cells during chronic enteritis. J Cell Mol Med, 
22(3), 1443-1451. doi:10.1111/jcmm.13257 
Singh, S., Arthur, S., Talukder, J., Palaniappan, B., Coon, S., & Sundaram, U. (2015). Mast cell 
regulation of Na-glutamine co-transporters B0AT1 in villus and SN2 in crypt cells during 
chronic intestinal inflammation. BMC Gastroenterol, 15, 47. doi:10.1186/s12876-015-
0275-5 
Singh, S., & Sundaram, U. (2015). Sa1802 Mechanism of Stimulation of Na-Glutamine Co-
Transporter SN2 by LTD4 in Intestinal Epithelial Cells. Gastroenterology, 148(4), S-
336-S-337. doi:10.1016/S0016-5085(15)31118-5 
Singh, S. K., Binder, H. J., Boron, W. F., & Geibel, J. P. (1995). Fluid absorption in isolated 
perfused colonic crypts. J Clin Invest, 96(5), 2373-2379. doi:10.1172/JCI118294 
Six, D. A., & Dennis, E. A. (2000). The expanding superfamily of phospholipase A(2) enzymes: 
classification and characterization. Biochim Biophys Acta, 1488(1-2), 1-19.  
Skayian, Y., & Kreydiyyeh, S. I. (2006). Tumor necrosis factor alpha alters Na+-K+ ATPase 
activity in rat cardiac myocytes: involvement of NF-kappaB, AP-1 and PGE2. Life Sci, 
80(2), 173-180. doi:10.1016/j.lfs.2006.08.037 
Skou, J. C. (1957). The influence of some cations on an adenosine triphosphatase from 
peripheral nerves. Biochim Biophys Acta, 23(2), 394-401.  
Skou, J. C. (1990). The fourth Datta lecture. The energy coupled exchange of Na+ for K+ across 
the cell membrane. The Na+, K(+)-pump. FEBS Lett, 268(2), 314-324.  
Skou, J. C., & Esmann, M. (1992). The Na,K-ATPase. J Bioenerg Biomembr, 24(3), 249-261.  
156 
Smith, W. L., DeWitt, D. L., & Garavito, R. M. (2000). Cyclooxygenases: structural, cellular, 
and molecular biology. Annu Rev Biochem, 69, 145-182. 
doi:10.1146/annurev.biochem.69.1.145 
Soltoff, S. P., Asara, J. M., & Hedden, L. (2010). Regulation and identification of Na,K-ATPase 
alpha1 subunit phosphorylation in rat parotid acinar cells. J Biol Chem, 285(47), 36330-
36338. doi:10.1074/jbc.M110.136465 
Stadnyk, A. W. (2002). Intestinal epithelial cells as a source of inflammatory cytokines and 
chemokines. Can J Gastroenterol, 16(4), 241-246.  
Suhail, M. (2010). Na, K-ATPase: Ubiquitous Multifunctional Transmembrane Protein and its 
Relevance to Various Pathophysiological Conditions. J Clin Med Res, 2(1), 1-17. 
doi:10.4021/jocmr2010.02.263w 
Sullivan, S., Alex, P., Dassopoulos, T., Zachos, N. C., Iacobuzio-Donahue, C., Donowitz, M., . . 
. Li, X. (2009). Downregulation of sodium transporters and NHERF proteins in IBD 
patients and mouse colitis models: potential contributors to IBD-associated diarrhea. 
Inflamm Bowel Dis, 15(2), 261-274. doi:10.1002/ibd.20743 
Sun, Y., & Ball, W. J., Jr. (1992). Determination of Na(+)-K(+)-ATPase alpha- and beta-
isoforms and kinetic properties in mammalian liver. Am J Physiol, 262(6 Pt 1), C1491-
1499. doi:10.1152/ajpcell.1992.262.6.C1491 
Sundaram, U., & West, A. B. (1997). Effect of chronic inflammation on electrolyte transport in 
rabbit ileal villus and crypt cells. Am J Physiol, 272(4 Pt 1), G732-741. 
doi:10.1152/ajpgi.1997.272.4.G732 
Sundaram, U., Wisel, S., & Coon, S. (2005). Mechanism of inhibition of proton: dipeptide co-
transport during chronic enteritis in the mammalian small intestine. Biochim Biophys 
Acta, 1714(2), 134-140. doi:10.1016/j.bbamem.2005.06.007 
Sundaram, U., Wisel, S., & Coon, S. (2007). Neutral Na-amino acid cotransport is differentially 
regulated by glucocorticoids in the normal and chronically inflamed rabbit small 
intestine. Am J Physiol Gastrointest Liver Physiol, 292(2), G467-474. 
doi:10.1152/ajpgi.00503.2005 
Sundaram, U., Wisel, S., & Fromkes, J. J. (1998a). Unique mechanism of inhibition of Na+-
amino acid cotransport during chronic ileal inflammation. Am J Physiol, 275(3 Pt 1), 
G483-489.  
157 
Sundaram, U., Wisel, S., & Fromkes, J. J. (1998b). Unique mechanism of inhibition of Na+-
amino acid cotransport during chronic ileal inflammation. Am J Physiol, 275(3), G483-
489. doi:10.1152/ajpgi.1998.275.3.G483 
Sundaram, U., Wisel, S., Rajendren, V. M., & West, A. B. (1997). Mechanism of inhibition of 
Na+-glucose cotransport in the chronically inflamed rabbit ileum. Am J Physiol, 273(4 Pt 
1), G913-919.  
Sweadner, K. J., McGrail, K. M., & Khaw, B. A. (1992). Discoordinate regulation of isoforms of 
Na,K-ATPase and myosin heavy chain in the hypothyroid postnatal rat heart and skeletal 
muscle. J Biol Chem, 267(2), 769-773.  
Sweadner, K. J., & Rael, E. (2000). The FXYD gene family of small ion transport regulators or 
channels: cDNA sequence, protein signature sequence, and expression. Genomics, 68(1), 
41-56. doi:10.1006/geno.2000.6274 
Szabo, S. (1987). Mechanisms of mucosal injury in the stomach and duodenum: time-sequence 
analysis of morphologic, functional, biochemical and histochemical studies. Scand J 
Gastroenterol Suppl, 127, 21-28.  
Szabo, S., & Goldberg, I. (1990). Experimental pathogenesis: drugs and chemical lesions in the 
gastric mucosa. Scand J Gastroenterol Suppl, 174, 1-8.  
Takeuchi, K., Yagi, K., Kato, S., & Ukawa, H. (1997). Roles of prostaglandin E-receptor 
subtypes in gastric and duodenal bicarbonate secretion in rats. Gastroenterology, 113(5), 
1553-1559.  
Talukder, J. R., Griffin, A., Jaima, A., Boyd, B., & Wright, J. (2014). Lactoferrin ameliorates 
prostaglandin E2-mediated inhibition of Na+ -glucose cotransport in enterocytes. Can J 
Physiol Pharmacol, 92(1), 9-20. doi:10.1139/cjpp-2013-0211 
Talukder, J. R., Kekuda, R., Saha, P., & Sundaram, U. (2008). Mechanism of leukotriene D4 
inhibition of Na-alanine cotransport in intestinal epithelial cells. Am J Physiol 
Gastrointest Liver Physiol, 295(1), G1-G6. doi:10.1152/ajpgi.00498.2007 
Tesori, V., Puglisi, M. A., Lattanzi, W., Gasbarrini, G. B., & Gasbarrini, A. (2013). Update on 
small intestinal stem cells. World J Gastroenterol, 19(29), 4671-4678. 
doi:10.3748/wjg.v19.i29.4671 
158 
Therien, A. G., & Blostein, R. (2000). Mechanisms of sodium pump regulation. Am J Physiol 
Cell Physiol, 279(3), C541-566. doi:10.1152/ajpcell.2000.279.3.C541 
Thodeti, C. K., & Sjolander, A. (2002). Leukotriene D4-induced calcium signaling in human 
intestinal epithelial cells. Adv Exp Med Biol, 507, 187-191.  
Thompson, C. B., & McDonough, A. A. (1996). Skeletal muscle Na,K-ATPase alpha and beta 
subunit protein levels respond to hypokalemic challenge with isoform and muscle type 
specificity. J Biol Chem, 271(51), 32653-32658.  
Tokhtaeva, E., Clifford, R. J., Kaplan, J. H., Sachs, G., & Vagin, O. (2012). Subunit isoform 
selectivity in assembly of Na,K-ATPase alpha-beta heterodimers. J Biol Chem, 287(31), 
26115-26125. doi:10.1074/jbc.M112.370734 
Tollstrom, T., Hellstrom, P. M., Johansson, C., & Pernow, B. (1988). Effects of prostaglandins 
E2 and F2 alpha on motility of small intestine in man. Dig Dis Sci, 33(5), 552-557.  
Toyoshima, C., Kanai, R., & Cornelius, F. (2011). First crystal structures of Na+,K+-ATPase: 
new light on the oldest ion pump. Structure, 19(12), 1732-1738. 
doi:10.1016/j.str.2011.10.016 
Track, N. S. (1980). The gastrointestinal endocrine system. Can Med Assoc J, 122(3), 287-292.  
Turnberg, L. (1991). Cellular basis of diarrhoea. The Croonian lecture 1989. J R Coll Physicians 
Lond, 25(1), 53-62.  
Urayama, O., Shutt, H., & Sweadner, K. J. (1989). Identification of three isozyme proteins of the 
catalytic subunit of the Na,K-ATPase in rat brain. J Biol Chem, 264(14), 8271-8280.  
Uribe, A., Alam, M., & Midtvedt, T. (1992). E2 prostaglandins modulate cell proliferation in the 
small intestinal epithelium of the rat. Digestion, 52(3-4), 157-164. 
doi:10.1159/000200948 
van der Flier, L. G., & Clevers, H. (2009). Stem cells, self-renewal, and differentiation in the 
intestinal epithelium. Annu Rev Physiol, 71, 241-260. 
doi:10.1146/annurev.physiol.010908.163145 
159 
Van Inwegen, R. G., Khandwala, A., Gordon, R., Sonnino, P., Coutts, S., & Jolly, S. (1987). 
REV 5901: an orally effective peptidoleukotriene antagonist, detailed 
biochemical/pharmacological profile. J Pharmacol Exp Ther, 241(1), 117-124.  
Vasarhelyi, B., Tulassay, T., Ver, A., Dobos, M., Kocsis, I., & Seri, I. (2000). Developmental 
changes in erythrocyte Na(+),K(+)-ATPase subunit abundance and enzyme activity in 
neonates. Arch Dis Child Fetal Neonatal Ed, 83(2), F135-138.  
Vilsen, B., Andersen, J. P., Petersen, J., & Jorgensen, P. L. (1987). Occlusion of 22Na+ and 
86Rb+ in membrane-bound and soluble protomeric alpha beta-units of Na,K-ATPase. J 
Biol Chem, 262(22), 10511-10517.  
Wallace, J. L. (2008). Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn't the 
stomach digest itself? Physiol Rev, 88(4), 1547-1565. doi:10.1152/physrev.00004.2008 
Wallace, J. L., Syer, S., Denou, E., de Palma, G., Vong, L., McKnight, W., . . . Ongini, E. 
(2011). Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by 
inducing dysbiosis. Gastroenterology, 141(4), 1314-1322, 1322 e1311-1315. 
doi:10.1053/j.gastro.2011.06.075 
Wallace, K. L., Zheng, L. B., Kanazawa, Y., & Shih, D. Q. (2014). Immunopathology of 
inflammatory bowel disease. World J Gastroenterol, 20(1), 6-21. 
doi:10.3748/wjg.v20.i1.6 
Waller, S. L. (1973). Prostaglandins and the gastrointestinal tract. Gut, 14(5), 402-417.  
Walsh, D. A., & Van Patten, S. M. (1994). Multiple pathway signal transduction by the cAMP-
dependent protein kinase. FASEB J, 8(15), 1227-1236.  
Walton, K. D., Mishkind, D., Riddle, M. R., Tabin, C. J., & Gumucio, D. L. (2018). Blueprint for 
an intestinal villus: Species-specific assembly required. Wiley Interdiscip Rev Dev Biol, 
7(4), e317. doi:10.1002/wdev.317 
Wang, Z. M., & Celsi, G. (1993). Glucocorticoids differentially regulate the mRNA for 
Na+,K(+)-ATPase isoforms in infant rat heart. Pediatr Res, 33(1), 1-4. 
doi:10.1203/00006450-199301000-00001 
160 
Wang, Z. M., Yasui, M., & Celsi, G. (1994). Glucocorticoids regulate the transcription of Na(+)-
K(+)-ATPase genes in the infant rat kidney. Am J Physiol, 267(2 Pt 1), C450-455. 
doi:10.1152/ajpcell.1994.267.2.C450 
Watanabe, Y., Kawakami, K., Hirayama, Y., & Nagano, K. (1993). Transcription factors 
positively and negatively regulating the Na,K-ATPase alpha 1 subunit gene. J Biochem, 
114(6), 849-855.  
Wenzl, H. H. (2012). Diarrhea in chronic inflammatory bowel diseases. Gastroenterol Clin 
North Am, 41(3), 651-675. doi:10.1016/j.gtc.2012.06.006 
Wild, G. E., & Thomson, A. B. (1995). Na(+)-K(+)-ATPase alpha 1- and beta 1-mRNA and 
protein levels in rat small intestine in experimental ileitis. Am J Physiol, 269(5 Pt 1), 
G666-675. doi:10.1152/ajpgi.1995.269.5.G666 
Wilson, P. D., Devuyst, O., Li, X., Gatti, L., Falkenstein, D., Robinson, S., . . . Burrow, C. R. 
(2000). Apical plasma membrane mispolarization of NaK-ATPase in polycystic kidney 
disease epithelia is associated with aberrant expression of the beta2 isoform. Am J Pathol, 
156(1), 253-268.  
Woo, A. L., James, P. F., & Lingrel, J. B. (2000). Sperm motility is dependent on a unique 
isoform of the Na,K-ATPase. J Biol Chem, 275(27), 20693-20699. 
doi:10.1074/jbc.M002323200 
Woodward, D. F., Pepperl, D. J., Burkey, T. H., & Regan, J. W. (1995). 6-Isopropoxy-9-
oxoxanthene-2-carboxylic acid (AH 6809), a human EP2 receptor antagonist. Biochem 
Pharmacol, 50(10), 1731-1733.  
Wu, J., Akkuratov, E. E., Bai, Y., Gaskill, C. M., Askari, A., & Liu, L. (2013). Cell signaling 
associated with Na(+)/K(+)-ATPase: activation of phosphatidylinositide 3-kinase IA/Akt 
by ouabain is independent of Src. Biochemistry, 52(50), 9059-9067. 
doi:10.1021/bi4011804 
Yang, H., Wang, X., Xiong, X., & Yin, Y. (2016). Energy metabolism in intestinal epithelial 
cells during maturation along the crypt-villus axis. Sci Rep, 6, 31917. 
doi:10.1038/srep31917 
Yokomizo, T., Izumi, T., Chang, K., Takuwa, Y., & Shimizu, T. (1997). A G-protein-coupled 
receptor for leukotriene B4 that mediates chemotaxis. Nature, 387(6633), 620-624. 
doi:10.1038/42506 
161 
Yokomizo, T., Kato, K., Terawaki, K., Izumi, T., & Shimizu, T. (2000). A second leukotriene 
B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological 
disorders. J Exp Med, 192(3), 421-432.  
Yoo, D., Lo, W., Goodman, S., Ali, W., Semrad, C., & Field, M. (2000). Interferon-gamma 
downregulates ion transport in murine small intestine cultured in vitro. Am J Physiol 
Gastrointest Liver Physiol, 279(6), G1323-1332. doi:10.1152/ajpgi.2000.279.6.G1323 
Yuan, Z., Cai, T., Tian, J., Ivanov, A. V., Giovannucci, D. R., & Xie, Z. (2005). Na/K-ATPase 
tethers phospholipase C and IP3 receptor into a calcium-regulatory complex. Mol Biol 
Cell, 16(9), 4034-4045. doi:10.1091/mbc.e05-04-0295 
Zhong, Z., Davidescu, A., Ehren, I., Ekberg, K., Jornvall, H., Wahren, J., & Chibalin, A. V. 
(2005). C-peptide stimulates ERK1/2 and JNK MAP kinases via activation of protein 
kinase C in human renal tubular cells. Diabetologia, 48(1), 187-197. doi:10.1007/s00125-
004-1602-5 
Ziegelhoffer, A., Kjeldsen, K., Bundgaard, H., Breier, A., Vrbjar, N., & Dzurba, A. (2000). 
Na,K-ATPase in the myocardium: molecular principles, functional and clinical aspects. 














APPENDIX A: INSTITUTIONAL REVIEW BOARD APPROVAL 
 
163 
APPENDIX B: ABBREVIATIONS  
AA Arachidonic acid 
AAMs Arachidonic acid metabolites 
ADP  Adenosine Diphosphate 
ALP Alkaline phosphatase activity 
ANOVA Analysis of Variance  
ASBT Apical sodium bile acid transporter 
ATF Activating transcription factor 
ATK Arachidonyl Trifluoromethyl Ketone 
ATP  Adenosine Triphosphate 
B0AT1 System B0 amino acid transporter 1 
BBM Brush border membrane 
BLM Basolateral membrane  
BSA Bovine serum albumin 
C-terminal COOH-terminal 
Ca2+ Calcium ion 
CaCl2 Calcium chloride  
Cal-c Calphostin-C 
cAMP Cyclic adenosine monophosphate 
CD Crohn’s Disease  
cDNA Complementary Deoxyribonucleic acid   
CFTR Cystic fibrosis transmembrane conductance regulator 
cGMP Cyclic guanosine monophosphate 
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Cl- Chloride ion 
COX Cyclooxygenase 
CRE cAMP response element  
CREB  cAMP response element binding protein 
CTF Cardiotonic factor  
CysLT Cysteinyl leukotriene receptors  
DMEM Dulbecco’s modified eagle media  
DMSO Dimethyl sulfoxide  
DMT1 Divalent metal transporter 1 
ECL Enhanced chemiluminescence 
EGFR Epidermal growth factor receptor 
ERK Extracellular signal-regulated kinases 
GI  Gastrointestinal 
GPCR G-protein-coupled receptors 
GPI  Glycosylphosphatidylinositol 
GRE Glucocorticoid response element 
H+ Hydrogen ion 
HCl Hydrochloric acid  
HCO3- Bicarbonate ion 
HEPES 4-(2-hydroxyethyl-1-piperazineethanesulfonic acid) 
HETEs Hydroxy eicosatetraenoic acids 
HIF  Hypoxic inducing factors 
HPETEs Hydroperoxyeicosateraenoic acids 
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HRE  Hypoxia response element  
HRP Horse radish peroxide  
IBD Inflammatory Bowel Disease 
ICC Immunocytochemistry  
IEC Intestinal epithelial cells 





IP3R Inositol triphosphate receptor  
 Isc Short-circuit current 
K+ Potassium ion 
KCl Potassium chloride 
kDa Kilo Dalton 
Km Michaelis-Menten constant 
LOX Lipoxygenase 
LT Leukotriene 
LTB4 Leukotriene B4 
LTC4 Leukotriene C4 
LTD4 Leukotriene D4 
LTE4 Leukotriene E4 
LTR Leukotriene receptor 
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LXA4 Lipoxins A4 
LXB4 Lipoxins B4 
M Molar  
MAPK Microtubule associated protein kinase 
MgCl2 Magnesium chloride  
MgSO4 Magnesium sulphate  
mM Millimolar 
MMC  Migrating motor complex 
MRE Mineralocorticoid response element 
mRNA Messenger Ribonucleic acid  
MTT 3-(4,5-dimethylthaizol-2-yl)-2,5-diphenlytetrazolium bromide 
N-terminal NH2-terminal 
N/A Not available  
Na-K-ATPase  Sodium Potassium Adenosine Triphosphate 
Na+ Sodium ion 
NaCl Sodium chloride 
NAcT Sodium alanine co-transporter 
NaHCO3 Sodium bicarbonate 
NaOH Sodium hydroxide  
NB Northern blotting 
NHE Na-Hydrogen exchanger  
NSAID Nonsteroidal inflammatory drugs  
OD Optical Density 
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OMG O-Methyl Glucose  
PBS Phosphate buffer saline 
PG  Prostaglandin 
PGD2 Prostaglandin D2 
PGE2 Prostaglandin E2 
PGF2 Prostaglandin F2 
PGG2 Prostaglandin G2 
PGH2 Prostaglandin H2 
PGI2 Prostacyclin I2 
PGRE  Prostaglandin response element 
Pi Inorganic phosphate  
PI3K Phosphoinositide 3-kinase 
PKA  Protein kinase A   
PKC  Protein kinase C 
PKG Protein kinase G     
PLA2 Phospholipase A2  
PLC Phospholipase C 
PMA Phorbol 12-myristate 13-acetate 
PO42- Phosphate ion  
PRE Progesterone element  
PRX Piroxicam 
PTK Protein tyrosine kinase 
PTP Protein tyrosine phosphatase  
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qRT-PCR Quantitive real time -Polymerase chain reaction 
RB+ Rubidium ion 
RbCl Rubidium chloride 
ROS Reactive oxygen species  
Rp-cAMP Rp-Cyclic adenosine monophosphate 
SBD  Smad binding domain 
SDS Sodium dodecyl sulphate  
SEM Standard error of mean 
Ser Serine  
SFM Serum free medium 
SGLT1 Sodium-Glucose Transporter 1 
SN2 System N transporter 2 
SO42- Sulphate ion 
Sp Specificity protein 
Src Sarcoma  
STAT Signal transducer and activator of transcription 
TBS Tris buffer saline  
TBST Tris buffer saline tween20 
TF Transcription Factor 
TJ Tight junction 
TNF-a Tumor necrosis factor-a 
TRE  Thyroid response elements 
TXA2 Thromboxane A2 
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TXB2 Thromboxane B2 
Tyr Tyrosine 
UC Ulcerative colitis  
Vmax Maximum rate of reaction 
WB Western blot  
WB-PM Western blot in plasma membrane 
WB-WC Western blot in Whole cell 
ZEB  Zinc finger E-Box Binding Homeobox 1  
ZO Zonula occludens 
μM Micromolar  
­ Up-regulation in in activity and expression 
¯ Down regulation in activity and expression 
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